Filed
Pursuant to Rule 424(b)(3)
Registration No. 333-157937
OPPENHEIMER HOLDINGS
INC.
PROPOSED DOMESTICATION — YOUR VOTE IS VERY
IMPORTANT
Dear Shareholders:
We are furnishing this management proxy circular to shareholders
of Oppenheimer Holdings Inc. in connection with the solicitation
of proxies by our management for use at an Annual and Special
Meeting of our shareholders. The meeting will be held on
May 8, 2009 at 10:00 a.m. (Toronto time), at the
Toronto Board of Trade, Rooms A/B/C/D, 100 King Street
West, Toronto, Ontario.
The purpose of the meeting is to (i) obtain shareholder
approval to change our jurisdiction of incorporation from the
federal jurisdiction of Canada to the State of Delaware in the
United States of America through the adoption of a certificate
of corporate domestication and a new certificate of
incorporation, (ii) elect nine directors,
(iii) appoint PricewaterhouseCoopers LLP as our auditors
and authorize the Board of Directors and Audit Committee to fix
the auditors’ remuneration, and (iv) receive our 2008
Annual Report.
We believe that our domestication will firmly and unambiguously
establish us as a U.S. corporation, which will level the playing
field with our principal competitors and assist us in achieving
our strategic goals. By domiciling in the United States, we may
enhance shareholder value over the long term with greater
acceptance in the capital markets and improved marketability of
our Class A non-voting shares. In addition, the change of
jurisdiction will provide us with tax efficiencies, among other
benefits, and potentially make us eligible for U.S. government
financial programs. We chose the State of Delaware to be our
domicile because the more favorable corporate environment
afforded by Delaware will help us compete effectively with other
public companies (many of which are incorporated in Delaware) in
raising capital and attracting and retaining skilled and
experienced personnel.
If we complete the domestication, we will continue our legal
existence in Delaware as if we had originally been incorporated
under Delaware law. In addition, each outstanding Class A
non-voting share and Class B voting share of Oppenheimer
Holdings Inc. as a Canadian corporation will then represent one
share of Class A Non-Voting Common Stock and Class B
Voting Common Stock, as applicable, of Oppenheimer Holdings Inc.
as a Delaware corporation. Our Class A non-voting shares
are currently traded on the New York Stock Exchange under the
symbol “OPY.” Following the completion of our
domestication, our Class A non-voting shares will continue
to be listed as shares of Class A Non-Voting Common Stock
on the New York Stock Exchange under the symbol “OPY.”
The proposal for domestication is subject to approval by at
least two-thirds of the votes cast by the holders of our
Class A non-voting shares and Class B voting shares,
voting together as a single class, whether in person or by proxy
at a meeting if a quorum, or a majority of the total outstanding
Class A non-voting shares and Class B voting shares,
are present. Dissenting shareholders have the right to be paid
the fair value of their shares under Section 190 of the
Canada Business Corporations Act. Our Board of Directors has
reserved the right to terminate or abandon our domestication at
any time prior to its effectiveness, notwithstanding shareholder
approval, if it determines for any reason that the consummation
of our domestication would be inadvisable or not in our and your
best interests. If approved by our shareholders, it is
anticipated that the domestication will become effective on or
about May 11, 2009 or as soon as practicable after the
meeting of our shareholders.
Your existing certificates representing your Oppenheimer
Holdings Inc. Class A non-voting shares and Class B
voting shares will represent the same number of the same class
of shares of our common stock after the domestication without
any action on your part. You will not have to exchange any share
certificates. We will issue new certificates to you representing
shares of capital stock of Oppenheimer Holdings Inc. as a
Delaware corporation upon a transfer of the shares by you or at
your request.
The accompanying management proxy circular provides a detailed
description of our proposed domestication and other information
to assist you in considering the proposals on which you are
asked to vote. We urge you to review this information carefully
and, if you require assistance, to consult with your financial,
tax or other professional advisers.
Our Board of Directors unanimously recommends that you vote
FOR each of the proposals described in this management proxy
circular, including the approval of our domestication.
Your vote is very important. Whether or not you plan to
attend the meeting, we ask that you indicate the manner in which
you wish your shares to be voted and sign and return your proxy
as promptly as possible in the enclosed envelope so that your
vote may be recorded. If your shares are registered in your
name, you may vote your shares in person if you attend the
meeting, even if you send in your proxy.
We appreciate your continued interest in our company.
Very truly yours,
Chairman and Chief Executive Officer
These securities involve a high degree of risk. See
“Risk Factors” beginning on page 12 of
this management proxy circular for a discussion of specified
matters that should be considered.
Neither the Securities and Exchange Commission nor any state
securities commission, or similar authority in Canada, has
approved or disapproved of these securities or determined if the
management proxy circular/prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.
This management proxy circular/prospectus is dated
April 2, 2009 and is first being mailed to shareholders on
or about April 3, 2009.
RISK
FACTORS
You should carefully consider the risks and uncertainties
described below, together with all of the other information and
risks included in, or incorporated by reference into, this
Circular, including our consolidated financial statements and
the related notes thereto incorporated by reference into this
Circular from our Annual Report on
Form 10-K
for the year ended December 31, 2008, before making a
decision whether to vote for the proposals described in this
Circular. The following risk factors and other information in
this Circular contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of
1934, as amended. This summary does not discuss all aspects of
U.S. or Canadian tax consequences that may apply in connection
with the domestication. In addition, please note that other tax
consequences may arise under applicable law in other countries.
If any of the following events or developments described below
actually occur, the business, financial condition or operating
results of Oppenheimer Holdings could be materially harmed. This
could cause the trading price of the Class A Non-Voting
Common Stock of Oppenheimer Holdings to decline, and you may
lose all or part of your investment.
Risks
Relating to the Domestication
The
amount of corporate tax payable by us will be affected by the
value of our property on the date of the
domestication.
For Canadian tax purposes, on the date of the domestication we
will be deemed to have a year end and will also be deemed to
have sold all of our property and received the fair market value
for those properties. We do not expect that we will be subject
to any Canadian taxation on this deemed disposition because of
the availability of an election that can be made pursuant to
subsection 93(1) of the ITA, as better described below under the
heading “Proposal 1 — The
Domestication — Canadian Tax Considerations”.
We will be subject to an additional corporate emigration tax
equal to 5% of the amount by which the fair market value of our
property, net of liabilities, exceeds the
paid-up
capital of our issued and outstanding shares. We have completed
certain calculations of our tax accounts with the assistance of
professional advisors, and assuming the fair market value of our
property reflects the market price of our stock, a stock price
of $13.50 per Class A Share and that the exchange rate of
the Canadian dollar to the U.S. dollar is CDN $1.00 equals
$0.80, we have estimated that this corporate emigration tax
would not exceed $4.0 million. The amount of such corporate
emigration tax will be increased (or reduced) by any increase
(or decrease) in the value of our stock price, and it is
possible that the Canadian federal tax authorities may not
accept our valuations or calculations of our tax accounts, which
may result in additional taxes payable as a result of the
domestication. As is customary, when a Canadian federal tax
liability depends largely on factual matters, we have not
applied to the Canadian federal tax authorities for a ruling on
this matter and do not intend to do so.
We are of the view that, for the foreseeable future, our
principal undertaking will be carrying on a financial services
business rather than an investment business for purposes of the
proposed “foreign investment entity” tax rules under
the ITA. As such, we should not qualify as a foreign investment
entity, and Canadian resident shareholders should not be
adversely affected by the proposed tax rules applicable to a
foreign investment entity. However, the determination of whether
or not we are a foreign investment entity must be made on an
annual basis at the end of each taxation year.
If the
IRS does not agree with the our calculation of the “all
earnings and profits amount” attributable to a
shareholder’s shares in the Corporation, Oppenheimer
Holdings’ stockholders may owe income taxes as a result of
the domestication.
We believe that the domestication will qualify as a tax-free
reorganization for U.S. federal income tax purposes and that
based upon a review of our earnings and profits, no U.S.
shareholder should be subject to U.S. federal income tax as a
result of the domestication. Based on a review of information
available to us, we believe that Oppenheimer Holdings Inc. has a
deficit in “earnings and profits.” As a result, no
U.S. shareholder should have a positive “all earnings and
profits amount” attributable to such shareholder’s
shares of the Corporation, and therefore no U.S. shareholder
should be required to include any such amount in income as a
result of the domestication. We did not have all historical
financial information since our incorporation in 1933 available
when calculating our earnings and profits, although we have
reviewed financial information dating back to 1945. It is
possible, although we believe highly unlikely, that we
recognized earnings and profits in taxable years for which we do
not have complete information. The amount of any such earnings
and profits would negatively impact our calculations. However,
based on the substantial amount of historical financial
information we have since 1945, our limited activity at the
holding company level and the size of our existing earnings and
profits deficit, we do not believe that a U.S. shareholder
should have a positive “all earnings and profits”
amount attributable to such shareholder’s shares in the
Corporation. However, if the IRS does not agree with our
calculation of the
12
“all earnings and profits amount”, a shareholder may
be subject to adverse U.S. federal income tax consequences on
the domestication. Any U.S. shareholder who owns, directly or
indirectly, 10% or more of the combined voting power of all
classes of our common stock at the time of the domestication
will have to recognize income, categorized as dividend income
for U.S. federal income tax purposes, equal to the “all
earnings and profits amount,” within the meaning of
Treasury
Regulation Section 1.367(b)-2,
allocable to such U.S. shareholder’s shares in the
Corporation. Any U.S. shareholder who owns less than 10% of the
combined voting power of all classes of our common shares and
whose shares have a fair market value of $50,000 or more on the
date of the domestication will, assuming the deemed dividend
election is made by such U.S. shareholder, have income in an
amount equal to the lesser of the gain, if any, on the
domestication or “all earnings and profits amount”
attributable to his shares in Oppenheimer Holdings Inc. U.S.
shareholders who own less than 10% of the combined voting power
of all classes of our common shares and whose shares have a fair
market value below $50,000 are not subject to tax on the
domestication. For additional information on the U.S. federal
income tax consequences of the domestication, see
“United States Federal Income Tax Consequences”.
The
rights of our shareholders under Canadian law will differ from
their rights under Delaware law, which will, in some cases,
provide less protection to shareholders following the
domestication.
Upon consummation of the domestication, our shareholders will
become stockholders of a Delaware corporation. There are
material differences between the CBCA and the DGCL and our
current and proposed charter and by-laws. For example, under
Canadian law, many significant corporate actions such as
amending a corporation’s articles of incorporation or
consummating a merger require the approval of at least
two-thirds of the votes cast by shareholders, whereas under
Delaware law, all that is required is a simple majority of the
total voting power of all of those entitled to vote on the
matter. Furthermore, shareholders under Canadian law are
entitled to appraisal rights under a number of extraordinary
corporate actions, including an amalgamation with another
unrelated corporation, certain amendments to a
corporation’s articles of incorporation or the sale of all
or substantially all of a corporation’s assets, whereas
under Delaware law, stockholders are only entitled to appraisal
rights for certain mergers or consolidations. As shown by the
examples above, if the domestication is approved, our
shareholders, in certain circumstances, may be afforded less
protection under the DGCL than they had under the CBCA. See
“Proposal 1 — The
Domestication — Comparison of Shareholder
Rights.”
The
proposed domestication will result in additional direct and
indirect costs whether or not completed.
The domestication will result in additional direct costs. We
will incur attorneys’ fees, accountants’ fees, filing
fees, mailing expenses and financial printing expenses in
connection with the domestication. The domestication may also
result in certain indirect costs by diverting the attention of
our management and employees from the
day-to-day
management of the business, which may result in increased
administrative costs and expenses.
13
FORWARD-LOOKING
STATEMENTS
From time to time, we may publish “forward looking
statements” within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act. We
generally identify forward-looking statements with the words
“plan,” “expect,” “anticipate,”
“estimate,” “may,” “will,”
“should” and similar expressions. We base these
forward-looking statements on our current expectations and
projections about future events.
We caution readers that a variety of factors could cause our
actual results to differ materially from those discussed in, or
implied by, these forward-looking statements. These risks and
uncertainties, many of which are beyond our control, include,
but are not limited to: (i) transaction volume in the
securities markets, (ii) the volatility of the securities
markets, (iii) fluctuations in interest rates,
(iv) changes in regulatory requirements which could affect
the cost and method of doing business, (v) fluctuations in
currency rates, (vi) general economic conditions, both
domestic and international, (vii) changes in the rate of
inflation and the related impact on the securities markets,
(viii) competition from existing financial institutions and
other participants in the securities markets, (ix) legal
developments affecting the litigation experience of the
securities industry and us, including developments arising from
the failure of the Auction Rate Securities markets,
(x) changes in federal and state tax laws which could
affect the popularity of products we sell, (xi) the
effectiveness of efforts to reduce costs and eliminate overlap,
(xii) war and nuclear confrontation, (xiii) our
ability to achieve our business plan, (xiv) corporate
governance issues, (xv) the impact of the credit crisis on
business operations, (xvi) the effect of bailout and
related legislation, (xvii) the consolidation of the
banking and financial services industry, (xviii) the
effects of the economy on our ability to find and maintain
financing options and liquidity, (xix) credit, operations,
legal and regulatory risks, and (xx) risks related to
foreign operations. Many factors could cause our actual results,
performance or achievements to be materially different from any
results, performance or achievements that may be expressed or
implied by such forward-looking statements including those which
are discussed under the heading “Risk Factors”
included elsewhere herein and incorporated by reference into
this Circular from Item 1A of our Annual Report on
Form 10-K
for the year ended December 31, 2008. Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward-looking statements prove incorrect,
actual results may vary materially from those described in or
incorporated by reference into this Circular as intended,
planned, anticipated, believed, estimated or expected. We do not
intend, and do not assume, any obligation to update these
forward-looking statements.
14
THE
MEETING
Solicitation
of Proxies
This Circular is forwarded to our Class A Shareholders and
Class B Shareholders in connection with the solicitation of
proxies by our management from the Class A Shareholders and
Class B Shareholders for use at our Annual and Special
Meeting of Shareholders to be held on May 8, 2009, at the
hour of 10:00 a.m. (Toronto time) at the Toronto Board of
Trade, Rooms A/B/C/D, 100 King Street West, Toronto,
Ontario and at any adjournments thereof for the purposes set
forth in the Notice of Meeting, which accompanies this Circular.
This Circular is dated April 2, 2009 and is first being
mailed to shareholders on or about April 3, 2009.
The record date for the determination of shareholders entitled
to receive notice of the Meeting is March 30, 2009. In
accordance with the provisions of the CBCA, we will prepare a
list of the Class A Shareholders and Class B
Shareholders as of the record date. Class B Shareholders
named in the list will be entitled to vote the Class B
Shares on all matters to be voted on at the Meeting, and the
Class A Shareholders named in the list will only be
entitled to vote the Class A Shares to approve the special
resolution for the domestication and the certificate of
incorporation of Oppenheimer Holdings (Proposal 1 in the
Notice of Meeting).
It is planned that the solicitation will be initially by mail,
but proxies may also be solicited by our employees. The cost of
such solicitation, estimated to be approximately $25,000, will
be borne by us.
No person is authorized to give any information or to make any
representations other than those contained in this Circular and,
if given or made, such information or representations should not
be relied upon as having been authorized by us. The delivery of
this Circular shall not, under any circumstances, create an
implication that there has not been any change in the
information set forth or incorporated by reference herein since
the date of this Circular. Except as otherwise stated, the
information contained in this Circular is given as of
April 2, 2009.
We have distributed copies of our Annual Report for the year
ended December 31, 2008, the Notice of Meeting, this
Circular, and forms of proxy for use by the Class A
Shareholders and Class B Shareholders to intermediaries
such as clearing agencies, securities dealers, banks and trust
companies or their nominees for distribution to our
non-registered shareholders whose shares are held by or in the
custody of such intermediaries. Intermediaries are required to
forward these documents to non-registered Class A
Shareholders and Class B Shareholders. The solicitation of
proxies from non-registered Class A Shareholders and
Class B Shareholders will be carried out by the
intermediaries, or by us if the names and addresses of
Class A Shareholders and Class B Shareholders are
provided by the intermediaries. Non-registered Class A
Shareholders and Class B Shareholders who wish to file
proxies should follow the instructions of their intermediary
with respect to the procedure to be followed. Generally,
non-registered Class A Shareholders and Class B
Shareholders will either: (i) be provided with a proxy
executed by the intermediary, as the registered shareholder, but
otherwise uncompleted and the non-registered holder may complete
the proxy and return it directly to our transfer agent; or
(ii) be provided with a request for voting instructions by
the intermediary, as the registered shareholder, and then the
intermediary must send to our transfer agent an executed proxy
form completed in accordance with any voting instructions
received by it from the non-registered holder and may not vote
in the event that no instructions are received.
Class A
Shares and Class B Shares
We have authorized and issued Class A Shares and
Class B Shares which are equal in all respects except that
the holders of Class A Shares, as such, are not entitled to
vote at meetings of our shareholders except as entitled to vote
by law, pursuant to our Articles of Continuance or as may be
required by regulatory authorities. Class A Shareholders
are not entitled to vote the Class A Shares owned or
controlled by them on the matters identified in the Notice of
Meeting to be voted on, except for the proposal to approve the
special resolution for our change of jurisdiction and approval
of the certificate of incorporation for Oppenheimer Holdings
(Proposal 1 in the Notice of Meeting).
Generally, Class A Shareholders are afforded the
opportunity to receive notices of all meetings of shareholders
and to attend and speak at such meetings. Class A
Shareholders are also afforded the opportunity to receive all
informational documentation sent to the Class B
Shareholders.
Class B Shareholders are entitled to one vote at all
meetings of shareholders for each Class B Share held as of
the record date for the meeting, except meetings at which only
the holders of a specified class of shares other than the
Class B Shares are entitled to vote.
15
Under the CBCA, in order to approve the change of jurisdiction,
we require affirmative votes, whether in person or by proxy,
from at least two-thirds of the votes cast by the holders of
Class A Shares and Class B Shares, voting together as
a single class at the Meeting if a quorum, or a majority of the
total outstanding Class A Shares and Class B Shares,
is present.
In the event of either a “take-over bid” or an
“issuer bid” (as those terms are defined in the
Securities Act of Ontario) being made for the Class B
Shares and no corresponding offer being made to purchase
Class A Shares, the Class A Shareholders would have no
right under our articles or under any applicable statute to
require that a similar offer be made to them to purchase their
Class A Shares.
Appointment
and Revocation of Proxies
Albert G. Lowenthal and, failing him, Elaine K. Roberts, or the
Management Nominees, has been appointed by the Board of
Directors to serve as the proxy for the shareholders at the
Meeting.
Shareholders have the right to appoint persons, other than the
Management Nominees, who need not be shareholders, to represent
them at the Meeting. To exercise this right, the shareholder may
insert the name of the desired person in the blank space
provided in the form of proxy accompanying this Circular or may
submit another form of proxy.
Proxies must be deposited with our transfer agent, CIBC Mellon
Trust Company, at its address P.O. Box 7010, Adelaide
Street Postal Station, Toronto, Ontario, Canada M5C 2W9, no
later than 48 hours prior to the commencement of the Meeting in
order for the proxies to be used at the Meeting. If you do not
deposit your proxy with the transfer agent at least 48 hours
prior to the commencement of the Meeting, your proxy will not be
used.
Class A Shares represented by properly executed proxies
will be voted by the Management Nominees on any ballot that may
be called for, unless the shareholder has directed otherwise,
for the proposal to approve the special resolution authorizing
the change of jurisdiction and approval of the certificate of
incorporation of Oppenheimer Holdings (Proposal 1 in the
Notice of Meeting).
Class B Shares represented by properly executed proxies
will be voted by the Management Nominees on any ballot that may
be called for, unless the shareholder has directed otherwise,
(i) for the proposal to approve the special resolution
authorizing the change of jurisdiction and the approval of the
certificate of incorporation of Oppenheimer Holdings
(Proposal 1 in the Notice of Meeting), (ii) for the
election of the nominated Directors (Proposal 2 in the
Notice of Meeting), and (iii) for the appointment of
auditors and authorizing the Board of Directors and the Audit
Committee to fix the remuneration of the auditors
(Proposal 3 in the Notice of Meeting).
Each form of proxy confers discretionary authority with respect
to amendments or variations to matters identified in the Notice
of Meeting to which the proxy relates and other matters which
may properly come before the Meeting. Management knows of no
matters to come before the Meeting other than the matters
referred to in the Notice of Meeting. However, if matters which
are not known to management should properly come before the
Meeting, the proxies will be voted on such matters in accordance
with the best judgment of the person or persons voting the
proxies.
A shareholder who has given a proxy has the power to revoke it
prior to the commencement of the Meeting by depositing an
instrument in writing executed by the shareholder or by the
shareholder’s attorney either at our registered office at
any time up to and including the last business day preceding the
day of the Meeting, or any adjournment thereof, or with the
Chairman of the Meeting on the day of the Meeting or any
adjournment thereof or in any other manner permitted by law. A
shareholder who has given a proxy has the power to revoke it
after the commencement of the Meeting as to any matter on which
a vote has not been cast under the proxy by delivering written
notice of revocation to the Chairman of the Meeting.
A shareholder who has given a proxy may also revoke it by
signing a form of proxy bearing a later date and returning such
proxy to our Secretary at our registered office prior to the
commencement of the Meeting.
Abstentions and broker non-votes will have no effect with
respect to the matters to be acted upon at the Meeting.
16
PROPOSALS TO
BE ACTED UPON
The Board of Directors recommends that the shareholders approve
a special resolution authorizing us to make an application for a
continuance under Section 188 of the CBCA to change our
jurisdiction of incorporation from the federal jurisdiction of
Canada to the State of Delaware, United States of America, by
way of a domestication under Section 388 of the DGCL, and
to approve the certificate of incorporation authorized in the
special resolution to be effective as of the date of our
domestication. Under the CBCA, in order to approve the
continuance, the special resolution requires affirmative votes,
in person or by proxy, from at least two-thirds of all the votes
cast by the Class A Shareholders and the Class B
Shareholders voting together as a single class at the Meeting if
a quorum, or a majority of the total outstanding Class A
Shares and Class B Shares is present.
The Board of Directors recommends that the shareholders vote
FOR the approval of the special resolution authorizing us to
change our jurisdiction of incorporation to Delaware and to
approve the certificate of incorporation of Oppenheimer
Holdings.
Our Articles of Continuance provide that our Board of Directors
consists of no less than five and no more than fifteen directors
to be elected annually. The term of office for each director is
from the date of the meeting at which the director is elected
until the close of the next annual meeting of shareholders or
until his or her successor is duly elected or appointed, unless
his or her office is earlier vacated in accordance with our
by-laws.
The Nominating and Corporate Governance Committee has
recommended, and the directors have determined, that nine
directors are to be elected at the Meeting. Management does not
contemplate that any of the nominees named below will be unable
to serve as a director, but, if such an event should occur for
any reason prior to the Meeting, the Management Nominees reserve
the right to vote for another nominee or nominees in their
discretion. The Board of Directors, upon the recommendation of
the Nominating and Corporate Governance Committee, recommends
the following nominees for election as directors, in accordance
with the Nominating and Corporate Governance Committee Charter
(available at www.opco.com): J.L. Bitove, R. Crystal, W.
Ehrhardt, M.A.M. Keehner, A.G. Lowenthal, K.W. McArthur, A.W.
Oughtred, E.K. Roberts and B. Winberg. The Nominating and
Corporate Governance Committee has reported that it is satisfied
that each of the nominees is fully able and fully committed to
serve the best interests of our shareholders. The election of
the directors nominated requires the affirmative vote of a
simple majority of the Class B Shares voted at the meeting.
Information regarding each of the director nominees and our
executive officers can be found in
“Management — Director Nominees and Executive
Officers.”
The Board of Directors recommends that the Class B
Shareholders vote FOR the election of J.L. Bitove, R. Crystal,
W. Ehrhardt, M.A.M. Keehner, A.G. Lowenthal, K.W. McArthur, A.W.
Oughtred, E.K. Roberts and B. Winberg as directors.
|
|
|
3.
|
APPOINTMENT
OF AUDITORS
|
The Audit Committee has nominated PricewaterhouseCoopers LLP for
reappointment as our auditors for the 2009 fiscal year. The
appointment of the auditors and the authorization of the Board
of Directors and the Audit Committee to fix the auditors’
remuneration requires the affirmative vote of a simple majority
of the Class B Shares voted at the Meeting.
The Board of Directors recommends that the Class B
Shareholders vote FOR the appointment of PricewaterhouseCoopers
LLP as our auditors.
In addition, our consolidated financial statements and
“Management’s Discussion and Analysis of Financial
Condition and Results of Operations” for the year ended
December 31, 2008 are included in the Annual Report on
Form 10-K,
which has been mailed to our shareholders with the Circular.
These consolidated financial statements are also available on
our website at www.opco.com and regulatory websites at
www.sedar.com (for SEDAR filings) or www.sec.gov
(for EDGAR filings).
17
PROPOSAL NO. 1 —
THE DOMESTICATION
General
The Board of Directors is proposing to change our jurisdiction
of incorporation from the federal jurisdiction of Canada to the
State of Delaware through a transaction called a
“continuance” under Section 188 of the CBCA, also
referred to as a “domestication” under
Section 388 of the DGCL, and approve a new certificate of
incorporation to be effective on the date of the domestication.
We will become subject to the DGCL on the date of our
domestication, but will be deemed for the purposes of the DGCL
to have commenced our existence in Delaware on the date we
originally commenced our existence in Canada. Under the DGCL, a
corporation becomes domesticated in Delaware by filing a
certificate of corporate domestication and a certificate of
incorporation for the corporation being domesticated. The Board
of Directors has unanimously approved our domestication and the
related certificate of incorporation of Oppenheimer Holdings,
believes it to be in our best interests and in the best
interests of our shareholders, and unanimously recommends
approval of the domestication and the approval of the
certificate of incorporation of Oppenheimer Holdings to our
shareholders.
The domestication will be effective on the date set forth in the
certificate of corporate domestication and the certificate of
incorporation, as filed with the office of the Secretary of
State of the State of Delaware. Thereafter, we will be subject
to the certificate of incorporation filed in Delaware, a copy of
which is attached to this Circular as Exhibit C. We will be
discontinued in Canada as of the date shown on the certificate
of discontinuance issued by the Director appointed under the
CBCA, which we expect to be the date of domestication in
Delaware. The Class A Shares will continue to be listed on
the NYSE under the trading symbol “OPY” and we will
continue to be subject to the rules and regulations of the NYSE
and the obligations imposed by each securities regulatory
authority in the United States, including the SEC. We will
continue to file periodic reports with the SEC pursuant to the
Securities Exchange Act of 1934, as amended, or the Exchange
Act. Upon our domestication, our Board of Directors intends to
adopt by-laws, copies of which are attached to this Circular as
Exhibit D. A copy of Section 190 of the CBCA
addressing dissenters’ rights in connection with the
continuance is attached to this Circular as Exhibit E.
The domestication will not interrupt our corporate existence or
operations, or the trading market of the Class A Shares.
Each outstanding Class A Share and Class B Share at
the time of the domestication will remain issued and outstanding
as a share of Class A Non-Voting Common Stock or
Class B Voting Common Stock, as applicable, of Oppenheimer
Holdings after our corporate existence is continued from Canada
under the CBCA and domesticated in Delaware under the DGCL.
Following the completion of our domestication, the Class A
Shares will continue to be listed on the NYSE under the trading
symbol “OPY.”
Principal
Reasons for the Domestication
Our Board of Directors has determined that the domestication
will result in an overall simplification of our corporate
structure which is in our best interests and the best interests
of our shareholders. The Board of Directors believes that the
achievement of our strategic goals would be enhanced by our
clear and unambiguous identification as a U.S. corporation.
All of our significant operating businesses are located in, and
our operating businesses have been headquartered for over
25 years in the United States. We have voluntarily reported
under the Exchange Act for approximately 20 years. Most of
our shareholders reside in the United States and our
Class A Shares are listed exclusively on the NYSE. Despite
this connection with the United States, we believe we are not
uniformly perceived by investors, customers, lenders, employees
or potential strategic partners as a U.S. company. Our Board of
Directors believes that the absence of a clear U.S. identity may
prevent us from maximizing the opportunities and relationships
with investors, existing and potential customers, lenders and
potential partners, many of whom prefer to engage in business
with a U.S. entity. By changing our jurisdiction of
incorporation from Canada to Delaware, and also changing our
corporate headquarters from Toronto to New York, we will firmly
and unambiguously establish ourselves as a U.S. corporation.
This will level the playing field with our principal
competitors, most of whom are U.S. corporations.
The Board of Directors also believes that by domiciling in the
United States we may enhance shareholder value over the long
term with greater acceptance of us in the capital markets and
improved marketability of our Class A Shares. The
Class A Shares are not presently covered by securities
analysts either in Canada or the United States. We believe that
one reason for this lack of coverage is that our business
resides in the United States but our corporate parent does not.
We believe there is a greater likelihood of such coverage if we
move our domicile to the United States.
18
In addition to the foregoing, the Board of Directors believes
that being domiciled in the United States should increase our
flexibility to enter into certain types of mergers, acquisitions
and business combination transactions with other U.S.
corporations which, if we remain a Canadian corporation, could
be more difficult to accomplish due to adverse tax consequences.
Recent events in the credit markets of the United States have
created significant market imbalances and placed pressure on our
capital as well as that of many of our competitors. In
connection with these disruptions, the U.S. government has
introduced a number of programs intended to add liquidity to the
markets through providing funding to financial services firms.
In general, these programs have been viewed as being directed
more at companies organized in the United States than companies
organized outside the United States, and a move to the United
States should enhance our eligibility under these programs. One
of these programs is the Capital Purchase Program, or CPP,
announced by the U.S. Treasury under its Troubled Asset Relief
Program, or TARP. Under this program, to the extent funds remain
available or more funds are allocated in the future, we may be
eligible for a capital injection from the U.S. government, in
exchange for which we may be required to issue preferred stock
and warrants to purchase our Class A Shares. The
availability of the CPP and other federal programs, many of
which have been announced but have not been fully implemented,
could assist us in resolving issues arising from the failure of
the auction rate securities market, which has trapped our
clients in illiquid auction rate securities. Many of our
competitors have redeemed auction rate securities from their
customers and our failure to have done so presents a significant
issue for us with our clients and regulators. We have no
assurance that we would qualify for CPP or any other federal
program nor have we determined that we would participate in any
of these programs. Overall, though, we believe the domestication
would put us in a better overall position to participate in
available programs than if we remain domiciled outside the
United States.
The Board of Directors chose the State of Delaware to be our
domicile because it believes the more favorable corporate
environment afforded by Delaware will help us compete more
effectively with other public companies, many of which are
incorporated in Delaware, in raising capital and in attracting
and retaining skilled, experienced personnel. For many years,
Delaware has followed a policy of encouraging public companies
to incorporate in the state by adopting comprehensive corporate
laws that are revised regularly in response to developments in
modern corporate law and changes in business circumstances. The
Delaware courts are known for their considerable expertise in
dealing with complex corporate issues and providing
predictability through a substantial body of case law construing
Delaware’s corporate law. Coupled with an active bar known
for continually assessing and recommending improvements to the
DGCL, these factors add greater certainty in complying with
fiduciary responsibilities and assessing risks associated with
conducting business.
In considering its recommendation in favor of the domestication,
our Board of Directors weighed the estimated tax liability to us
arising from this transaction. See
“Proposal 1 — The
Domestication — United States and Canadian Income Tax
Considerations.” With the assistance of professional
advisors, we have reviewed our assets, liabilities,
paid-up
capital and other tax balances and assuming that the market
price of our Class A Shares does not exceed $13.50 per
share and that the exchange rate of the Canadian dollar to the
U.S. dollar is CDN $1.00=$0.80, it is anticipated that Canadian
income taxation arising from the domestication would not exceed
$4.0 million. Accordingly, due to the recent decline in the
share price of the Class A Shares, this potential tax
liability would be substantially less than it would have been if
the domestication had occurred in the past several years.
For the reasons set forth above, our Board of Directors believes
that the estimated benefits of domestication outweigh the
detriment attributable to our potential tax liability.
Effects
of the Domestication
There are material differences between Canadian corporate law
and Delaware corporate law with respect to shareholders’
rights, and Delaware law may offer shareholders more or less
protection depending on the particular matter. A detailed
overview of the material differences is set forth below.
Applicable Law. As of the effective date of
the domestication, our legal jurisdiction of incorporation will
be Delaware, and we will no longer be subject to the provisions
of the CBCA. All matters of corporate law will be determined
under the DGCL. We will retain our original incorporation date
in Canada as our date of incorporation for purposes of the DGCL.
Assets, Liabilities, Obligations, Etc. Under
Delaware law, as of the effective date of the domestication, all
of our assets, property, rights, liabilities and obligations
immediately prior to the domestication will continue to be our
assets, property, rights, liabilities and obligations. Canadian
corporate law ceases to apply to us on the date shown on the
19
certificate of discontinuance to be issued by the Director
appointed under the CBCA, which we expect to be the date of
domestication in Delaware. We will be thereafter become subject
to the obligations imposed under Delaware corporate law.
Business and Operations. The domestication, if
approved, will effect a change in the legal jurisdiction of
incorporation as of the effective date of the domestication, but
our business and operations will remain the same.
Officers
and Directors
Our Board of Directors currently consists of nine members, J.L.
Bitove, R. Crystal, W. Ehrhardt, M.A.M. Keehner, A.G. Lowenthal
(Chairman), K.W. McArthur, A.W. Oughtred, E.K. Roberts, and B.
Winberg. These directors have been nominated for election at the
Meeting, and subject to their re-election at the Meeting, the
Board of Directors will consist of the same nine individuals
after the domestication. Immediately following the
domestication, our officers will also be unchanged. Our officers
are A.G. Lowenthal (Chief Executive Officer), E.K. Roberts
(President, Treasurer) and D. McNamara (Secretary).
Treatment
of the Outstanding Capital Stock, Options and Warrants
The existing share certificates representing our Class A
Shares and Class B Shares will continue to represent shares
the same number of the same class of our common stock after the
domestication without any action on your part. You will not be
required to exchange any share certificates. We will only issue
new certificates to you representing shares of capital stock of
Oppenheimer Holdings upon a transfer of your shares or at your
request. Holders of our outstanding options and warrants will
continue to hold the same securities, which will remain
exercisable for an equivalent number of shares of the same class
of common stock of Oppenheimer Holdings, for the equivalent
exercise price per share, without any action by the holder.
Shareholder
Approval
The domestication is subject to various conditions, including
approval of the special resolution authorizing the domestication
and the approval of the certificate of incorporation of
Oppenheimer Holdings from our Class A Shareholders and
Class B Shareholders, voting together as a class. A copy of
the special resolution is attached to this Circular as
Exhibit A. Under the CBCA, the change of jurisdiction
requires affirmative votes, whether in person or by proxy from
at least two-thirds of the votes cast by the holders of our
Class A Shares and Class B Shares, voting together as
a single class, at the Meeting where a quorum, or a majority of
our total outstanding Class A Shares and Class B
Shares, is present. Assuming we receive the requisite
shareholder approval for the domestication, our Board of
Directors will retain the right to terminate or abandon the
domestication if it determines that consummating the
domestication would be inadvisable or not in our or our
shareholders’ best interests, or if all of the respective
conditions to consummation of the domestication have not
occurred. There are no time limits on the duration of the
authorization resulting from a favorable shareholder vote.
Regulatory
and Other Approvals
The change of jurisdiction is subject to the authorization of
the Director appointed under the CBCA. The Director is empowered
to authorize the change of jurisdiction if, among other things,
he is satisfied that the change of jurisdiction will not
adversely affect our creditors or shareholders.
Subject to the authorization of the continuance by the Director
appointed under the CBCA, and the approval of our Board of
Directors and shareholders, we anticipate that we will file with
the Secretary of State of the State of Delaware a certificate of
corporate domestication and a certificate of incorporation
pursuant to Section 388 of the DGCL, and that we will be
domesticated in Delaware on the effective date of such filings.
Promptly thereafter, we intend to give notice to the Director
appointed under the CBCA that we have been domesticated under
the laws of the State of Delaware and request that the Director
appointed under the CBCA issue us a certificate of
discontinuance bearing the same date as the date of
effectiveness of our certificate of corporate domestication and
certificate of incorporation by the Secretary of State of the
State of Delaware.
Comparison
of Shareholder Rights
The principal attributes of our capital stock before and after
domestication are comparable, however, there will be material
differences in the rights of our shareholders under Delaware law
as described below.
20
General. On the effective date of the
domestication, we will be deemed for the purposes of the DGCL to
have been incorporated under the laws of the State of Delaware
from our inception and we will be governed by the Delaware
certificate of incorporation filed with the certificate of
corporate domestication. Differences between Canadian corporate
law and Delaware corporate law and between our current articles
of incorporation and by-laws and the proposed Delaware
certificate of incorporation and by-laws will result in various
changes in the rights of our shareholders. The following summary
comparison highlights provisions of applicable Canadian
corporate law and our current Canadian articles of incorporation
and by-laws and Delaware corporate law and the proposed
certificate of incorporation and by-laws of Oppenheimer
Holdings. The proposed certificate of incorporation and by-laws
of Oppenheimer Holdings are attached to this Circular as
Exhibit C and Exhibit D, respectively.
Capital Structure. Under our current Canadian
articles of incorporation, we presently have the authority to
issue an unlimited number of Class A Shares, no par value,
99,680 Class B Shares, no par value, and an unlimited
number of preferred shares, issuable in a series, no par value.
Under our proposed Delaware certificate of incorporation, the
total number of shares of capital stock that Oppenheimer
Holdings will have the authority to issue is 100,099,680,
consisting of 50,000,000 shares of Class A Non-Voting
Common Stock, par value $0.001 per share, 99,680 shares of
Class B Voting Common Stock, par value $0.001 per share,
and 50,000,000 shares of preferred stock, par value $0.001
per share. Under Canadian law, there is no franchise tax on our
authorized capital stock. Pursuant to Delaware law, there will
be a franchise tax assessed on the authorized capital stock of
Oppenheimer Holdings. With authorized capital stock consisting
of 50,000,000 shares of Class A Non-Voting Common
Stock, par value $0.001 per share, 99,680 shares of
Class B Voting Common Stock, par value $0.001 per share,
and 50,000,000 shares of preferred stock, par value $0.001
per share, the franchise tax for Oppenheimer Holdings is
expected to be $165,000 per year.
Shareholder Approval; Vote on Extraordinary Corporate
Transactions. Canadian law generally requires a
vote of shareholders on a greater number and diversity of
corporate matters than Delaware law, such as a corporate name
change, a creation of a new class of shares, or an increase or
decrease of the minimum or maximum number of directors.
Furthermore, many matters requiring shareholder approval under
Canadian law must be approved by a special resolution of not
less than two-thirds of the votes cast by shareholders who voted
on those matters. In some cases, such as an amendment to the
articles of a corporation that affects classes of shares
differently, a special resolution to approve an extraordinary
corporate action is also required to be approved separately by
the holders of a class or series of shares, whether or not
shares of such class or series otherwise carry the right to vote.
Under Delaware law, a sale, lease or exchange of all or
substantially all the property or assets of a Delaware
corporation or an amendment to its certificate of incorporation
requires the approval of the holders of a majority of the voting
power of the outstanding shares entitled to vote thereon.
Mergers or consolidations also generally require the approval of
the holders of a majority of the outstanding voting power of the
corporation. However, stockholder approval is not required by a
Delaware corporation if such corporation’s certificate of
incorporation is not amended by the merger; each share of stock
of such corporation outstanding immediately prior to the merger
will be an identical outstanding share of the surviving
corporation after the effective date of the merger; and the
number of shares of common stock, including securities
convertible into common stock, issued in the merger does not
exceed 20% of such corporation’s outstanding common stock
immediately prior to the effective date of the merger. In
addition, stockholder approval is not required by a Delaware
corporation if it is the surviving corporation in a merger with
a subsidiary in which its ownership was 90% or greater.
Amendments to the Governing Documents. Under
Canadian law, amendments to the articles of incorporation
generally require the approval of not less than two-thirds of
the votes cast by shareholders voting on the resolution. If the
proposed amendment would affect a particular class of securities
in certain specified ways, the holders of shares of that class
would be entitled to vote separately as a class on the proposed
amendment, whether or not the shares otherwise carried the right
to vote. Our current by-laws allow the directors to make, amend
or repeal any by-law. When directors make, amend or repeal a
by-law, they are required under the CBCA to submit the change to
shareholders at the next meeting of shareholders. Shareholders
may confirm, reject or amend the by-law, the amendment or the
repeal with the approval of a majority of the votes cast by
shareholders who voted on the resolution.
Under the DGCL, an amendment to a corporation’s certificate
of incorporation requires the approval of holders of a majority
of the voting power of the outstanding stock entitled to vote on
the matter. In addition, under the DGCL, if the amendment to the
certificate of incorporation would increase or decrease the
aggregate number of authorized shares of a class, increase or
decrease the par value of the shares of such class, or alter or
change the powers, preferences or special rights of the shares
of such class so as to affect that class adversely, that class
is entitled to vote separately on the
21
amendment whether or not it is designated as voting stock.
Furthermore, if the proposed amendment would alter or change the
powers, preferences or special rights of one or more series of
any class so as to affect that class adversely, but would not so
affect the entire class, then only the shares of the series so
affected by the amendment would be considered a separate class
for purposes of the class vote. The DGCL gives stockholders the
power to adopt, amend or repeal the by-laws of the Delaware
corporation. The board of directors of a Delaware corporation
has no power to amend the by-laws unless the certificate of
incorporation confers such power on the board of directors in
addition to the stockholders. The proposed certificate of
incorporation of Oppenheimer Holdings will authorize the Board
of Directors to adopt, amend or repeal the by-laws of
Oppenheimer Holdings. Unlike Canadian law, there is no
requirement to submit changes to the by-laws to stockholders
under Delaware law.
Place of Meetings. The CBCA provides that
meetings of shareholders must be held at the place within Canada
provided in the by-laws or, in the absence of such provision, at
the place within Canada that the directors determine. A meeting
of shareholders may be held at a place outside of Canada if the
place is specified in the articles of incorporation or all the
shareholders entitled to vote at the meeting agree that the
meeting is to be held at that place. Our articles provide that
meetings of shareholders may be held at our registered office or
such places in or outside Canada as our directors may from time
to time determine. The DGCL provides that meetings of the
stockholders be held at any place in or outside of Delaware
designated by, or in the manner provided in, the certificate of
incorporation or by-laws. The proposed by-laws of Oppenheimer
Holdings provide that meetings of the stockholders will be held
at any place designated by the Board of Directors.
Quorum of Shareholders. The CBCA provides
that, unless the by-laws provide otherwise, a quorum of
shareholders is present at a meeting of shareholders
(irrespective of the number of persons actually present at the
meeting) if holders of a majority of the shares entitled to vote
at the meeting are present in person or represented by proxy.
The current by-laws provide that the presence of at least two
shareholders, in person or by proxy, entitled to vote and
holding or representing in the aggregate not less than a
majority of the outstanding shares entitled to vote at the
meeting constitutes a quorum. Under the DGCL, the certificate of
incorporation or by-laws may specify the required quorum, but
generally a quorum may consist of no less than one-third of the
total voting power. The proposed by-laws of Oppenheimer Holdings
provide that the presence of two stockholders, represented in
person or by proxy, holding a majority of the voting power of
the outstanding shares entitled to vote at the meeting shall
constitute a quorum at a meeting of stockholders.
Call of Meetings. The CBCA provides that
holders of not less than five percent of our issued voting
shares may requisition the directors requiring them to call and
hold a special meeting for the purposes stated in the
requisition. The current by-laws provide that a special meeting
of shareholders may be called by the Board of Directors, the
Chairman of the Board, our Managing Director or our President.
The DGCL provides that a special meeting of the stockholders may
be called by the board of directors or by any person or persons
as may be authorized by the certificate of incorporation or
by-laws. The proposed by-laws of Oppenheimer Holdings provide
that a special meeting of stockholders may be called by the
Board of Directors, the Chief Executive Officer, the Chairman of
the Board, or the President.
Shareholder Consent in Lieu of Meeting. Under
the CBCA, shareholders can take action by written resolution and
without a meeting only if all shareholders entitled to vote on
that resolution sign the written resolution. Under the DGCL,
unless otherwise limited by the certificate of incorporation,
stockholders may act by written consent without a meeting if
holders of outstanding stock representing not less than the
minimum number of votes that would be necessary to take the
action at an annual or special meeting execute a written consent
providing for the action. The proposed certificate of
incorporation of Oppenheimer Holdings will prohibit action by
written consent of the stockholders.
Director Election, Qualification and
Number. Our current by-laws allow for the
election of directors by a majority of votes cast at an annual
meeting of shareholders. Our proposed by-laws will allow for the
election of directors by a plurality of votes cast at an annual
meeting of shareholders. The CBCA states that a distributing
corporation must have no fewer than three directors, at least
two of whom are not officers or employees of the corporation or
its affiliates. Additionally, at least 25% of the directors must
be Canadian residents unless the corporation has fewer than four
directors, in which case at least one director must be a
Canadian resident. The DGCL has no similar requirements;
however, the governance standards of the NYSE require the
majority of a listed company’s Board of Directors to be
independent. The proposed by-laws of Oppenheimer Holdings
prescribe a minimum of three and a maximum of eleven directors.
Fiduciary Duty of Directors. Directors of a
corporation incorporated or organized under the CBCA or DGCL
have fiduciary obligations to the corporation and its
shareholders. The CBCA requires directors of a Canadian
corporation, in exercising their powers and discharging their
duties, to act honestly and in good faith with a view to the
best interests of the corporation and exercise the care,
diligence and skill that a reasonably prudent person would
exercise in comparable circumstances.
22
Under Delaware common law, directors have a duty of care and a
duty of loyalty. The duty of care requires that the directors
act in an informed and deliberative manner and inform
themselves, prior to making a business decision, of all material
information reasonably available to them. The duty of loyalty is
the duty to act in good faith, not out of self-interest, and in
a manner which the directors reasonably believe to be in the
best interests of the stockholders. In addition, the DGCL
provides that a transaction between a Delaware corporation and
one of its directors or officers or an entity affiliated with
one of its directors or officers is not voidable solely for such
reason so long as (i) the material facts of the
director’s or officer’s interest in the transaction
are disclosed to the board of directors and a majority of the
disinterested directors approve the transaction, (ii) the
material facts of the director’s or officer’s interest
in the transaction are disclosed to the stockholders and the
transaction is specifically approved in good faith by the
stockholders or (iii) the transaction is fair to the
Delaware corporation at the time approved by the board of
directors or stockholders.
Personal Liability of Directors. The CBCA
prescribes circumstances where directors can be liable for
malfeasance or nonfeasance. Certain actions to enforce a
liability imposed by the CBCA must be brought within two years
from the date of the resolution authorizing the act at issue. A
director will be deemed to have complied with his fiduciary
obligations to the corporation under the CBCA if he relied in
good faith on:
|
|
|
| |
•
|
financial statements represented to him by an officer or in a
written report of the auditors fairly reflecting the financial
condition of the corporation; or
|
| |
| |
•
|
a report of a person whose profession lends credibility to a
statement made by the professional person.
|
The CBCA also contains other provisions limiting personal
liability of a corporation’s directors.
The proposed certificate of incorporation of Oppenheimer
Holdings limits the liability of directors to us and our
stockholders to monetary damages for breach of fiduciary duty as
a director. However, such limitation of liability cannot be
relied upon in respect of proscribed conduct, described in the
DGCL to include:
|
|
|
| |
•
|
any breach of the director’s duty of loyalty to the
corporation or its stockholders;
|
| |
| |
•
|
acts or omissions not in good faith or which involve intentional
misconduct or a knowing violation of law;
|
| |
| |
•
|
an unlawful payment of a dividend or an unlawful stock purchase
or redemption; and
|
| |
| |
•
|
any transaction from which the director derived an improper
personal benefit.
|
Indemnification of Officers and
Directors. Under the CBCA and pursuant to our
current by-laws, we will indemnify present or former directors
or officers against all costs, charges and expenses, including
an amount paid to settle an action or satisfy a judgment that is
reasonably incurred by the individual in relation to any civil,
criminal, administrative, investigative or other proceeding in
which the individual is involved because of his or her
association with us. In order to qualify for indemnification
such directors or officers must:
|
|
|
| |
•
|
have acted honestly and in good faith with a view to the best
interests of the corporation; and
|
| |
| |
•
|
in the case of a criminal or administrative action or proceeding
enforced by a monetary penalty, have had reasonable grounds for
believing that his conduct was lawful.
|
Currently, we have indemnity agreements in place for all of our
directors and we carry liability insurance for our and our
subsidiaries’ officers and directors.
The CBCA also provides that such persons are entitled to
indemnity from the corporation in respect of all costs, charges
and expenses reasonably incurred in connection with the defense
of any such proceeding if the person was not judged by the court
or other competent authority to have committed any fault or
omitted to do anything that the person ought to have done, and
otherwise meets the qualifications for indemnity described above.
Delaware law permits a corporation to indemnify its present or
former directors and officers, employees and agents made a
party, or threatened to be made a party, to any third party
proceeding by reason of the fact that such person is or was a
director, officer, employee or agent of the corporation, against
expenses (including attorney’s fees), judgments, fines and
amounts paid in settlement actually and reasonably incurred by
such person in connection with such action, suit or proceeding,
if such person:
|
|
|
| |
•
|
acted in good faith and in a manner the person reasonably
believed to be in or not opposed to the best interests of the
corporation; and
|
| |
| |
•
|
with respect to any criminal action or proceeding, had no
reasonable cause to believe such conduct was unlawful.
|
23
In a derivative action, or an action by or in the right of the
corporation, the corporation is permitted to indemnify
directors, officers, employees and agents against expenses
actually and reasonably incurred by them in connection with the
defense or settlement of an action or suit if they acted in good
faith and in a manner that they reasonably believed to be in or
not opposed to the best interests of the corporation. However,
in such a case, no indemnification shall be made if the person
is adjudged liable to the corporation, unless and only to the
extent that, the court in which the action or suit was brought
or the Court of Chancery of the State of Delaware shall
determine upon application that such person is fairly and
reasonably entitled to indemnity for such expenses despite such
adjudication of liability to the corporation.
The DGCL allows the corporation to advance expenses before the
resolution of an action, if in the case of current directors and
officers, such persons agree to repay any such amount advanced
if they are later determined not to be entitled to
indemnification. The proposed by-laws of Oppenheimer Holdings
generally provide for mandatory indemnification and advancement
of expenses of our directors and officers to the fullest extent
permitted under Delaware law; provided, however, that directors
and officers shall not be entitled to indemnification for
actions initiated by such parties unless the Board of Directors
authorizes such action. Following the domestication, Oppenheimer
Holdings will enter into indemnity agreements with each of our
officers and directors. In addition, Oppenheimer Holdings will
carry liability insurance for its and its subsidiaries’
officers and directors.
Derivative Action. Under the CBCA, a
complainant, who is defined as either a present or former
registered holder or beneficial owner of a security of a
corporation or any of its affiliates; a present or former
director or officer of a corporation or any of its affiliates;
the Director appointed under the CBCA; or any other person who,
in the discretion of a court, is a proper person to make an
application under the CBCA relating to shareholder remedies, may
apply to the court for the right to bring an action in the name
of and on behalf of a corporation or any of its subsidiaries, or
to intervene in an existing action to which they are a party for
the purpose of prosecuting, defending or discontinuing the
action on behalf of the entity. Under the CBCA, the court must
be satisfied that:
|
|
|
| |
•
|
the complainant has given proper notice to the directors of the
corporation or its subsidiary of the complainant’s
intention to apply to the court if the directors of the
corporation or its subsidiary will not bring, diligently
prosecute or defend or discontinue the action;
|
| |
| |
•
|
the complainant is acting in good faith; and
|
| |
| |
•
|
it appears to be in the interest of the corporation or its
subsidiary that the action be brought, prosecuted, defended or
discontinued.
|
Under the CBCA, the court in a derivative action may make any
order it sees fit including orders pertaining to the control or
conduct of the lawsuit by the complainant or the making of
payments to former and present shareholders and payment of
reasonable legal fees incurred by the complainant.
Similarly, under Delaware law, a stockholder may bring a
derivative action on behalf of the corporation to enforce a
corporate right, including the breach of a director’s duty
to the corporation. Delaware law requires that the plaintiff in
a derivative suit be a stockholder of the corporation at the
time of the wrong complained of and remain so throughout the
duration of the suit; that the plaintiff make a demand on the
directors of the corporation to assert the corporate claim
unless the demand would be futile; and that the plaintiff is an
adequate representative of the other stockholders.
Dissenters’ Rights. The CBCA provides
that shareholders of a corporation entitled to vote on certain
matters are entitled to exercise dissent rights and demand
payment for the fair value of their shares. Dissent rights exist
when there is a vote upon matters such as:
|
|
|
| |
•
|
any amalgamation with another corporation (other than with
certain affiliated corporations);
|
| |
| |
•
|
an amendment to our articles of incorporation to add, change or
remove any provisions restricting the issue, transfer or
ownership of shares;
|
| |
| |
•
|
an amendment to our articles of incorporation to add, change or
remove any restriction upon the business or businesses that the
corporation may carry on;
|
| |
| |
•
|
a continuance under the laws of another jurisdiction;
|
| |
| |
•
|
a sale, lease or exchange of all or substantially all the
property of the corporation other than in the ordinary course of
business; and
|
| |
| |
•
|
a court order permitting a shareholder to dissent in connection
with an application to the court for an order approving an
arrangement proposed by the corporation.
|
24
However, a shareholder is not entitled to dissent if an
amendment to the articles of incorporation is effected by a
court order approving a reorganization or by a court order made
in connection with an action for an oppression remedy.
The DGCL grants appraisal rights only in the case of certain
mergers or consolidations and not in the case of other
fundamental changes such as the sale of all or substantially all
of the assets of the corporation or amendments to the
certificate of incorporation, unless so provided in the
corporation’s certificate of incorporation. The proposed
certificate of incorporation of Oppenheimer Holdings does not
include any such provisions. Under Delaware law, stockholders
who have neither voted in favor of nor consented to the merger
or consolidation have the right to seek appraisal of their
shares in connection with certain mergers or consolidations by
demanding payment in cash for their shares equal to the fair
value of such shares. Fair value is determined by a court in an
action timely brought by the stockholders who have properly
demanded appraisal of their shares. In determining fair value,
the court may consider all relevant factors, including the rate
of interest which the resulting or surviving corporation would
have had to pay to borrow money during the pendency of the court
proceeding.
No appraisal rights are available for shares of any class or
series listed on a national securities exchange (such as our
Class A Shares) or held of record by more than 2,000
stockholders. However, appraisal rights are available if the
agreement of merger or consolidation would require the holders
of stock to accept for their stock anything except:
|
|
|
| |
•
|
stock of the surviving corporation;
|
| |
| |
•
|
stock of another corporation which is either listed on a
national securities exchange or held of record by more than
2,000 stockholders;
|
| |
| |
•
|
cash in lieu of fractional shares; or
|
| |
| |
•
|
some combination of the above.
|
In addition, under Delaware law, appraisal rights are not
available for any shares of the surviving corporation if the
merger did not require the vote of the stockholders of the
surviving corporation.
Oppression Remedy. Under the CBCA, a
complainant has the right to apply to a court for an order where
an act or omission of the corporation or an affiliate effects a
result, or the business or affairs of which are or have been
conducted in a manner, or the exercise of the directors’
powers are or have been exercised in a manner, that would be
oppressive or unfairly prejudicial to or would unfairly
disregard the interest of any security holder, creditor,
director or officer of the corporation. On such application, the
court may make any interim or final order it thinks fit,
including an order restraining the conduct complained of. There
are no equivalent statutory remedies under the DGCL; however,
stockholders may be entitled to remedies for a violation of a
director’s fiduciary duties under Delaware common law.
Business Combinations. Section 203 of the
DGCL provides, with some exceptions, that a Delaware corporation
may not engage in any business combination with a person, or an
affiliate or associate of such person, who is an interested
stockholder for three years from the time that person became an
interested stockholder unless:
|
|
|
| |
•
|
the board of directors approved the transaction before the
“interested stockholder” obtained such status;
|
| |
| |
•
|
upon consummation of the transaction that resulted in the
stockholder becoming an “interested stockholder,” the
“interested stockholder” owned at least 85% of a
Delaware corporation’s outstanding voting stock at the time
the transaction commenced, excluding for purposes of determining
the number of shares outstanding those shares owned (i) by
persons who are directors and are also officers and (ii)
employee stock plans in which the participants do not have the
right to determine confidentially whether shares held subject to
the plans will be tendered in the tender or exchange offer; or
|
| |
| |
•
|
on or subsequent to such date, the business combination or
merger is approved by the board of directors and authorized at
an annual or special meeting of stockholders, and not by written
consent, by two-thirds of the holders of the outstanding common
stock not owned by the “interested stockholder.”
|
A “business combination” is defined to include
mergers, asset sales and other transactions resulting in
financial benefit to a stockholder. In general, an
“interested stockholder” is a person who, together
with affiliates and associates, owns 15% or more of a
corporation’s voting stock or within three years did own
15% or more of a corporation’s voting stock.
A corporation may, at its option, exclude itself from the
coverage of Section 203 by an appropriate provision in its
certificate of incorporation. The proposed certificate of
incorporation of Oppenheimer Holdings does not contain such an
exclusion from Section 203 of the DGCL.
25
There is no comparable provision relating to business
combinations under the CBCA, but restrictions on business
combinations do exist under applicable Canadian securities laws.
Examination of Corporate Records. Under the
CBCA, shareholders, creditors and their personal representatives
may examine certain corporate records, such as the securities
register and a list of shareholders, and any other person may do
so on payment of a reasonable fee. Each such person must provide
an affidavit containing specific information. A list of
shareholders or information from a securities register may not
be used except in connection with an effort to influence the
voting of shareholders of the corporation, an offer to acquire
securities of the corporation or any other matter relating to
the affairs of the corporation.
Under Delaware law, for any proper purpose, stockholders have
the right to inspect, upon written demand under oath stating the
purpose for such inspection, the corporation’s stock
ledger, list of stockholders and its other books and records,
and to make copies or extracts of the same. A proper purpose
means a purpose reasonably related to a person’s interest
as a stockholder.
Anti-Takeover Effects. Some powers granted to
companies under Delaware law may allow a Delaware corporation to
make itself potentially less vulnerable to hostile takeover
attempts. These powers include the ability to:
|
|
|
| |
•
|
implement a staggered board of directors, which prevents an
immediate change in control of the board;
|
| |
| |
•
|
require that notice of nominations for directors be given to the
corporation prior to a meeting where directors will be elected,
which may give management an opportunity to make a greater
effort to solicit its own proxies;
|
| |
| |
•
|
only allow the board of directors to call a special meeting of
stockholders, which may thwart a raider’s ability to call a
meeting to make disruptive changes;
|
| |
| |
•
|
eliminate stockholders’ action by written consent, which
would require a raider to attend a meeting of stockholders to
approve any proposed action by the corporation;
|
| |
| |
•
|
remove a director from a staggered board only for cause, which
gives some protection to directors on a staggered board from
arbitrary removal;
|
| |
| |
•
|
provide that the power to determine the number of directors and
to fill vacancies be vested solely in the board, so that the
incumbent board, not a raider, would control vacant board
positions;
|
| |
| |
•
|
provide for supermajority voting in some circumstances,
including mergers and certificate of incorporation amendments;
and
|
| |
| |
•
|
issue “blank check” preferred stock, which may be used
to make a corporation less attractive to a raider.
|
The proposed certificate of incorporation and/or by-laws of
Oppenheimer Holdings will include the following provisions which
may make Oppenheimer Holdings less vulnerable to hostile
takeover attempts:
|
|
|
| |
•
|
requirement that stockholders provide prior notice by a certain
date to nominate directors;
|
| |
| |
•
|
restrictions on the ability of stockholders to call a special
meeting of stockholders;
|
| |
| |
•
|
the elimination of the ability of stockholders to take action by
written consent;
|
| |
| |
•
|
the board of directors may determine the number of directors and
fill vacancies on the board of directors; and
|
| |
| |
•
|
the board of directors may issue “blank check”
preferred stock.
|
Other than the ability of our Board of Directors to determine
and issue preferred shares without shareholder approval and to
determine the number of directors (within a range provided in
our articles) and to fill vacancies between annual meetings of
shareholders, our existing articles and Canadian law do not
include the anti-takeover provisions listed above that will be
included in the certificate of incorporation and/or by-laws of
Oppenheimer Holdings.
Proposed
Certificate of Incorporation and By-Laws of Oppenheimer
Holdings
We have included provisions in the proposed certificate of
incorporation and by-laws of Oppenheimer Holdings that do not
simply reflect the default provisions of Delaware law. They are
as follows:
Voting Rights Of Common Stock. Under Delaware
law, unless the certificate of incorporation otherwise provides,
each stockholder is entitled to one vote for each share of
common stock held by such stockholder. Under the proposed
certificate of incorporation of Oppenheimer Holdings,
Oppenheimer Holdings will issue two classes of common stock,
each with different voting rights. The proposed capital
structure of Oppenheimer Holdings is consistent with our current
capital structure. Holders of Oppenheimer Holdings’
Class B Voting Common Stock are entitled to one vote for
each share
26
of common stock held by them; holders of Oppenheimer
Holdings’ Class A Non-Voting Common Stock are only
entitled to vote as required under Delaware law.
“Blank-Check” Preferred Stock Issuance Authority
For Board Of Directors. Under Delaware law, the
powers, preferences and rights, and the qualifications,
limitations or restrictions in respect of any series of
preferred stock must be set forth in the certificate of
incorporation, or, if authority is vested in the board of
directors by the certificate of incorporation, in the
resolutions providing for the issuance of such series of
preferred stock. The proposed certificate of incorporation of
Oppenheimer Holdings contains a provision granting its Board of
Directors the authority to fix by resolution the powers,
preferences, and rights, and the qualifications, limitations or
restrictions in respect of any series of preferred stock.
Increase or Decrease In Amount Of Authorized
Stock. Under Delaware law, the holders of
outstanding shares of a class of stock are entitled to vote as a
class on a proposed amendment to increase or decrease the number
of authorized shares of such class unless the certificate of
incorporation provides that such number of shares may be
increased or decreased by the affirmative vote of holders of a
majority of the voting power of the outstanding stock entitled
to vote. The proposed certificate of incorporation of
Oppenheimer Holdings contains such a provision and requires the
vote of the holders of a majority of the voting power of all of
its outstanding stock entitled to vote to increase or decrease
the aggregate number of authorized shares of any class of stock.
By-Laws. Under Delaware law, unless otherwise
provided in the certificate of incorporation or by-laws, the
holders of a majority in voting power of the shares present at a
meeting of stockholders have the power to adopt, amend or repeal
the by-laws of the corporation. In addition, if the certificate
of incorporation so provides, the board of directors also has
the power to adopt, amend or repeal the by-laws. The proposed
certificate of incorporation of Oppenheimer Holdings provides
that the Board of Directors has the power to make, amend, alter,
change, add to or repeal the by-laws. Additionally, the proposed
by-laws of Oppenheimer Holdings provide that a majority in
outstanding voting power of the shares entitled to vote shall
have the power to adopt, amend, or repeal the by-laws.
Stockholders’ Meetings. The proposed
certificate of incorporation of Oppenheimer Holdings will
provide that the holders of Class A Non-Voting Common Stock
will have the right to attend all stockholders’ meetings
and receive the same informational distributions from
Oppenheimer Holdings relating to such meetings as provided to
the holders of Class B Voting Common Stock. This provision
is consistent with the rights which we have traditionally
afforded our Class A Shareholders.
Stockholder Action by Written Consent. Under
Delaware law, unless otherwise provided in a corporation’s
certificate of incorporation, stockholders representing a
majority of the outstanding voting power of a corporation
entitled to vote on a matter may act by written consent. The
proposed certificate of incorporation of Oppenheimer Holdings
will prohibit action by written consent of the stockholders.
Presentation of Nominations and Proposals at Meetings of
Stockholders. Delaware law does not provide
procedures for stockholders to nominate individuals to serve on
the board of directors or to present other proposals at meetings
of stockholders. The proposed by-laws of Oppenheimer Holdings
contain procedures governing stockholder nominations and
stockholder proposals. The proposed by-laws of Oppenheimer
Holdings allow only the holders of Class B Voting Common
Stock to nominate individuals to serve on the board of directors
and to present other proposals at meetings of stockholders. To
nominate an individual to the board of directors of Oppenheimer
Holdings at an annual or special stockholders meeting, or to
present other proposals at an annual meeting, a stockholder must
provide advance notice to Oppenheimer Holdings, in the case of
an annual meeting, not fewer than 90 days nor more than
120 days prior to the first anniversary of the date of
Oppenheimer Holdings’ annual meeting for the preceding year
and, in the case of a special meeting, not later than the close
of business on the later of the 90th day prior to such special
meeting or the 10th day following the day on which public
announcement is first made of the date of the special meeting
and of the nominees proposed by the board of directors of
Oppenheimer Holdings to be elected at such meeting.
Number Of Directors. Under Delaware law, the
number of directors is fixed by, or in the manner provided in,
the by-laws of a corporation, unless the certificate of
incorporation fixes the number of directors. The proposed
by-laws of Oppenheimer Holdings provides that the number of
directors must be set by a resolution adopted by a majority of
the authorized number of directors. The proposed by-laws of
Oppenheimer Holdings provide that the number of directors on the
board of directors may not be less than three or more than
eleven.
Vacancies And Newly Created
Directorships. Under Delaware law, vacancies and
newly created directorships may be filled by a majority of
directors then in office unless the certificate of incorporation
or the by-laws otherwise provide.
27
The proposed by-laws of Oppenheimer Holdings provide that any
vacancies and newly created directorships on the board of
directors of Oppenheimer Holdings may be filled by a majority of
the directors then in office.
Dissent
Rights of Shareholders
Section 190 of the CBCA is reprinted in its entirety as
Exhibit E to this Circular. Shareholders may exercise their
dissent rights in connection with the proposal to approve the
continuance (Proposal 1 in the Notice of Meeting).
If you wish to dissent and do so in compliance with
Section 190 of the CBCA, you will be entitled to be paid
the fair value of the shares you hold if the continuance occurs.
Fair value is determined as of the close of business on the day
before the continuance is approved by shareholders.
If you wish to dissent, you must send us your written objection
to the continuance at or before the Meeting. If you vote in
favor of the continuance, you in effect lose your rights to
dissent. If you abstain or vote against the continuance, you
preserve your dissent rights if you comply with Section 190
of the CBCA.
However, it is not sufficient to vote against the continuance or
to abstain. You must also provide a separate dissent notice at
or before the Meeting. If you grant a proxy and intend to
dissent, the proxy must instruct the proxy holder to vote
against the continuance in order to prevent the proxy holder
from voting such shares in favor of the continuance and thereby
voiding your right to dissent. Under the CBCA, you have no right
of partial dissent. Accordingly, you may only dissent as to all
your shares.
Under Section 190 of the CBCA, you may dissent only for
shares that are registered in your name. In many cases, people
beneficially own shares that are registered either:
|
|
|
| |
•
|
in the name of an intermediary, such as a bank, trust company,
securities dealer, broker, trustee, administrator of self
administered registered retirement savings plans, registered
retirement income funds, registered educational savings plans
and similar plans and their nominees; or
|
| |
| |
•
|
in the name of a clearing agency in which the intermediary
participates, such as CDS Clearing and Depository Services
Limited or The Depository Trust Company.
|
If you want to dissent and your shares are registered in someone
else’s name, you must contact your intermediary and either:
|
|
|
| |
•
|
instruct your intermediary to exercise the dissenters’
rights on your behalf (which, if the shares are registered in
the name of a clearing agency, will require that the shares
first be re-registered in your intermediary’s name); or
|
| |
| |
•
|
instruct your intermediary to re-register the shares in your
name, in which case you will have to exercise your
dissenters’ rights directly.
|
In other words, if your shares are registered in someone
else’s name, you will not be able to exercise your
dissenters’ rights directly unless the shares are
re-registered in your name. A dissenting shareholder may only
make a claim under Section 190 of the CBCA with respect to
all of the shares of a class held on behalf of any one
beneficial owner and registered in the name of the dissenting
shareholder. We are required to notify each shareholder who has
filed a dissent notice when and if the continuance has been
approved. This notice must be sent within ten days after our
shareholders approve the continuance. We will not send a notice
to any shareholder who voted to approve the continuance or who
has withdrawn his dissent notice.
Within 20 days after receiving the above notice from us, or
if you do not receive such notice, within 20 days after
learning that the continuance has been approved, you must send
us a payment demand containing:
|
|
|
| |
•
|
your name and address;
|
| |
| |
•
|
the number of shares you own; and
|
| |
| |
•
|
a demand for payment of the fair value of your shares.
|
Within 30 days after sending a payment demand, you must
send to us directly at our corporate address, P.O. Box
2015, Suite 1110, 20 Eglinton Avenue West, Toronto,
Ontario, Canada M4R 1K8, or through our transfer agent, CIBC
Mellon Trust Company, the certificates representing your
shares. If you fail to send us a dissent notice, a payment
demand or your share certificates within the appropriate time
frame, you forfeit your right to dissent and your right to be
paid the fair value of your shares. Our transfer agent will
endorse on your share certificates a notice that you are a
dissenting shareholder and will return the share certificates to
you.
28
Once you send a payment demand to us, you cease to have any
rights as a shareholder. Your only remaining right is the right
to be paid the fair value of your shares. Your rights as a
shareholder will be reinstated if:
|
|
|
| |
•
|
you withdraw your payment demand prior to an offer being made by
us;
|
| |
| |
•
|
we fail to make you an offer of payment and you withdraw the
dissent notice; or
|
| |
| |
•
|
the continuance does not happen.
|
Within seven days of the later of the effective date of the
continuance or the date we receive your payment demand, we must
send you a written offer to pay for your shares. This must
include a written offer to pay you an amount considered by our
Board of Directors to be the fair value of your shares
accompanied by a statement showing how that value was
determined. The offer must include a statement showing the
manner used to calculate the fair value. Each offer to pay
shareholders must be on the same terms. We must pay you for your
shares within ten days after you accept our offer. Any such
offer lapses if we do not receive your acceptance within
30 days after the offer to pay has been made to you.
If we fail to make an offer to pay for your shares, or if you
fail to accept the offer within the specified period, we may,
within fifty days after the effective date of the continuance,
apply to a court to fix a fair value for your shares. If we fail
to apply to a court, you may apply to a court for the same
purpose within a further period of twenty days. You are not
required to give security for costs in such a case.
All dissenting shareholders whose shares have not been purchased
will be joined as parties and bound by the decision of the
court. We are required to notify each affected dissenting
shareholder of the date, place and consequences of the
application and of his right to appear and be heard in person or
by counsel. The court may determine whether any person who is a
dissenting shareholder should be joined as a party. The court
will then fix a fair value for the shares of all dissenting
shareholders who have not accepted a payment offer from us. The
final order of a court will be rendered against us for the
amount of the fair value of the shares of all dissenting
shareholders. The court may, in its discretion, allow a
reasonable rate of interest on the amount payable to each
dissenting shareholder and appoint an appraiser to assist in the
determination of a fair value for the shares.
THIS IS ONLY A SUMMARY OF THE DISSENTING SHAREHOLDER PROVISIONS
OF THE CBCA. THEY ARE TECHNICAL AND COMPLEX. IT IS SUGGESTED
THAT IF YOU WANT TO AVAIL YOURSELF OF YOUR RIGHTS THAT YOU SEEK
YOUR OWN LEGAL ADVICE. FAILURE TO COMPLY STRICTLY WITH THE
PROVISIONS OF THE CBCA MAY PREJUDICE YOUR RIGHT OF DISSENT.
SECTION 190 OF THE CBCA IS ATTACHED HEREIN AS
EXHIBIT E AND IS INCORPORATED HEREIN BY REFERENCE.
Accounting
Treatment of the Domestication
Our domestication as a Delaware corporation represents a
transaction between entities under common control. Assets and
liabilities transferred between entities under common control
are accounted for at carrying value. Accordingly, the assets and
liabilities of Oppenheimer Holdings will be reflected at their
carrying value to us. Any of our shares that we acquire from
dissenting shareholders will be treated as an acquisition of
treasury stock at the amount paid for the shares.
United
States and Canadian Income Tax Considerations
The domestication may have income tax consequences in both the
United States and Canada. The material tax consequences of the
domestication to us and our current shareholders are summarized
below.
United
States Federal Income Tax Consequences
The following discussion sets forth certain material United
States federal income tax consequences of the domestication to
Oppenheimer Holdings Inc., the Canadian corporation, and the
U.S. Holders (as defined below) and
Non-U.S.
Holders (as defined below) of its Class A Shares and
Class B Shares, as well as certain of the expected material
federal income and estate tax consequences of the ownership and
disposition of the shares of Oppenheimer Holdings Inc., the
Delaware corporation. Some aspects of this summary involve
transfers between Oppenheimer Holdings Inc. as a Canadian
corporation and Oppenheimer Holdings Inc. as a Delaware
corporation. To avoid confusion where a distinction is
necessary, Oppenheimer Holdings Inc. as a Canadian corporation
is referred to as “Oppenheimer Canada” and Oppenheimer
Holdings Inc. as a Delaware Corporation is referred to as
“Oppenheimer Delaware.”
This discussion does not address all aspects of taxation that
may be relevant to particular holders in light of their personal
investment or tax circumstances or to persons that are subject
to special tax rules. In particular, this description of United
States tax consequences does not address the tax treatment of
special classes of holders, such as banks, insurance
29
companies, tax-exempt entities, financial institutions,
broker-dealers, persons holding shares of our capital stock as
part of a hedging or conversion transaction or as part of a
“straddle,” United States expatriates, holders who
acquired their Class A Shares and Class B Shares in
Oppenheimer Canada pursuant to the exercise of employee stock
options or otherwise as compensation or through a tax-qualified
retirement plan and holders who exercise dissent rights. We
assume in this discussion that you hold our capital stock as a
capital asset within the meaning of the Internal Revenue Code of
1986, as amended, or the Code. This discussion is based on
current provisions of the Code, United States Treasury
Regulations, judicial opinions, published positions of the
United States Internal Revenue Service, or the IRS, and other
applicable authorities, all as in effect on the date of this
management proxy circular and all of which are subject to
differing interpretations or change, possibly with retroactive
effect. This discussion does not give a detailed discussion of
any state, local or foreign tax considerations. We urge you to
consult your tax advisor about the United States federal tax
consequences of acquiring, holding, and disposing of the capital
stock of Oppenheimer Canada and Oppenheimer Delaware, as well as
any tax consequences that may arise under the laws of any
foreign, state, local, or other taxing jurisdiction or under any
applicable tax treaty.
As used in this summary, the term “U.S. Holder” means
a beneficial owner of our capital stock that is for United
States federal income tax purposes:
|
|
|
| |
•
|
a citizen or resident of the United States;
|
| |
| |
•
|
a corporation (including any entity treated as a corporation for
United States federal income tax purposes) created or organized
under the laws of the United States, any state thereof, or the
District of Columbia;
|
| |
| |
•
|
an estate the income of which is taxable in the United States
regardless of its source; or
|
| |
| |
•
|
a trust, the administration of which is subject to the primary
supervision of a United States Court and one or more United
States persons have the authority to control all substantial
decisions of the trust, or that has a valid election in effect
under applicable United States Treasury regulations to be
treated as a United States person.
|
If a partnership (including for this purpose any other entity,
either organized within or without the United States, that is
treated as a partnership for United States federal income tax
purposes) holds the shares, the tax treatment of a partner as a
beneficial owner of the shares, generally will depend upon the
status of the partner and the activities of the partnership.
Foreign partnerships also generally are subject to special
United States federal income tax documentation requirements. A
beneficial owner of our capital stock who is not a U.S. Holder
is referred to below as a
“Non-U.S.
Holder.”
Code
Section 368 Reorganization Provisions
The change in our place of incorporation will constitute a
reorganization within the meaning of Code
Section 368(a)(1)(F), which we refer to as an F
Reorganization, and generally will not represent a taxable
transaction to Oppenheimer Canada for United States federal
income tax purposes, provided that holders of not more than 1%
of Oppenheimer Canada’s shares entitled to vote on the
transaction elect to exercise their dissenters’ rights
(“Dissenting Shareholders”). Under IRS guidance, if
holders of less than 1% of Oppenheimer Canada’s shares
entitled to vote on the domestication exercise their dissenters
rights, the domestication would qualify as an F Reorganization.
If the domestication does not qualify as an F Reorganization for
the reason stated above, it will qualify as a tax-free
transaction to Oppenheimer Canada under Code
Section 368(a)(1)(D) of the Code, which we refer to as a D
Reorganization, unless Oppenheimer Canada is required to use an
amount of its assets to satisfy claims of Dissenting
Shareholders which would prevent Oppenheimer Canada from
transferring substantially all of its assets to Oppenheimer
Delaware. Historically, for advance ruling purposes, the IRS
defines “substantially all” to mean 70% of the fair
market value of gross assets, and at least 90% of the fair
market value of net assets of such entity. In determining if
Oppenheimer Delaware acquires “substantially all” of
the assets of Oppenheimer Canada, payments of cash by
Oppenheimer Canada to Dissenting Shareholders will not be
considered assets acquired by Oppenheimer Delaware. Oppenheimer
Canada will satisfy the “substantially all” test
unless it is required to pay to Dissenting Shareholders more
than 30% of the fair market value of its gross assets and more
than 10% of the fair market value of its net assets. Oppenheimer
Canada believes that the amount it may be required to pay to
Dissenting Shareholders will not prevent it from transferring
“substantially all” of its assets to Oppenheimer
Delaware within the meaning of the IRS ruling guidelines.
Oppenheimer Canada believes based on all relevant facts that the
domestication qualifies as a tax-free reorganization. To the
extent that the domestication would not qualify as a tax-free
reorganization based on the tests set forth above, the Board of
Directors of Oppenheimer Canada will abandon the domestication.
30
However, to the extent that Oppenheimer Canada owns any United
States real property interests, as that term is defined in Code
Section 897(c)(1), Oppenheimer Canada will recognize gain
to the extent consideration received by Oppenheimer Canada for
such interest exceeds Oppenheimer Canada’s adjusted tax
basis in such interest, regardless of whether the transaction
qualifies as an F Reorganization or a D Reorganization. We do
not own any material interests in United States real property,
as that term is defined in Code Section 879(c)(1).
In the event the domestication does not qualify as either an F
Reorganization or a D Reorganization, a U.S. Holder would
recognize gain or loss with respect to his shares of Oppenheimer
Canada equal to the difference between the stockholder’s
basis in his Oppenheimer Canada shares and the fair market
value, as of the effective time of the domestication, of the
Oppenheimer Delaware shares. In such event, a stockholder’s
aggregate basis in the Oppenheimer Delaware shares would equal
its fair market value and such stockholder’s holding period
would begin the day after the domestication.
Effects
of Code Section 367
Code Section 367 applies to certain non-recognition
transactions involving foreign corporations. When it applies,
Code Section 367 has the effect of imposing income tax on
U.S. Holders in connection with transactions that would
otherwise be tax free. Code Section 367 would apply to the
domestication under the circumstances discussed below.
U.S. Holders who own, directly or by attribution, 10% or more of
the combined voting power of all classes of stock of Oppenheimer
Canada, which we refer to as a 10% Shareholder, would be
required to recognize as dividend income the “all earnings
and profits amount”, which we refer to as the “all
earnings and profits amount”, as determined under
Section 1.367(b)-2
of the United States Treasury Regulations, attributable to their
shares in Oppenheimer Canada.
A U.S. Holder that is not a 10% Shareholder is not required to
include the “all earnings and profits amount”
attributable to such U.S. Holder’s shares in Oppenheimer
Canada in income. Instead, absent making an election discussed
below to include the “all earnings and profits amount”
attributable to such U.S. Holder’s shares in Oppenheimer
Canada in income, which we refer to as a Deemed Dividend
Election, such U.S. Holder must recognize gain, but will not
recognize any loss, on his or her shares if such shares have a
fair market value of $50,000 or more on the date of the exchange
and the fair market value of Oppenheimer Delaware stock received
in the exchange exceeds the U.S. Holder’s tax basis of the
shares of Oppenheimer Canada surrendered in the exchange.
However, such U.S. Holder can make the Deemed Dividend Election
to include in income as a dividend the “all earnings and
profits amount” attributable to the shares owned by such
U.S. Holder in Oppenheimer Canada. If a U.S. Holder makes such
an election, then such holder does not recognize any gain on the
exchange. A Deemed Dividend Election can be made only if the
company gives the U.S. Holder the information which provides the
“all earnings and profits amount” for such holder and
the U.S. Holder elects and files certain notices with such
holder’s federal income tax return for the year in which
the exchange occurred. U.S. Holders should consult with their
own tax advisors regarding whether to make the Deemed Dividend
Election and, if advisable, the appropriate filing requirements
with respect to this election.
A U.S. Holder that is not a 10% Shareholder and owns shares in
Oppenheimer Canada with a fair market value of less than $50,000
on the day of the exchange is not subject to tax on the
domestication.
The term “all earnings and profits amount” as defined
under Treas.Reg.§1.367(b)-2(d) means the net positive
earnings (if any) of a foreign corporation that are determined
according to principles substantially similar to those
applicable to domestic corporations, but taking into account the
adjustments under the provisions of Code §312(k) relating
to the computation of depreciation, Code §312(n) relating
to adjustments to earnings and profits for certain items that
more closely conform to economic gain or loss, and the
miscellaneous provisions under Code §964 relating to
foreign taxes and foreign corporation’s earnings and
profits. Code §964 and §986, and the regulations
thereunder, contain the rules for adjusting earnings and profits
under foreign GAAP to U.S. GAAP and U.S. tax accounting, as well
as rules for determining the currency in which earnings must be
computed for U.S. tax purposes.
Based on all available information, we believe that no U.S.
Holder should have a positive “all earnings and profits
amount” attributable to such U.S. Holder’s shares of
Oppenheimer Canada, and accordingly no U.S. Holder, neither a
10% Shareholder nor a U.S. Holder that is not a 10% Shareholder
and who makes a Deemed Dividend Election, should be required to
include any such amount in income on the domestication. Our
belief with respect to the “all earnings and profits
amount” results from detailed calculations performed by a
nationally recognized accounting firm based on information
provided to them by us. Oppenheimer Canada’s earnings and
profits for this purpose were calculated in conformity with the
relevant provisions of the Code and the Treasury Proposed and
Final Regulations in force as of the date of this Circular, the
current administrative rulings and practices of the IRS and
judicial decisions as they relate to
31
those statutes and regulations. We do not have all historical
financial information since our incorporation in 1933 although
we have reviewed financial information dating back to 1945. It
is possible, although we believe highly unlikely, that we
recognized earnings and profits in taxable years for which we do
not have complete information. The amount of any such earnings
and profits could, if material, negatively impact our
calculations. However, based on the substantial financial
information we have from 1945, our limited activity at the
holding company level and the size of our existing earnings and
profits deficit, we do not believe that a U.S. Holder should
have a positive “all earnings and profits” amount
attributable to such U.S. Holder’s shares of Oppenheimer
Canada. As a result, we believe that no U.S. Holder should be
required to include any such amount in income as a result of the
domestication. However, no assurance can be given that the IRS
will agree with us. If it does not, a U.S. Holder may be subject
to adverse U.S. federal tax consequences.
Passive
Foreign Investment Company Considerations
In addition to the discussion under the heading “Effects of
Code Section 367” above, the domestication might be a
taxable event to U.S. Holders if Oppenheimer Canada is or ever
was a passive foreign investment company, or a PFIC, under
Section 1297 of the Code, provided that
Section 1291(f) of the Code is currently effective.
Generally, a foreign corporation is a PFIC if 75% or more of its
gross income for a taxable year is passive income or if, on
average for such taxable year, 50% or more of the value of its
assets held by the corporation during a taxable year produce or
are held to produce passive income. Passive income includes
dividends, interest, rents and royalties, but excludes rents and
royalties that are derived in the active conduct of a trade or
business and that are received from an unrelated person, as well
as interest, dividends, rents and royalties received from a
related person that are allocable to income of such related
person other than passive income. For purposes of these rules,
Oppenheimer Canada would be considered to own the assets of and
recognize the income of any subsidiary corporations as to which
it owns 25% or more of the value of their outstanding stock, in
proportion to such ownership. If a foreign corporation is
classified as a PFIC for any taxable year during which a U.S.
Holder owns stock in the foreign corporation, the foreign
corporation generally remains thereafter classified as a PFIC
with respect to that stockholder. Oppenheimer Canada believes
that it is not and has never been a PFIC. Accordingly, the
domestication should not be a taxable event for any U.S. Holder
based on an application of the PFIC rules. However, the
determination of whether a foreign corporation is a PFIC is
primarily factual and there is little administrative or judicial
authority on which to rely to make a determination. Hence, the
IRS might not agree that Oppenheimer Canada is not a PFIC.
Section 1291(f) of the Code generally requires that, to the
extent provided in regulations, a United States person who
disposes of stock of a PFIC recognizes gain notwithstanding any
other provision of the Code. No final Treasury regulations have
been promulgated under this statute. Proposed Treasury
regulations were promulgated in 1992 with a retroactive
effective date. If finalized in their current form, these
regulations would generally require gain recognition by United
States persons exchanging stock of Oppenheimer Canada for stock
of Oppenheimer Delaware, if Oppenheimer Canada were classified
as a PFIC at any time during such United States person’s
holding period in such stock and such person had not made either
a “qualified electing fund” election under Code
Section 1295 for the first taxable year in which such U.S.
Holder owned Oppenheimer Canada shares or in which Oppenheimer
Canada was a PFIC, whichever is later; or a
“mark-to-market”
election under Code Section 1296. The tax on any such gain
so recognized would be imposed at the rate applicable to
ordinary income and an interest charge would apply based on a
complex set of computational rules designed to offset the tax
deferral to such stockholders on our undistributed earnings.
However, we are unable to predict at this time whether, in what
form, and with what effective date, final Treasury Regulations
under Code Section 1291(f) will be adopted.
Basis and
Holding Period Considerations
If the domestication is a tax free reorganization within the
meaning of Section 368 of the Code, the tax basis of
Oppenheimer Delaware’s stock received by the shareholder in
the exchange will equal his or her tax basis in Oppenheimer
Canada’s shares surrendered in the exchange increased by
any gain recognized by such U.S. Holder in the exchange or the
“all earnings and profits amount” included in the
income of such U.S. Holder. The holding period for the
Oppenheimer Delaware stock will be the same as the U.S.
Holder’s holding period for the Oppenheimer Canada shares
surrendered in the exchange, provided that the shares were held
as a capital asset.
If the domestication is not a tax free reorganization within the
meaning of Section 368 of the Code, the tax basis of
Oppenheimer Delaware’s stock distributed to the U.S. Holder
will equal his or her tax basis in the shares surrendered plus
any gain recognized. The holding period will begin on the date
of the exchange.
32
Consequences
to Non-U.S.
Holders
The exchange of shares of Oppenheimer Canada for stock of
Oppenheimer Delaware by a
Non-U.S.
Holder will not be a taxable transaction for such holder for
United States federal income tax purposes.
Dividends
Oppenheimer Delaware anticipates paying cash dividends on its
stock. If Oppenheimer Delaware pays dividends on shares of its
stock, such dividends paid to
Non-U.S.
Holders will generally be subject to withholding of United
States federal income tax at the rate of 30%, or such lower rate
as may be specified by an applicable income tax treaty, provided
Oppenheimer Delaware has received proper certification
(generally on IRS
Form W-8BEN)
of the application of such income tax treaty. A
Non-U.S.
Holder that is eligible for a reduced rate of United States
federal withholding tax under an income tax treaty may obtain a
refund or credit of any excess amounts withheld by filing an
appropriate claim for a refund with the IRS. Pursuant to the
income tax treaty between the United States and Canada (the
“Treaty”), dividends paid by a United States
corporation to a Canadian resident where each qualifies for
benefits under the Treaty are subject to United States federal
withholding tax at a maximum rate of 15%.
Non-U.S.
Holders should consult their tax advisors regarding their
eligibility for claiming benefits under the Treaty and regarding
their particular circumstances to claim a tax credit or tax
deduction against their Canadian (or other) tax liability for
any United States federal withholding tax.
Dividends that are effectively connected with a
Non-U.S.
Holder’s conduct of a trade or business in the United
States or, if provided in an applicable income tax treaty,
dividends that are attributable to a
Non-U.S.
Holder’s permanent establishment in the United States, are
not subject to the U.S. withholding tax, but are instead taxed
in the manner applicable to U.S. Holders. In that case, we will
not have to withhold United States federal withholding tax if
the Non-U.S.
Holder complies with applicable certification and disclosure
requirements (generally on IRS
Form W-8ECI).
In addition, dividends received by a foreign corporation that
are effectively connected with the conduct of a trade or
business in the United States may be subject to a branch profits
tax at a 30% rate, or a lower rate specified in an applicable
income tax treaty.
Gain on
Disposition
A Non-U.S.
Holder generally will not be subject to United States federal
income tax, including by way of withholding, on gain recognized
on a sale or other disposition of stock of Oppenheimer Delaware
unless any one of the following is true:
|
|
|
| |
•
|
the gain is effectively connected with the
Non-U.S.
Holder’s conduct of a trade or business in the United
States and, if an applicable tax treaty requires, attributable
to a U.S. permanent establishment maintained by such
Non-U.S.
Holder;
|
| |
| |
•
|
the Non-U.S.
Holder is an individual who is present in the United States for
183 or more days in the taxable year of the sale, exchange or
other disposition and certain other requirements are met; or
|
| |
| |
•
|
the stock of Oppenheimer Delaware constitutes a United States
real property interest by reason of our status as a “United
States real property holding corporation” (which we refer
to as a USRPHC) for United States federal income tax
purposes at any time during the shorter of the period during
which such
Non-U.S.
Holder holds the stock of Oppenheimer Delaware; or the
5-year
period ending on the date such
Non-U.S.
Holder disposes of the stock of Oppenheimer Delaware and, in the
event of common stock that is regularly traded on an established
securities market for tax purposes, the
Non-U.S.
Holder held, directly or indirectly, at any time within the
five-year period preceding such disposition more than 5% of such
regularly traded common stock.
|
We do not anticipate that Oppenheimer Delaware will become a
USRPHC. However, since the determination of USRPHC status in the
future will be based upon the composition of its assets from
time to time and there are uncertainties in the application of
certain relevant rules, there can be no assurance that it will
not become a USRPHC in the future.
U.S.
Federal Estate Taxes
Capital stock of Oppenheimer Delaware owned or treated as owned
by an individual who at the time of death is a
Non-U.S.
Holder will be included in his or her estate for United States
federal estate tax purposes, unless an applicable estate tax
treaty provides otherwise.
33
Information
Reporting and Backup Withholding
A Non-U.S.
Holder may have to comply with specific certification procedures
to establish that the holder is not a United States person as
described above (generally on IRS
Form W-8BEN),
or otherwise establish an exemption, in order to avoid backup
withholding and information reporting tax requirements with
respect to our payments of dividends on the stock of Oppenheimer
Delaware.
The payment of the proceeds of the disposition of stock by a
Non-U.S.
Holder to or through the United States office of a broker
generally will be reported to the IRS and reduced by backup
withholding unless the
Non-U.S.
Holder either certifies its status as a
Non-U.S.
Holder under penalties of perjury or otherwise establishes an
exemption and the broker has no actual knowledge to the
contrary. Information reporting requirements, but not backup
withholding, will also apply to payments of the proceeds from
sales of our stock by foreign offices of United States brokers
or foreign brokers with certain types of relationships to the
United States, unless the broker has documentary evidence in its
records that the holder is a
Non-U.S.
Holder and certain other conditions are met, or the holder
otherwise establishes an exemption.
Backup withholding is not an additional tax. Any amounts that
are withheld under the backup withholding rules will be refunded
or credited against the
Non-U.S.
Holder’s United States federal income tax liability if
certain required information is furnished to the IRS.
Non-U.S.
Holders should consult their own tax advisors regarding
application of backup withholding in their particular
circumstance and the availability of and procedure for obtaining
an exemption from backup withholding under current United States
Treasury regulations.
Canadian
Tax Considerations
The following summary fairly describes the principal Canadian
federal income tax considerations relating to legal continuance
of the Corporation to Delaware in respect of shareholders of the
Class A Shares and the Class B Shares (collectively
the “shares”) who, for the purposes of the Income Tax
Act (Canada) (the “ITA”): (i) hold their shares
as capital property; (ii) deal at arm’s length with
us; (iii) are not affiliated with us, and (iv) in
respect of whom we are not a foreign affiliate within the
meaning of the ITA, or who hold more than 10% of either the
Class A Shares or the Class B Shares. A shareholder
will generally be considered to hold shares as capital property,
unless the shareholder holds the shares in the course of
carrying on a business, acquired the shares in a transaction
that is an adventure in the nature of trade, or holds the shares
as
“mark-to-market”
property for the purposes of the ITA. Shareholders should
consult their own tax advisors if they have questions as to
whether they in fact hold the shares as capital property.
Moreover, shareholders who do not hold the shares as capital
property should consult their own tax advisors regarding the
consequences of the continuance.
This summary is not applicable to a shareholder: (i) that
is a “financial institution” for the purposes of the
mark-to-market
rules contained in the ITA; (ii) that is a “specified
financial institution” or “restricted financial
institution” as defined in the ITA; (iii) an interest
in which is a “tax shelter investment” as defined
under the ITA, or (iv) to whom the functional currency
reporting rules in subsection 261 of the ITA would apply. Such
shareholders should consult their own tax advisors.
This summary is based upon the current provisions of the ITA,
the regulations thereunder (the “Regulations”), the
Canada-United
States Income Tax Convention, 1980, as amended (the “Tax
Treaty”), and counsel’s understanding of the current
administrative practices and policies of the Canada Revenue
Agency (the “CRA”). This summary also takes into
account all specific proposals to amend the ITA and the
Regulations (the “Proposed Amendments”) announced by
the Minister of Finance (Canada) prior to the date hereof and
assumes that all Proposed Amendments will be enacted in their
current form. However, there can be no assurance that the
Proposed Amendments will be enacted in the form proposed or at
all. Except for the Proposed Amendments, this summary does not
take into account or anticipate any changes in law, whether by
legislative, governmental or judicial action or decision, nor
does it take into account provincial, territorial or foreign
income tax considerations, which may differ from the Canadian
federal income tax considerations discussed below. An advance
income tax ruling will not be sought from the CRA in respect of
our continuance transaction.
Although portions of this summary of “Canadian Tax
Considerations” that are applicable to shareholders
considered to be resident of the United States for purposes of
the Tax Treaty (the “US resident shareholders”) may
also apply to shareholders residing in other jurisdictions, this
summary does not specifically address the tax consequences to
such other shareholders and accordingly such other shareholders
are urged to contact their own tax advisors to determine the
particular tax consequences applicable to them.
The following summary is based on the facts set out in this
Circular and on additional information provided to Canadian tax
counsel by our management.
34
All amounts relevant to the computation of income under the ITA
must be reported in Canadian dollars. Any amount that is
expressed or denominated in a currency other than Canadian
dollars, including adjusted cost base, proceeds of disposition,
and dividends must be converted into Canadian dollars based on
the currency exchange rate prevailing on the date each amount
arises.
This summary is of a general nature only and is not
exhaustive of all possible Canadian federal income tax
considerations. This summary is not intended to be, nor should
it be construed to be, legal or tax advice to any shareholder.
Accordingly, shareholders should consult their own tax advisers
for advice as to the income tax consequences having regard to
their own particular circumstances.
Tax
Consequences Applicable to Us
On the continuance, we will be deemed to be resident in the
United States, and to no longer be resident in Canada. Under the
ITA, the change in our residence from Canada to the United
States will cause our tax year to end immediately before the
continuance, and a new tax year to begin at the time of the
continuance.
Furthermore, we will be deemed to have disposed of all of our
property immediately before the continuance for proceeds of
disposition equal to the fair market value of our property at
that time. This deemed disposition may cause us to incur a
Canadian tax liability as a result of the deemed capital gain.
Management intends to mitigate this potential tax liability by
making a timely tax election under subsection 93(1) of the ITA
to treat a portion of the deemed proceeds of disposition as
being a tax-deductible inter-corporate dividend that would
reduce the amount of this capital gain. Such election must be
made by us while resident in Canada, and immediately after the
deemed disposition of our property.
Furthermore, we will be subject to a separate corporate
emigration tax imposed by the ITA on a corporation departing
from Canada. The emigration tax will be imposed on the amount by
which the fair market value of all of our property immediately
before the continuance exceeds the aggregate of our liabilities
at that time (other than dividends payable and taxes payable in
connection with this emigration tax) and the amount of
paid-up
capital on all of our issued and outstanding shares. Tax will be
imposed at a rate of 5% on our net assets determined under the
foregoing formula, unless one of the main reasons for our
changing of residence to the United States was to reduce the
amount of this corporate emigration tax or the amount of
Canadian withholding tax paid by us, in which case the rate will
be 25%.
With the assistance of professional advisors, we have reviewed
our assets, liabilities,
paid-up
capital and other tax balances and assuming that the market
price of our Class A Shares does not exceed $13.50 per
share and that the exchange rate of the Canadian dollar to the
U.S. dollar is CDN $1.00 equals $0.80, it is anticipated that
Canadian income taxation arising on the continuance would not
exceed $4.0 million. This conclusion is based in part on
determinations of factual matters, including determinations
regarding the fair market value of our assets and tax
attributes. Furthermore, the facts underlying the assumptions
and conclusions used by management may change prior to the
effective time of the continuance. We have not applied to the
CRA for a ruling as to the amount of Canadian taxes payable as a
result of the continuance and do not intend to apply for such a
ruling given the factual nature of the determinations involved.
There can be no assurance that the CRA will accept the
valuations or management’s estimate of the amount of
Canadian taxes that will be payable upon the continuance.
Accordingly, there is no assurance that the CRA will conclude
after the effective time of the continuance that no additional
Canadian taxes are due as a result of the continuance or that
the amount of such additional Canadian taxes will not be
significant.
Due to the change in residence upon the continuance, we will no
longer be subject to taxation in Canada on our worldwide income.
However, if we carry on business in Canada, we may be subject to
Canadian tax on our Canadian-source business profits.
Shareholders
Resident in Canada
The following portion of this summary of “Canadian Tax
Considerations” applies to our shareholders who are
resident in Canada for the purposes of the ITA.
Our shareholders who remain holding the shares after the
continuance, will not be considered to have disposed of their
shares by reason only of the continuance. Accordingly, the
continuance will not cause the Canadian resident shareholders to
realize a capital gain or loss on their shares and there will be
no effect on the adjusted cost base of their shares.
Following the continuance, any dividends received by an
individual (including a trust) who is a Canadian resident
shareholder will be included in computing the individual’s
income for tax purposes and will not be eligible for the
gross-up and
dividend tax credit treatment generally applicable to dividends
on shares of taxable Canadian corporations.
35
Any dividends received by a corporate shareholder will be
included in calculating that corporation’s income for tax
purposes and the corporation will not be entitled to deduct the
amount of such dividends in computing its taxable income. A
“Canadian-controlled private corporation” (as defined
in the ITA) may be liable to pay an additional refundable tax of
62/3%
on its “aggregate investment income” which is defined
to include amounts in respect of taxable capital gains and
certain dividends. To the extent that U.S. withholding taxes are
imposed on dividends paid by us, the amount of such tax will
generally be eligible for a Canadian foreign tax credit or tax
deduction subject to the detailed rules and limitations under
the ITA. Canadian resident shareholders are advised to consult
their own tax advisors with respect to the availability of such
a Canadian foreign tax credit or tax deduction having regard to
their particular circumstances.
Foreign
Property Information Reporting
A shareholder that is a “specified Canadian entity”
for a taxation year and whose total cost amount of
“specified foreign property” at any time in the year
exceeds C$100,000 (as such terms are defined under the ITA) will
be required to file an information return for the year to
disclose certain prescribed information. Subject to certain
exceptions, a Canadian resident shareholder will generally be a
specified Canadian entity. The shares should be classified
within the definition of “specified foreign property”.
Canadian resident shareholders should consult their own tax
advisors as to whether they must comply with these reporting
requirements.
Dissenting
Shareholders
Although the matter is not free from doubt, it is reasonable to
conclude based on administrative positions published by the CRA
that the amount paid to a Canadian resident shareholder who
dissents to the continuance should be treated as receiving
proceeds of disposition for his shares. Accordingly, the
dissenting Canadian resident shareholder would recognize a
capital gain or loss to the extent that the amount received as
proceeds for the disposition of the shares exceeds or is less
than the shareholder’s adjusted cost base of the shares.
Interest awarded by a court to a dissenting Canadian resident
shareholder will be included in the shareholder’s income
for purposes of the ITA.
Dissenting Canadian resident shareholders should consult their
own tax advisers for advice as to the income tax consequences to
them of our continuance, having regard to their own particular
circumstances.
U.S.
Resident Shareholders
The following portion of this summary of “Canadian Tax
Considerations” applies to our shareholders who are
residents of the United States for purposes of the Tax Treaty,
and who do not use or hold their shares in the course of
carrying on a business in Canada.
After the continuance, U.S. resident shareholders will not be
considered to have disposed of their shares by reason only of
the continuance. Accordingly, the continuance will not cause
these U.S. resident shareholders to realize a capital gain or
loss on their shares, and will have no effect on the adjusted
cost base of their shares.
After the continuance, U.S. resident shareholders will not be
subject to Canadian withholding tax on dividends received from
us.
After the continuance, neither the Class A Shares or
Class B Shares will be taxable Canadian property to U.S.
resident shareholders, and therefore will not cause such
shareholders to be subject to taxation in Canada on any
subsequent disposition of such shares, provided that not more
than 50% of the fair market value of the shares is derived
directly or indirectly from one or any combination of real
property situated in Canada, Canadian resource properties and
timber resource properties. Based on representations from
management regarding the fair market value of our shares, it is
not expected that the Class A Shares and Class B
Shares will be classified as taxable Canadian property.
Dissenting
U.S. Resident Shareholders
Although the matter is not free from doubt, it is reasonable to
conclude based on administrative positions published by the CRA
that the amount paid to a U.S. resident shareholder who dissents
to the continuance should be treated as proceeds of disposition
of their shares. Based on this conclusion, no tax under the ITA
needs to be withheld or remitted on a payment made to a U.S.
resident shareholder who dissents.
Interest received by a U.S. resident shareholder consequent upon
the exercise of the dissent rights will be not subject to
withholding tax under the ITA.
36
Eligibility
for Investment
Following the continuance, the Class A Shares will continue
to be listed on the NYSE. Because the Class A Shares will
continue to be listed on a designated stock exchange, the
Class A Shares will continue to be a qualified investment
for certain deferred income plans under the ITA, namely trusts
governed by deferred profit sharing plans, registered retirement
savings plans, registered retirement income funds, registered
education savings plans, registered disability saving plans and
tax-free savings accounts.
Following the continuance, the Class B Shares will not be
listed on any stock exchange. As such, our Class B Shares
will not be a qualified investment for certain deferred income
plans under the ITA, namely trusts governed by deferred profit
sharing plans, registered retirement savings plans, registered
retirement income funds, registered education savings plans,
registered disability saving plans and tax-free savings
accounts. The tax consequences to such a deferred income plan of
holding the Class B Shares as non-qualified investments are
complex, and persons holding Class B Shares in such a plan
are urged to consult with their own tax advisors regarding the
potential consequences.
37
DESCRIPTION
OF CAPITAL STOCK
Unless the context provides otherwise, the following description
of our capital stock assumes the consummation of the
domestication has already occurred. The following description of
Oppenheimer Holdings’ capital stock is not complete and is
subject to and qualified in its entirety by the proposed
certificate of incorporation and by-laws of Oppenheimer
Holdings, which are attached as Exhibits C and D,
respectively, to this Circular, and by the provisions of
Delaware law.
Oppenheimer Holdings’ authorized capital stock consists of
50,000,000 shares of Class A Non-Voting Common Stock,
par value $0.001 per share, 99,680 shares of Class B
Voting Common Stock, par value $0.001 per share, and
50,000,000 shares of preferred stock, par value $0.001 per
share.
As of March 30, 2009 there were
12,968,992 Class A Shares, 99,665 Class B Shares
and no preferred shares issued and outstanding. Assuming the
domestication had occurred on March 30, 2009, there would
have been 12,968,992 shares of Class A Non-Voting
Common Stock, 99,665 shares of Class B Voting Common
Stock and no shares of preferred stock issued and outstanding.
Common
Stock
Holders of Class B Voting Common Stock are entitled to one
vote for each share held of record on all matters on which
stockholders are permitted to vote. Holders of Class A
Non-Voting Common Stock are not entitled to vote on any matters
unless expressly permitted under Delaware law. The proposed
certificate of incorporation of Oppenheimer Holdings provides
that, except as otherwise provided by law, the affirmative vote
of a majority in voting power of the shares of Class B
Voting Common Stock, present in person or represented by proxy
at a meeting at which a quorum is present shall be the act of
the stockholders. Delaware law requires the affirmative vote of
a majority in voting power of the outstanding shares to
authorize certain extraordinary actions, such as mergers,
consolidations, dissolutions or an amendment to the
certification of incorporation of Oppenheimer Holdings. There is
no cumulative voting for the election of directors. The
Class A stockholders shall have the right to attend all
stockholders’ meetings and receive the same informational
distributions relating to those meetings as provided to the
Class B stockholders. Upon a liquidation, Oppenheimer
Holdings’ creditors and any holders of preferred stock with
preferential liquidation rights will be paid before a
distribution to holders of the common stock of Oppenheimer
Holdings. The Class A and Class B stockholders are
treated equally for purposes of liquidation rights. The holders
of the common stock of Oppenheimer Holdings would be entitled to
receive a pro rata amount per share of any excess distribution.
Holders of common stock have no preemptive or subscription
rights. There are no conversion rights, redemption rights,
sinking fund provisions or fixed dividend rights with respect to
the common stock. All outstanding shares of the common stock are
fully paid and nonassessable.
Preferred
Stock
The proposed certificate of incorporation of Oppenheimer
Holdings empowers the Board of Directors to issue up to
50,000,000 shares of preferred stock from time to time, in
one or more series. The Board of Directors also may fix the
designation, powers, preferences and rights and the
qualifications, limitations and restrictions of those shares,
including dividend rights, conversion rights, voting rights,
redemption rights, terms of sinking funds, liquidation
preferences and the number of shares constituting any series or
the designation of the series. Terms selected could decrease the
amount of earnings and assets available for distribution to
holders of common stock. The rights of holders of the common
stock will be subject to the rights of the holders of any
preferred shares that may be issued in the future. Additionally,
the issuance of preferred stock may have the effect of
decreasing the market price of the common stock. Although there
are no shares of preferred stock currently outstanding and
Oppenheimer Holdings has no present intention to issue any
shares of preferred stock, any issuance could have the effect of
making it more difficult for a third party to acquire a majority
of Oppenheimer Holdings’ outstanding voting stock.
38
Potential
Anti-takeover Effect of Delaware Law, Our Certificate of
Incorporation and Bylaws
Oppenheimer Holdings will be subject to the “business
combinations” provisions of the DGCL. In general, such
provisions prohibit a publicly held Delaware corporation from
engaging in various “business combination”
transactions with any “interested stockholder” for a
period of three years after the time of the transaction on which
the person became an “interested stockholder,” unless:
|
|
|
| |
•
|
the corporation’s board of directors approved the
transaction before the “interested stockholder”
obtained such status;
|
| |
| |
•
|
upon consummation of the transaction that resulted in the
stockholder becoming an “interested stockholder,” the
“interested stockholder” owned at least 85% of the
voting stock of the corporation outstanding at the time the
transaction commenced, excluding for purposes of determining the
number of shares outstanding those shares owned (i) by
persons who are directors and are also officers and
(ii) employee stock plans in which the participants do not
have the right to determine confidentially whether shares held
subject to the plans will be tendered in the tender or exchange
offer; or
|
| |
| |
•
|
on or subsequent to such time, the business combination or
merger is approved by the corporation’s board of directors
and authorized at an annual or special meeting of stockholders,
and not by written consent, by two-thirds of the holders of the
outstanding common stock not owned by the “interested
stockholder.”
|
A “business combination” is defined to include certain
mergers, asset sales and other transactions resulting in
financial benefit to a stockholder. In general, an
“interested stockholder” is a person who, together
with affiliates and associates, owns 15% or more of a
corporation’s voting stock or within three years owned 15%
or more of a corporation’s voting stock. The statute could
prohibit or delay mergers or other takeover or change in control
attempts.
Provisions of the proposed certificate of incorporation and
by-laws of Oppenheimer Holdings providing that only a majority
of the Board of Directors, the Chairman of the Board of
Directors, the Chief Executive Officer or the President may call
special meetings of stockholders, or providing that stockholders
are prohibited from taking action by written consent, may have
the effect of making it more difficult for a third party to
acquire control of Oppenheimer Holdings, or of discouraging a
third party from attempting to acquire control of Oppenheimer
Holdings. In addition, the certificate of incorporation of
Oppenheimer Holdings allows the Board of Directors to issue up
to 50,000,000 shares of preferred stock that could have,
when issued, voting rights or preferences that could impede the
success of any hostile takeover, or delay a change in control or
change in Oppenheimer Holdings’ management.
Listing
The Class A Non-Voting Common Stock of Oppenheimer Holdings
will be listed on the NYSE under the trading symbol
“OPY.”
Transfer
Agent and Registrar
The transfer agent and registrar for the common stock of
Oppenheimer Holdings is CIBC Mellon Trust Company. The
transfer agent’s address is P.O. Box 7010, Adelaide Street
Postal Station, Toronto, Ontario, Canada M5C 2W9 and Mellon
Investor Services, Inc., 85 Challenger Road, Ridgefield Park,
New Jersey 07660 and the telephone number is
(416) 643-5500
or
(800) 387-0825.
Proxies from registered holders are to be sent to CIBC Mellon
Trust Company, P.O. Box 721, Agincourt, Ontario, Canada
M1S 0A1 and the fax number is
(416) 368-2502.
39
Notes:
|
|
| (1)
|
There is no Executive Committee of the Board of Directors.
Messrs. Ehrhardt, Keehner, McArthur and Winberg are members
of the Audit Committee. Messrs. Bitove, Crystal and Keehner
are members of the Nominating/Corporate Governance Committee.
Messrs. Ehrhardt, Keehner and Winberg are members of the
Compensation and Stock Option Committee.
|
| |
| (2)
|
A.W. Oughtred is a director of CI Financial Corp., the shares of
which are listed on the Toronto Stock Exchange.
|
| |
| (3)
|
M.A.M. Keehner is an advisory director of CIK Enterprises, LLC,
a private company based in Indianapolis, Indiana.
|
|
|
| (4) (a) |
None of the nominees is, or has been, within 10 years of
the date of this Circular, a director or executive officer of a
corporation that:
|
|
|
|
| |
(i)
|
was the subject of a cease trade or similar order that denied
the corporation access to any exemption under securities
legislation for more than 30 days; or
|
| |
| |
(ii)
|
became bankrupt, made a proposal under bankruptcy or insolvency
legislation or was subject to or instituted any proceedings,
arrangement or compromise with creditors or had a receiver,
receiver manager or trustee appointed.
|
|
|
|
| |
(b)
|
None of the nominees has personally, or has a personal holding
company controlled by the nominee, within 10 years before
the date of this Circular become bankrupt, made a proposal under
bankruptcy or insolvency legislation or become subject to or
instituted any proceedings, arrangement or compromise with
creditors or had a receiver, receiver manager or trustee
appointed.
|
| |
| |
(c)
|
None of the nominees has personally, or has a personal holding
company controlled by the nominee, been subject to penalties or
sanctions relating to securities legislation or entered into a
settlement with a securities regulatory authority or has been
subject to any other penalties or sanctions that would likely be
considered important to a reasonable investor making an
investment decision, except for Mr. Lowenthal who, with
Oppenheimer & Co., a subsidiary, in June 2003 agreed
to a stipulation of facts and consented to penalty with the NYSE
resulting in a fine to Oppenheimer & Co. and
Mr. Lowenthal, as disclosed in our Quarterly Report on
Form 10-Q
for the quarterly period ended June 30, 2003.
|
Compensation
Discussion and Analysis
Introduction
The following Compensation Discussion and Analysis describes the
material elements of compensation for our named executive
officers identified in the “Summary Compensation
Table”, or the Named Executives. The Compensation and Stock
Option Committee of the Board, or the Compensation Committee,
makes all decisions for the total direct compensation (that is
the base salary, bonus awards, stock options and stock awards)
of our executive officers, including the Named Executives. The
Compensation Committee’s recommendations for the total
direct compensation of our Chief Executive Officer are subject,
in part, to the Performance-Based Compensation Agreement,
amended and restated March 15, 2005, which was included as
Schedule E in our Proxy Circular dated March 24, 2005
and for which we received shareholder approval on May 9,
2005. We refer to this agreement in this Circular as the
Performance-Based Compensation Agreement.
The
day-to-day
design and administration of health benefits, the deferred
compensation plans and the 401(k) plan and other employee
benefit plans and policies applicable to salaried
U.S.-based
employees in general are handled by our Human Resources, Finance
and Legal Departments. The Compensation Committee remains
responsible for certain fundamental changes outside the
day-to-day
requirements necessary to maintain these plans and policies.
We have adopted a Compensation and Stock Option Committee
Charter which is posted on our website at www.opco.com.
The processes and procedures of the Compensation Committee are
discussed below as is the role of the Compensation Committee in
dealing with the Chief Executive Officer’s compensation and
the compensation of other Named Executives. Under its charter,
the Compensation Committee is required to discharge the Board of
Director’s responsibilities relating to compensation of our
senior executive officers and to report on its practices to our
shareholders in our annual management proxy circular. The
Compensation Committee considers recommendations from the Chief
Executive Officer with respect to the compensation of Named
Executives other than the Chief Executive Officer.
For the purposes of determining 2008 executive compensation, the
Compensation Committee did not retain compensation consultants
although the Compensation Committee may retain compensation
consultants when it deems necessary.
Objectives
and Policies
The Compensation Committee’s objective is to provide a
competitive compensation program with appropriate incentives for
superior performance, thereby providing a strong and direct link
between corporate and individual
41
performance and compensation. Our compensation policy with
respect to our Named Executives has the following stated
objectives:
|
|
|
| |
•
|
recruit, motivate, reward and retain the high performing
executive talent required to create superior long-term total
shareholder returns in comparison to our peer group;
|
| |
| |
•
|
reward executives for short-term performance as well as growth
in enterprise value over the long-term;
|
| |
| |
•
|
provide a competitive package relative to industry-specific and
general industry comparisons; and
|
| |
| |
•
|
ensure effective utilization and development of talent by
working in concert with other management processes, such as
performance appraisal, succession planning and management
development.
|
Our compensation program for senior executive officers,
including the Named Executives, consists of the following key
elements: a base salary, an annual bonus, grants of share-based
compensation (stock options and/or stock awards) and, in the
case of the Chief Executive Officer, the Performance-Based
Compensation Agreement.
In arriving at its recommendations concerning the specific
components of our compensation program, the Compensation
Committee considers certain public information about the
compensation paid by a group of comparable public U.S.
broker-dealers. To this end, the Compensation Committee reviewed
the published information provided in the 2008 proxy circulars
filed by: Legg Mason, Jefferies Group, Raymond James Financial
Inc., Knight Capital Group, Inc., Piper Jaffray Companies,
Friedman Billings Ramsay, Stifel Financial Corp., KBW Group, SWS
Group Inc., Cowen Group, Ladenberg Thalman Financial Services
Inc., Labranche Sanders Morris Harris and JPM Group.
Approximately half of this peer group had a higher market
capitalization than ours and approximately half of the peer
group had a lower market capitalization than ours at the time of
the review. The information provided by this peer review was
used to ensure that our compensation is generally competitive
with the industry. The Compensation Committee does not have any
formal benchmarking strategy or any specific targets. The goal
of the Compensation Committee is to provide the compensation
structure to enable us to retain and reward the executive
officers that we believe are critical to our long-term success.
The Compensation Committee also structures compensation to
ensure that a portion of the Named Executives’ compensation
is directly related to corporate performance and other factors
that directly and indirectly influence shareholder value.
The Compensation Committee believes incentive compensation
(annual bonus and to a lesser extent, share-based awards) should
comprise between 65% to 95% of total compensation for the Named
Executives because:
|
|
|
| |
•
|
these executive officers are in positions to influence corporate
direction;
|
| |
| |
•
|
their compensation is “at risk” in proportion to
financial results that warrant such payments;
|
| |
| |
•
|
tying the majority of total compensation to incentive payments
helps ensure focus on our goals; and
|
| |
| |
•
|
the volatile nature of our market-driven business should be
reflected in compensation.
|
Generally, the Compensation Committee’s approach has been
to approve total compensation including the annual bonus for our
Named Executives. The Compensation Committee does not
necessarily grant share-based awards on an annual basis to
employees, including the Named Executives, but considers the
number of outstanding share-based awards already awarded to the
employee when determining total compensation in any year. Upon
the expiration of an employee’s share-based awards, the
Compensation Committee makes the determination whether or not to
grant new awards and on what terms. All share-based awards are
priced at fair value at the grant date. The Compensation
Committee believes that, as shareholders, the Named Executives
will be motivated to consistently deliver financial results that
build wealth for all shareholders over the long-term. The
adoption of Statement of Financial Accounting Standards, or
SFAS, 123(R), “Share-Based Payment”, on
January 1, 2006, requires us to expense stock options.
Since 2006, we granted only a very limited number of stock
options and none to the Named Executives. The Compensation
Committee is cognizant of the impact of SFAS 123(R) on our
financial results and will strive to balance the granting of
stock options and stock awards with the other objectives of
executive compensation set forth above. See discussion under
“Stock Option Grants” and “Stock
Awards” below.
The Compensation Committee believes that this approach best
serves the interests of shareholders by enabling us to structure
compensation in a way that meets the requirements of the highly
competitive environment in which we operate, while ensuring that
senior executive officers are compensated in a manner that
advances both our short and long-term interests and those of our
shareholders. The Compensation Committee is limited in its
ability to make share-based awards due to the relatively small
number of our outstanding Class A Shares and our policy
that share-based compensation not exceed 20% of the outstanding
Class A Shares. At March 30, 2009, we had shareholder
approval to award 2,394,176 Class A Shares pursuant to our
share-based awards plans (18.3% of its outstanding Class A
and Class B Shares), of which
42
1,259,574 Class A Shares are the subject of current
share-based compensation arrangements and subject to vesting
requirements.
Compensation for our senior executive officers, except the Chief
Executive Officer, involves a significant component of
remuneration which is contingent on our performance and that of
the senior executive officer: the annual bonus (which permits
individual performance to be recognized on an annual basis, and
which is based, in significant part, on an evaluation of the
contribution made by the officer) and share-based awards (which
directly relate a portion of compensation to stock price
appreciation realized by our shareholders).
On January 14, 2008, we acquired a large part of the U.S.
capital markets business of CIBC World Markets Corporation, or
CIBC. In connection with this acquisition, offers of employment
were made to certain former CIBC employees. The terms of certain
of these offers of employment included guaranteed salary and
bonus amounts for fiscal 2008 as well as stock option awards and
/or stock awards. In connection with the CIBC acquisition, we
agreed to pay CIBC future payments of deferred incentive
compensation to former CIBC employees for awards made by CIBC
prior to January 14, 2008: an estimated $54.3 million
over three years from 2008 through 2010 (2008 —
$5.3 million;
2009 -
$18.4 million; 2010 — $30.6 million). We
recorded approximately $40.2 million of such expense in the
consolidated statement of operations for the year ended
December 31, 2008 ($33.2 million is included in
compensation and related expenses and $7.0 million is
included in interest expense). In excess of 50% of these total
incentive compensation commitments were accrued in 2008. The
CIBC acquisition is described in note 18 to our
consolidated financial statements for the year ended
December 31, 2008 included in Item 8 of our Annual
Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular. Messrs. Heinberg, Perman
and Holmes, hereinafter called the Former CIBC Executives,
appear as Named Executives in our Summary Compensation Table.
Determination
of 2008 Compensation
The Compensation Committee, with recommendations from the Chief
Executive Officer, determined all compensation for each Named
Executive, except the Chief Executive Officer and the Former
CIBC Executives, for 2008. For a discussion of the compensation
for the Chief Executive Officer, see the section entitled
“Chief Executive Officer Compensation”
below. Compensation was guaranteed in 2008 for the Former CIBC
Executives. The Former CIBC Executives were previously employed
by CIBC and transferred to Oppenheimer & Co., our
subsidiary, on January 14, 2008, as part of our acquisition
of certain assets of the U.S. investment banking business of
CIBC World Markets Corp. pursuant to an Asset Purchase Agreement
entered into on November 2, 2007, which we refer to as the
CIBC Acquisition, with their acceptance of employment in January
2008. The compensation guarantees for the Former CIBC Executives
applied only to compensation awarded in 2008. In addition, the
Former CIBC Executives received deferred incentive compensation
for awards made by CIBC prior to January 14, 2008. The CIBC
Acquisition is described in note 18 to our consolidated
financial statements for the year ended December 31, 2008
included in Item 8 of our Annual Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular.
The Compensation Committee determines each Named
Executive’s, except that of the Former CIBC
Executives’, annual salary, annual bonus and share-based
awards by reference to the executive’s position,
responsibilities and performance. Some of the factors considered
by the Compensation Committee are:
|
|
|
| |
•
|
the position’s responsibilities relative to our total
earnings, use of invested capital, and the stable generation of
earnings and cash flows, and
|
| |
| |
•
|
the position’s impact on key strategic initiatives.
|
The Chief Executive Officer assessed each Named Executive’s
(other than the Chief Executive Officer’s and the Former
CIBC Executives’) performance under the performance
assessment policies, and the Compensation Committee assessed the
Chief Executive Officer’s performance. Our performance
assessment policy rates performance in different competencies,
as follows:
|
|
|
| |
•
|
strategic thinking;
|
| |
| |
•
|
integrity;
|
| |
| |
•
|
managing employee performance and morale;
|
| |
| |
•
|
financial responsibility;
|
| |
| |
•
|
achievement focus;
|
| |
| |
•
|
business judgment;
|
43
|
|
|
| |
•
|
planning & organization;
|
| |
| |
•
|
leadership;
|
| |
| |
•
|
mentoring;
|
| |
| |
•
|
relationship building;
|
| |
| |
•
|
compliance with regulatory requirements and company policies;
|
| |
| |
•
|
profitability of business unit, if applicable;
|
| |
| |
•
|
conflict resolution; and
|
| |
| |
•
|
communication.
|
Base Salary. Salaries paid to senior executive
officers (other than the Chief Executive Officer and the Former
CIBC Executives) are reviewed annually by the Compensation
Committee considering recommendations made by the Chief
Executive Officer to the Compensation Committee, based upon the
Chief Executive Officer’s assessment of the nature of the
position, and the skills, experience and performance of each
senior executive officer, as well as salaries paid by comparable
companies in our industry. The Compensation Committee then makes
recommendations to the Board of Directors with respect to base
salaries. Base salaries paid to senior officers in 2008 were not
increased from 2007 levels except with respect to
Ms. Roberts whose base salary was increased by $25,000 to
compensate for her ineligibility to receive directors’ fees
in 2008 in accordance with our policy to pay directors’
fees only to non-employee directors beginning in 2008.
Annual Bonus. Bonuses paid to our senior
executive officers (other than the Chief Executive Officer and
the Former CIBC Executives) are reviewed annually by the
Compensation Committee considering recommendations made by the
Chief Executive Officer to the Compensation Committee, based
upon the Chief Executive Officer’s assessment of the
performance of the Corporation and his assessment of the
contribution of each senior executive to that performance. The
Compensation Committee then makes recommendations to the Board
of Directors with respect to bonuses. Annual bonuses for our
senior executive officers were lower in 2008 compared to 2007 in
response to the operational losses experienced by us in 2008
compared to record earnings in 2007. The Compensation Committee
recognizes that the severe downturn in the economic environment
coupled with the high costs in 2008 associated with the CIBC
Acquisition contributed to the financial losses in fiscal 2008.
However, despite the high level of effort from the senior
executive officers in 2008, their bonus compensation was scaled
back to reflect our operational losses in 2008. Senior executive
officers, including the Chief Executive Officer, have the right
to elect to defer a portion of their annual bonus and
performance-based compensation under our Executive Deferred
Compensation Plan, a non-qualified unfunded plan.
Stock Option Grants. Under our 2006 Equity
Incentive Plan, or EIP, our senior executive officers and
employees may be granted stock options by the Compensation
Committee based upon a variety of considerations, including the
date of the last grant made to the officer or employee, as well
as considerations relating to the contribution and performance
of the specific optionee. In addition, stock option grants may
be awarded as a retention tool for new employees. Due to the
relatively high cost of stock option awards since the adoption
of SFAS 123(R) on January 1, 2006, we have generally
limited our use of this type of award.
On January 29, 2008, the Compensation Committee, in
accordance with the EIP, granted options to purchase up to
225,136 Class A Shares, which we refer to as the
“Retention Options”, to the investment bankers, or the
“Optionees” previously employed by CIBC World Markets
Corporation who transferred to our company on January 14,
2008, as part of the CIBC Acquisition, including 28,500 to
Mr. Heinberg and 7,495 to Mr. Perman.
The November 2, 2007 Asset Purchase Agreement for the CIBC
Acquisition provided that certain CIBC World Markets investment
bankers would, if they transferred to our company and so
elected, be granted options as part of their
compensation/retention packages. We negotiated offer letters
with each of the Optionees commencing December 12, 2007 and
culminating with signed offer letters on January 9, 2008
which provided that the Optionees electing to receive Retention
Options would be granted Retention Options at the time of the
Board of Directors meeting next following the closing of the
CIBC Acquisition with exercise prices equal to the closing price
of the Class A Shares on the NYSE on the date of the Board
of Directors meeting which would be no later than
January 31, 2008. Two of the Named Executives,
Messrs. Heinberg and Perman, were recipients of Retention
Options.
44
On January 29, 2008, the date of the Board of Directors
meeting next following the closing of the CIBC Acquisition, the
Compensation Committee granted the Retention Options with an
exercise price of $39.45 per Class A Share, the closing
price of the Class A Shares on that date. The Retention
Options are three-year options which vest as to one-third each
on the first and second anniversary dates of the grants and as
to the balance 90 days prior to their expiry date.
Also on January 29, 2008, the Board approved our unaudited
financial results for the year ended December 31, 2007
which were released on January 30, 2008, on which date the
closing price for the Class A Shares on the NYSE was $43.99
per share and had ranged between $43.65 and $47.80 during that
time. Because we were legally obligated to grant the Retention
Options which do not begin to vest for one year from the grant
date and the recipients of the options did not have information
with respect to our 2007 financial results, the Compensation
Committee granted the options on such date.
No Backdating or Spring Loading. We do not
backdate options or grant options retroactively. In addition, we
do not plan to coordinate grants of options so that they are
made before the announcement of favorable information, or after
the announcement of unfavorable information. Our options are
granted by the Compensation Committee at fair market value on a
fixed date or event (such as the first regular meeting of the
Board of Directors following an employee’s hire), with all
required approvals obtained in advance of or on the actual grant
date. All grants of options are made by the Compensation
Committee.
Fair Market Value. Fair market value has been
consistently determined, as required by the EIP, as the share
closing price on the NYSE on the grant date.
Stock Awards. Under our Employee Share Plan,
or the ESP, our and our subsidiaries’ executive officers
and employees (other than the Chief Executive Officer) are
granted stock awards by the Compensation Committee based upon
the recommendations of the Chief Executive Officer and based
upon a variety of considerations, relating to the contribution
and performance of the specific award recipient. A limited
number of senior executives and employees, none of whom are
Named Executives, are offered the opportunity to receive up to
25% of their year-end bonus in Class A Shares. For example,
under the terms of this offer, if extended, the employee may
elect (in December 2008) with respect to his/her
2009 year-end bonus to purchase Class A Shares at fair
market value on a pre-determined date in the first week of
January 2010, determined by the Compensation Committee. If such
election is made, the executive is awarded a number of
restricted Class A Shares equal to 15% of the Class A
Shares purchased by the executive, which restricted Class A
Shares vest on the third anniversary date of the award of such
shares. In addition, stock awards may be awarded as an
inducement to employment for new employees and as a retention
tool for existing employees. Stock awards are invariably subject
to a vesting period and we believe that these awards are useful
in retaining our key executive personnel. On January 29,
2008, we awarded 417,363 restricted Class A Shares to our
employees under the ESP, including 25,000 to the Chief Executive
Officer, 10,000 to Ms. Roberts, 10,000 to Mr. Heinberg
and 10,000 to Mr. Perman. These awards vest on
January 28, 2011. On February 25, 2009, we awarded
additional restricted Class A Shares to our employees under
the ESP, including 75,000 to Mr. Lowenthal and 10,000 to
each of Ms. Roberts and Mr. Holmes.
Executive Deferred Compensation Plan. The
Executive Deferred Compensation Plan, or EDCP, was established
with a dual purpose. The EDCP, together with its sister plan,
the Deferred Incentive Plan, or DIP, is maintained to offer
certain high-performing financial advisors bonuses requiring a
mandatory deferral subject to vesting provisions. Further
description of the EDCP and the DIP can be found in note 12
to our consolidated financial statements for the year ended
December 31, 2008 included in Item 8 of our Annual
Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular. The EDCP also provides for
voluntary deferral of year-end bonuses by our senior executives.
These voluntary deferrals are not subject to vesting. We do not
make contributions to the EDCP for the Named Executives and
other senior level executives. Mr. Lowenthal has made
voluntary deferrals into the EDCP in past years. The EDCP
provides a benefit to participants in that the
participant’s year-end bonus can be deferred on a tax free
basis until a pre-designated future time. This type of benefit
is commonly available to senior executive officers of our
competitors and is offered by us in order to remain competitive.
Benefits. The Named Executives who are
U.S.-based
salaried employees participate in a variety of benefits designed
to enable us to attract and retain our workforce in a
competitive marketplace. We help ensure a productive and focused
workforce through reliable and competitive health and other
benefits. Deferred compensation and 401(k) plans help employees,
especially long-service employees, save and prepare financially
for retirement. The Named Executives receive the same benefits
as all full-time employees. Our qualified 401(k) Plan allowed
employees to contribute up to $15,500 for 2008 plus an
additional $5,000 for employees over age 50. Employees may
continue to retain their 401(k) Plan account after they leave us
so long as their account balance is $5,000 or more. At
age 70.5, minimum distributions must begin.
Ms. Roberts, who is a Canadian-based salaried employee,
only receives health benefits.
45
Perquisites. The Named Executives, along with
other senior management employees, are provided a limited number
of perquisites whose primary purpose is to minimize distractions
from the executive’s attention to important corporate
initiatives. An item is not a perquisite if it is integrally and
directly related to the performance of the executive’s
duties. An item that is not integrally and directly related to
the performance of the executive’s duties is a perquisite
if it confers a direct or indirect benefit that has a personal
aspect, without regard to whether it may be provided for some
business reason or for our convenience, unless it is generally
available on a non-discriminatory basis to all employees.
We provide the following perquisites, all of which are
quantified in the “Summary Compensation Table” below
and detailed in the “All Other Compensation Table”
below.
Parking — Mr. Lowenthal and
Ms. Roberts have company-paid parking arrangements. This
benefit is included in the “Summary Compensation
Table” below.
We do not provide the Named Executives with any other
perquisites, such as split-dollar life insurance, reimbursement
for legal counseling for personal matters, or tax reimbursement
payments. We do not provide loans to executive officers, other
than margin loans in margin accounts with us in connection with
the purchase of securities (including our securities) which
margin accounts are substantially on the same terms, including
interest rates and collateral, as those prevailing from time to
time for comparable transactions with non-affiliated persons and
do not involve more than the normal risk of collectibility. See
“Certain Relationships and Related Party
Transactions” below.
Separation and Change in Control
Arrangements. The Named Executives are not
eligible for benefits and payments if employment terminates in a
separation or if there is a change in control. We do not sponsor
a pension plan for our employees.
Chief
Executive Officer Compensation
Mr. A.G. Lowenthal, our Chairman of the Board and Chief
Executive Officer, is paid an annual base salary set by the
Compensation Committee, plus performance-based compensation
under the Performance-Based Compensation Agreement and, at the
discretion of the Compensation Committee, is eligible for
bonuses and grants of stock options and restricted shares.
On March 15, 2005, we entered into the Performance-Based
Compensation Agreement with Mr. Lowenthal, which was
approved by the Class B Shareholders on May 9, 2005.
The purpose of the Performance-Based Compensation Agreement is
to allow the Compensation Committee to set the annual terms
under which Mr. Lowenthal’s annual performance-based
compensation is to be calculated during the term thereof.
Mr. Lowenthal’s role in determining our success or
failure has greater bearing on our ultimate results and
financial condition than our other executive officers’
because of the nature of his role as Chief Executive Officer.
Therefore, the Compensation Committee has determined that his
compensation should be subject to higher risk on both the upside
and the downside to reflect our results.
In March of 2008, the Compensation Committee established
performance goals under the Performance-Based Compensation
Agreement entitling Mr. Lowenthal to a Performance Award
under the Performance-Based Compensation Agreement for the year
2008 of an aggregate of up to $5 million (the maximum bonus
available in a single year) determined by the application of a
formula based on the following components: (a) an amount
equal to 5% of the amount by which our consolidated profit
before income taxes for the year ended December 31, 2008
exceeds 10% of our consolidated shareholders’ equity as at
December 31, 2007; plus (b) an amount equal to
(i) 2.5% of the amount by which our consolidated profit
before income tax for the year ended December 31, 2008 is
greater than $0 and less than $10 million; plus
(ii) 4% of the amount by which our consolidated profit
before income tax for the year ended December 31, 2008 is
greater than $10 million and less than $40 million;
plus (iii) 5% of the amount by which our consolidated
profit before income tax for the year ended December 31,
2008 is greater than $40 million; plus (c) an amount
equal to the amount by which the closing price of the
Class A Shares on the NYSE (the “Market Value”)
of one Class A Share at December 31, 2008 exceeds the
Market Value of one Class A Share at December 31, 2007
multiplied by 200,000 shares. The application of the 2008
formula as set out above produced a bonus of nil for fiscal
2008. Mr. Lowenthal’s bonus is included in the
“Summary Compensation Table” below. In March of 2008,
the Compensation Committee set Mr. Lowenthal’s base
salary for 2008 at $500,000.
46
U.S.
Internal Revenue Code Section 162(m)
We are a Canadian taxpayer. However, because
Oppenheimer & Co., our subsidiary, is also a U.S.
taxpayer, most compensation issues are affected by the Code.
Section 162(m) of the Code generally disallows a tax
deduction for annual compensation (other than compensation that
qualifies as performance-based compensation within the meaning
of Section 162(m)) in excess of $1 million paid to our
Chief Executive Officer and our three other most highly
compensated executive officers, other than the Chief Executive
Officer and the Chief Financial Officer, whose compensation is
required to be disclosed in this Circular.
Messrs. Heinberg, Perman and Holmes are not subject to
Section 162(m) because they are not executive officers and
we are not required to disclose their compensation. The
Performance-Based Compensation Agreement was adopted and
approved by the Class B Shareholders so that it would
satisfy the requirements for performance-based compensation.
To the extent consistent with our general compensation
objectives, the Compensation Committee considers the potential
effect of Section 162(m) on compensation paid to our
executive officers. However, the Compensation Committee reserves
the right to award and recommend the awarding of non-deductible
compensation in any circumstances it deems appropriate. Further,
because of ambiguities and uncertainties as to the application
and interpretation of Section 162(m) and the regulations
issued thereunder, no assurance can be given, notwithstanding
our efforts to qualify, that the compensation paid by us to our
executive officers will in fact satisfy the requirements for the
exemption from the Section 162(m) deduction limit.
Executive
Compensation
COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Messrs. Ehrhardt, Keehner and Winberg served as members of
the Compensation Committee for the fiscal year ending
December 31, 2008. None of the members of the Compensation
Committee is or has ever been one of our officers or employees.
No interlocking relationship exists between our Board of
Directors or Compensation Committee and the board of directors
or compensation committee of any other entity.
47
REPORT OF
THE COMPENSATION AND STOCK OPTION COMMITTEE
The Compensation Committee, comprised of independent directors,
reviewed and discussed the above Compensation Discussion and
Analysis with our management. In reaching its conclusions, the
members of the Compensation Committee were aware of the recent
focus of the media, the government and the general population on
the compensation of executives and employees of financial
service companies. The Compensation Committee determined that
our practices aligned pay practices with corporate success, and
that the payments made to executives and employees were
substantially so aligned, except that in the case of a
substantial number of new employees who, as a result of the
terms of the CIBC Acquisition, had their compensation
contractually determined for the fiscal year 2008 and no
measurement standard could be applied to align the compensation
with benefits received by us. Based on the review and
discussions, the Compensation Committee approved and recommended
to our Board of Directors that the Compensation Discussion and
Analysis be included in this Circular.
Members
of the Compensation and Stock Option Committee
Michael A.M. Keehner — Chairman
William Ehrhardt
Burton Winberg
48
SUMMARY
COMPENSATION TABLE
For the Year Ended December 31, 2008
The following table sets forth the total annual compensation
paid or accrued by us to or for the account of our Chief
Executive Officer, and our President and Chief Financial
Officer, for the three years ended December 31, 2008, our
only officers whose total cash compensation exceeded $100,000
for the year ended December 31, 2008. In an effort to
provide more complete disclosure, the table also lists the next
three most highly paid executive officers of our subsidiary,
Oppenheimer & Co., whose total cash compensation for
the year ended December 31, 2008 exceeded $100,000. The
three executive officers of Oppenheimer & Co.
appearing in the table below are not officers of Oppenheimer
Holdings Inc., and they do not perform policy making functions
for Oppenheimer Holdings Inc.
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and Nonqual-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
ified Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
|
Year
|
|
|
Salary ($)
|
|
|
Bonus ($)
|
|
|
Awards ($)
|
|
|
Awards ($)
|
|
|
Compensation
|
|
|
Earnings ($)
|
|
|
Compensation($)
|
|
|
Total ($)
|
|
|
Name and Principal Position (a)
|
|
(b)
|
|
|
(c)
|
|
|
(d)(1)
|
|
|
(e)(2)
|
|
|
(f)(2)
|
|
|
(g)(1)
|
|
|
(h)(3)
|
|
|
(i)(4)
|
|
|
(j)
|
|
|
|
|
A. G. Lowenthal
|
|
|
2008
|
|
|
$
|
500,000
|
|
|
|
—
|
|
|
$
|
276,721
|
|
|
$
|
155,517
|
|
|
|
—
|
|
|
|
—
|
|
|
|
5,750
|
|
|
$
|
937,988
|
|
|
Chairman, CEO, and
|
|
|
2007
|
|
|
$
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
335,769
|
|
|
$
|
5,000,000
|
|
|
|
—
|
|
|
$
|
40,741
|
|
|
$
|
5,876,510
|
|
|
Director of the Corporation and Oppenheimer
|
|
|
2006
|
|
|
$
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
664,057
|
|
|
$
|
3,950,000
|
|
|
|
—
|
|
|
$
|
42,099
|
|
|
$
|
5,156,156
|
|
|
E. K. Roberts
|
|
|
2008
|
|
|
$
|
225,000
|
|
|
$
|
150,000
|
|
|
$
|
110,689
|
|
|
$
|
77,759
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,700
|
|
|
$
|
566,148
|
|
|
President, Treasurer, CFO
|
|
|
2007
|
|
|
$
|
200,000
|
|
|
$
|
500,000
|
|
|
|
—
|
|
|
$
|
125,241
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
30,675
|
|
|
$
|
855,916
|
|
|
and Director of the Corporation and Treasurer of Oppenheimer
|
|
|
2006
|
|
|
$
|
200,000
|
|
|
$
|
400,000
|
|
|
|
—
|
|
|
$
|
192,510
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
34,100
|
|
|
$
|
893,780
|
|
|
M.
Heinberg(5)
|
|
|
2008
|
|
|
$
|
200,000
|
|
|
$
|
2,594,250
|
|
|
$
|
115,333
|
|
|
$
|
86,788
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
2,996,371
|
|
|
Senior Managing Director Investment Banking for Oppenheimer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B.
Perman(5)
|
|
|
2008
|
|
|
$
|
178,000
|
|
|
$
|
1,184,500
|
|
|
$
|
115,333
|
|
|
$
|
30,452
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1,500,657
|
|
|
Senior Managing Director Leverage Finance for Oppenheimer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C.
Holmes(5)
|
|
|
2008
|
|
|
$
|
185,000
|
|
|
$
|
1,061,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1,246,000
|
|
|
Senior Managing Director Equity Capital Markets for Oppenheimer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Summary Compensation Table:
|
|
| (1)
|
The Bonus and Non-Equity Incentive Plan Compensation amounts are
not reduced by the Named Executive’s election, if any, to
defer receipt of bonuses into the EDCP or an election to convert
a portion of his bonus into the purchase of Class A Shares.
None of these conditions applied in 2008.
|
| |
| (2)
|
The values of stock options (granted under the EIP) and stock
awards (granted under the ESP) represent the dollar amounts
recognized for financial statement reporting purposes for the
years ended December 31, 2008, 2007 and 2006 based on grant
date fair value and represent the amortized cost of these awards
to us in the applicable fiscal year. Stock options and stock
awards are valued at grant date fair value. We recognize the
expense of share-based awards over the vesting period of the
award. The underlying assumptions and methodology used to value
our stock options and stock awards are described in note 12
to our consolidated financial statements for the year ended
December 31, 2008 included in Item 8 of our Annual
Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular. Details of stock options and
stock awards held by the Named Executives appear in the
“Outstanding Equity Awards Table” and notes thereto,
appearing below.
|
| |
| (3)
|
We offer a non-qualified deferred compensation plan into which
senior executives, including the U.S. Named Executives, may
elect to defer some or all of their year-end bonuses. No
above-market earnings were recorded. Details about the earnings
from the EDCP appear below in the “Nonqualified Deferred
Compensation Table.”
|
| |
| (4)
|
See the chart below — “All Other Compensation
Table” — for a description of the amounts
appearing in column (i). All other compensation includes
perquisites.
|
| |
| (5)
|
Messrs. Heinberg, Perman and Holmes joined our company on
January 14, 2008 as part of the CIBC Acquisition. In
connection with the CIBC Acquisition, we agreed to pay CIBC for
future payments of deferred incentive compensation to former
CIBC employees for awards made by CIBC prior to January 14,
2008. Messrs. Heinberg, Perman and Holmes are three of
these former CIBC employees. In 2008, 29,447, 7,129, and 9,005
deferred incentive compensation awards vested for
Messrs. Heinberg, Perman, and Holmes, respectively,
representing a total amount due to CIBC by us of
$3.3 million related to this deferred incentive
compensation. Pursuant to terms of their employment with us, the
minimum amounts to be paid to Messrs. Heinberg, Perman and
Holmes’ salaries and year-end bonuses were guaranteed for
fiscal 2008, and such amounts are reflected in the “Summary
Compensation Table”. The CIBC Acquisition is described in
note 18 to our consolidated financial statements for the
year ended December 31, 2008 included in Item 8 of our
Annual Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular.
|
49
The following table describes non-employee director options held
at December 31, 2008 as well as the grant date fair value
of options granted in 2008 and numbers of unvested options
outstanding, as applicable.
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intrinsic Value
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
of Unexercised
|
|
|
Date Fair
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Options (as at
|
|
|
Value of
|
|
|
Unvested
|
|
|
|
|
|
|
|
|
|
|
Exercise
|
|
|
Options
|
|
|
December 31,
|
|
|
Equity
|
|
|
Options
|
|
|
Name(4)
|
|
Grant Date
|
|
|
Expiry Date
|
|
|
Price
|
|
|
Granted
|
|
|
2008)(2)
|
|
|
Awards(1)
|
|
|
Outstanding(3)
|
|
|
|
|
J. L. Bitove
|
|
|
2/25/2007
|
|
|
|
2/24/2012
|
|
|
$
|
35.03
|
|
|
|
25,000
|
|
|
$
|
nil
|
|
|
$
|
335,700
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R. Crystal
|
|
|
1/02/2006
|
|
|
|
1/01/2011
|
|
|
$
|
19.99
|
|
|
|
20,000
|
|
|
$
|
nil
|
|
|
$
|
156,525
|
|
|
|
20,000
|
|
|
|
|
|
1231/2006
|
|
|
|
12/31/2011
|
|
|
$
|
33.40
|
|
|
|
5,000
|
|
|
|
|
|
|
|
—
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
K. W. McArthur
|
|
|
5/17/2004
|
|
|
|
5/16/2009
|
|
|
$
|
28.00
|
|
|
|
15,000
|
|
|
$
|
nil
|
|
|
$
|
145,740
|
|
|
|
—
|
|
|
|
|
|
1/01/2005
|
|
|
|
12/31/2010
|
|
|
$
|
25.53
|
|
|
|
5,000
|
|
|
|
|
|
|
|
—
|
|
|
|
7,500
|
|
|
|
|
|
1/02/2006
|
|
|
|
1/01/2011
|
|
|
$
|
19.99
|
|
|
|
5,000
|
|
|
|
|
|
|
|
—
|
|
|
|
2,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A.W. Oughtred
|
|
|
2/25/2007
|
|
|
|
2/24/2012
|
|
|
$
|
35.03
|
|
|
|
25,000
|
|
|
$
|
nil
|
|
|
$
|
335,700
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B. Winberg
|
|
|
2/25/2007
|
|
|
|
2/24/2012
|
|
|
$
|
35.03
|
|
|
|
25,000
|
|
|
$
|
nil
|
|
|
$
|
335,700
|
|
|
|
25,000
|
|
Notes:
|
|
| (1)
|
The underlying assumptions and methodology used to value our
stock options are described in note 12 to our consolidated
financial statements for the year ended December 31, 2008
included in Item 8 of our Annual Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular.
|
| |
| (2)
|
The intrinsic value of unexercised options is based on the
closing price of the Class A Shares on the NYSE on
December 31, 2008 of $12.88.
|
| |
| (3)
|
Stock options held by the non-employee directors vest as
follows: 25% on the second anniversary of grant, 25% on the
third anniversary of grant, 25% on the fourth anniversary of
grant and the balance six months before the expiry date.
|
| |
| (4)
|
Stock options on 5,000 Class A Shares will be granted to
each of M.A.M. Keehner and W. Ehrhardt on May 5, 2009, the
completion date of their first full year of service.
|
Directors’
and Officers’ Insurance
We carry liability insurance for our directors and officers and
the directors and officers of our subsidiaries. Between
November 30, 2007 and November 30, 2008, our aggregate
insurance coverage was $30 million with a $2.5 million
deductible and an aggregate annual premium of $663,000. The
coverage was renewed for a further year effective
November 30, 2008 at an aggregate annual premium of
$850,000.
Under our by-laws, we are obligated to indemnify our and our
subsidiaries’ directors and officers to the maximum extent
permitted by the CBCA. We have entered into indemnity agreements
with each of our directors providing for such indemnities.
Corporate
Governance
Our Class A Shares are listed on the NYSE. We are subject
to the corporate governance and disclosure requirements of the
Canadian securities administrators, or the CSA, the corporate
governance listing standards of the NYSE, the applicable rules
of the SEC, and the provisions of the Sarbanes-Oxley Act of 2002.
Our Nominating and Corporate Governance Committee and our Board
of Directors continue to monitor regulatory changes and best
practices in corporate governance and consider amendments to our
practices and policies as appropriate.
Our Statement of Corporate Governance Practices, Code of Conduct
and Committee Charters, as well as our Code of Ethics and
Business Ethics for Directors, Officers and Employees and our
Whistleblower Policy, are posted on our website at
www.opco.com. These documents are available at no charge
and can also be requested by writing to us at our head office or
by making an email request to investorrelations@opy.ca.
Mandate
and Duties of the Board of Directors
The fundamental responsibility of the Board of Directors is to
supervise the management of our business with a view to
maximizing shareholder value and ensuring corporate conduct in a
legal and ethical manner through a system of corporate
governance and internal controls appropriate to our business.
Given the nature of our business and the size and
53
composition of the Board of Directors, the Board of Directors
has determined that there is no current need to develop specific
mandates or position descriptions for the Board of Directors,
the Lead Director, the Chief Executive Officer or the chairs of
the Board committees. The Board of Directors has adopted a
statement of Corporate Governance Guidelines to which it
adheres. We have a Code of Conduct and Business Ethics for
Directors, Officers and Employees which is posted on our
website — www.opco.com — and
available in hard copy from our head office. No waivers were
granted in 2008 or to date in 2009 under the Code of Conduct and
Business Ethics for Directors, Officers and Employees.
In fulfilling its mandate, the Board of Directors’
responsibilities include:
|
|
|
| |
•
|
the establishment and maintenance of an appropriate system of
corporate governance, including practices to ensure that the
Board of Directors functions effectively and independently of
management;
|
| |
| |
•
|
monitoring and overseeing our strategic planning;
|
| |
| |
•
|
monitoring the performance of our business, identifying and
evaluating opportunities and risks and controlling risk;
|
| |
| |
•
|
overseeing monitoring systems for internal controls, audit and
information management systems;
|
| |
| |
•
|
assessing and monitoring the performance of senior management
and overseeing succession planning;
|
| |
| |
•
|
remuneration of executive officers and senior management and
reviewing our general compensation policy;
|
| |
| |
•
|
reviewing and approving our financial statements and overseeing
our compliance with applicable audit, accounting and financial
reporting requirements; and
|
| |
| |
•
|
overseeing corporate communications to all stakeholders.
|
Independence
of the Board of Directors
Six of our current nine directors are independent (and six of
the nine individuals nominated for election as directors at the
Meeting will be independent) as required by the NYSE Corporate
Governance Rules. To be considered independent under these
rules, the Board of Directors must determine that a director has
no direct or indirect material relationship with us. The Board
of Directors has determined that Messrs. Bitove, Crystal,
Ehrhardt, Keehner, McArthur and Winberg (the non-management
Directors) are independent directors, and that
Mr. Lowenthal, our Chairman of the Board of Directors and
Chief Executive Officer, Ms. Roberts, our President and
Treasurer and Mr. Oughtred, our former Secretary, are not
independent.
The Board of Directors has not adopted formal categorical
standards to assist in determining independence. The Board of
Directors has considered the relationship of each
non-management/officer director and has made a determination
that the six of our non-management/officer directors are
independent.
Until November 30, 2008, Mr. Crystal was a partner in
the law firm of Thelen Reid Brown Raysman & Steiner
LLP, which firm provided legal services to us. In view of the
professional ethical standards which govern his conduct, the
fact that less than one percent of the annual revenues of his
former firm were derived from us, and that Mr. Crystal
receives no direct compensation from us other than his
director’s compensation, his former relationship with us is
not material for purposes of determining that he is an
independent director. Mr. Crystal has been a partner of
Seyfarth Shaw LLP since December 1, 2008. Seyfarth Shaw LLP
does not have a relationship with us.
At each regular Board and Audit Committee meeting, the
independent directors are afforded an opportunity to meet in the
absence of management. During 2008, five meetings of the
independent directors were held in the absence of management.
Additionally, at regular meetings of the Audit Committee (five
regular meetings annually), the members of the Committee are
afforded the opportunity to meet with the auditors in the
absence of management.
The independent directors and the directors that are not
independent understand the need for directors to be
independent-minded and to assess and question management
initiatives and recommendations from an independent perspective.
The Board of Directors’ Lead Director, Mr. K. W.
McArthur, is an independent director who, among other things,
chairs sessions of the independent directors.
Orientation
and Continuing Education
The Nominating/Corporate Governance Committee of the Board of
Directors, as required by its charter, is responsible for the
orientation of new directors to our business, the role of the
Board of Directors and the Board committees.
54
The Board of Directors encourages the directors to maintain the
skill and knowledge necessary to meet their obligations as
directors. This includes attendance at continuing education
sessions and providing written materials on governance and
related matters. Mr. A. W. Oughtred is certified as an
Institute of Corporate Directors Director (ICD.D).
Mr. Keehner attended an Institutional Shareholder Services
accredited education conference for board directors in 2008 and
earned eight credits.
Director,
Committee Assessments
The Board of Directors does not currently have a formal director
assessment process. The Board of Directors’ Lead Director
is responsible for assessing the performance and contribution of
individual Board of Directors members with members of the
Nominating/Corporate Governance Committee and, if necessary,
addressing issues arising from such assessments.
The Board of Directors formally assesses the Audit Committee on
an annual basis.
Nominating
and Corporate Governance Committee
Each member of the Nominating/Corporate Governance Committee is
independent. The duties of this Committee, which include the
recruitment of directors and the nomination of individuals for
Board positions, are set out as follows:
|
|
|
| |
•
|
make recommendations to the Board of Directors with respect to
corporate governance;
|
| |
| |
•
|
when necessary, oversee the recruitment of new directors;
|
| |
| |
•
|
nominate candidates for election or appointment to the Board of
Directors;
|
| |
| |
•
|
maintain an orientation program for new directors and oversees
the continuing education needs of directors;
|
| |
| |
•
|
evaluate director performance;
|
| |
| |
•
|
review and make recommendations with respect to our Corporate
Governance Guidelines; and
|
| |
| |
•
|
review and approve governance reports for publication in our
management proxy circular and Annual Report on
Form 10-K.
|
The Nominating/Corporate Governance Committee Charter provides
that the Nominating/Corporate Governance Committee is
responsible for ensuring that our Board of Directors is composed
of directors who are fully able and fully committed to serve the
best interests our shareholders. Factors considered by the
Nominating/Corporate Governance Committee in assessing director
performance and, when needed, recruiting new directors include
character, judgment, experience, compatibility with the existing
Board of Directors, ethics, standards and integrity. The
Nominating/Corporate Governance Committee will consider nominees
recommended by Class B Shareholders. Nominees recommended
by Class B Shareholders will be given appropriate
consideration and will be evaluated in the same manner as other
nominees. Class B Shareholders who wish to submit nominees
for director for consideration by the Nominating/Corporate
Governance Committee for election at our 2009 Annual and Special
Meeting of Shareholders may do so by submitting in writing such
nominee’s name, in compliance with the procedures and along
with the other information required by our By-laws and
Regulation 14A under the Exchange Act (including such
nominee’s written consent to being named in the proxy
statement as a nominee and to serving as a director if elected),
to our Secretary, at 20 Eglinton Avenue West, Suite 1110,
Toronto, Ontario, Canada M4R 1K8 within the time frames set
forth under the heading “Shareholder Proposals”.
Compensation
and Stock Option Committee
The Board of Directors has adopted a Compensation and Stock
Option Committee Charter. All members of the Compensation and
Stock Option Committee are independent. The Compensation and
Stock Option Committee:
|
|
|
| |
•
|
makes recommendations to the Board of Directors with respect to
our compensation policy;
|
| |
| |
•
|
makes recommendations to the Board of Directors with respect to
salary, bonus and benefits paid and provided to our senior
management;
|
| |
| |
•
|
authorizes grants of stock options and other stock-based awards
and recommends modifications to the plans in accordance with the
provisions of our 2006 Equity Incentive Plan and Employee Share
Plan;
|
| |
| |
•
|
grants certain compensation awards to our senior management
based on criteria linked to the performance of the individual
and/or our company;
|
55
REPORT OF
THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
As required by the Nominating/Corporate Governance
Committee’s Charter, the Nominating/Corporate Governance
Committee reports as follows:
|
|
|
| |
•
|
The Nominating/Corporate Governance Committee is responsible for
maintaining and developing governance principles consistent with
high standards of corporate governance.
|
| |
| |
•
|
The Nominating/Corporate Governance Committee assessed the
composition and size of the Board of Directors and determined
that the incumbent directors are performing effectively and has
recommended that the slate remain unchanged.
|
| |
| |
•
|
The Nominating/Corporate Governance Committee determined that
Messrs. Bitove, Crystal, Ehrhardt, Keehner, McArthur and
Winberg are independent in accordance with our independence
standards. In addition, the Nominating/Corporate Governance
Committee monitored director attendance at Board of Directors
and committee meetings and determined that all directors
attended 100% of meetings and that such attendance meets
acceptable standards.
|
| |
| |
•
|
The Nominating/Corporate Governance Committee supervised the
Board of Directors’ annual review of our Corporate
Governance Guidelines.
|
Members
of the Nominating/Corporate Governance Committee
Richard Crystal — Chairman
John L. Bitove
Michael A.M. Keehner
59
Security
Ownership of Certain Beneficial Owners and Management
Our authorized capital includes 99,665 Class B Shares
all of which are issued and outstanding, and an unlimited number
of Class A Shares of which 12,968,992 Class A
Shares were outstanding, and an unlimited number of First
Preference Shares issuable in series of which none were
outstanding as of March 30, 2009.
The following table sets forth certain information regarding the
beneficial ownership of each class of our shares as of
March 30, 2009, with respect to (i) each person known
by us to beneficially own, or exercise control or discretion
over, more than 5% (except as otherwise indicated) of any class
of our shares, (ii) each of our directors and nominees for
director, (iii) each of our executive officers named in the
“Summary Compensation Table” set forth herein and
(iv) our directors, nominees for director and executive
officers as a group. The address of each beneficial owner for
which an address is not otherwise indicated is: c/o Oppenheimer
Holdings Inc., P.O. Box 2015, Suite 1110, 20 Eglinton
Avenue West, Toronto, Ontario, Canada M4R 1K8.
For purposes of the table, beneficial ownership is determined
pursuant to
Rule 13d-3
of the Exchange Act, pursuant to which a person or group of
persons is deemed to have “beneficial ownership” of
shares which such person or group has the right to acquire
within 60 days after March 30, 2009. The percentage of
shares deemed outstanding is based on 12,968,992 Class A
Shares and 99,665 Class B Shares outstanding as of
March 30, 2009. In addition, for purposes of computing the
percentage of Class A Shares owned by each person, the
percentage includes all Class A Shares issuable upon the
exercise of outstanding options held by such persons within
60 days after March 30, 2009.
There are no outstanding rights to acquire beneficial ownership
of any Class B Shares.
Mr. A.G. Lowenthal and Mrs. Olga Roberts have advised us
that they intend to vote all of the Class B Shares owned
and controlled by them for the matters referred to in the Notice
of Meeting to be voted on at the Meeting and all of the
Class A Shares owned and controlled by them for
Proposal 1 in the Notice of Meeting to be voted on at the
Meeting.
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Shares
|
|
|
Class B Shares
|
|
|
Name of Beneficial Owner
|
|
Shares
|
|
|
%
|
|
|
Shares
|
|
|
%
|
|
|
|
|
Private Capital Management,
L.P.(1)
|
|
|
1,289,922
|
|
|
|
9.9
|
%
|
|
|
—
|
|
|
|
—
|
|
|
Mackenzie Financial
Corporation(2)
|
|
|
803,919
|
|
|
|
6.2
|
%
|
|
|
—
|
|
|
|
—
|
|
|
GMT Capital
Corp.(3)
|
|
|
800,478
|
|
|
|
6.2
|
%
|
|
|
—
|
|
|
|
—
|
|
|
Howson Tattersall Investment Counsel
Ltd.(4)
|
|
|
797,719
|
|
|
|
6.2
|
%
|
|
|
—
|
|
|
|
—
|
|
|
River Road Asset Management,
LLC(5)
|
|
|
699,555
|
|
|
|
5.4
|
%
|
|
|
—
|
|
|
|
—
|
|
|
Olga
Roberts(6)
|
|
|
324,955
|
|
|
|
2.5
|
%
|
|
|
44,309
|
|
|
|
44.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officers, Directors,
and Others
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Albert G.
Lowenthal(7)
|
|
|
2,872,569
|
|
|
|
22.1
|
%
|
|
|
50,975
|
|
|
|
51.1
|
%
|
|
J.L.
Bitove(8)
|
|
|
6,730
|
|
|
|
*
|
|
|
|
20
|
|
|
|
*
|
|
|
R.
Crystal(9)
|
|
|
14,300
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
W. Ehrhardt
|
|
|
1,000
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
M.
Heinberg(10)
|
|
|
9,775
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
C.
Holmes(11)
|
|
|
20,655
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
M.A.M. Keehner
|
|
|
1,000
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
K.W.
McArthur(12)
|
|
|
66,950
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
A.W.
Oughtred(13)
|
|
|
13,050
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
B. Perman
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
E.K.
Roberts(14)
|
|
|
176,594
|
|
|
|
1.4
|
%
|
|
|
220
|
|
|
|
*
|
|
|
B.
Winberg(15)
|
|
|
15,050
|
|
|
|
*
|
|
|
|
—
|
|
|
|
—
|
|
|
Executive Officers and Directors as a group (12 persons)
|
|
|
3,197,673
|
|
|
|
24.7
|
%
|
|
|
51,221
|
|
|
|
51.4
|
%
|
|
|
| *
|
Less than 1%
|
| |
| (1)
|
Based solely on a Schedule 13G filed with the SEC on
May 12, 2008 by Private Capital Management, L.P.
(“PCM”), all such shares are beneficially owned by
PCM, a registered investment advisor. PCM has sole voting power
and sole dispositive power of 190,404 Class A Shares. PCM
has shared voting power and shared dispositive power of
1,690,092 Class A Shares. PCM exercises shared voting
authority with respect to Class A Shares held by those PCM
clients that have delegated proxy voting authority to PCM. Such
delegation may be granted or revoked at any
|
60
December 11, 2006. Class A Shares authorized for
issuance under the Equity Incentive Plans as of
December 31, 2008 are as follows:
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Class A
|
|
|
|
|
|
Number of Class A
|
|
|
|
|
Shares to be issued
|
|
|
Weighted average
|
|
|
Shares remaining
|
|
|
|
|
upon exercise of
|
|
|
exercise price of
|
|
|
available for
|
|
|
Plan
|
|
outstanding options
|
|
|
outstanding options
|
|
|
future issuance
|
|
|
|
|
1996 Equity Incentive Plan
|
|
|
581,347
|
|
|
$
|
29.80
|
|
|
|
0
|
|
|
2006 Equity Incentive Plan
|
|
|
359,385
|
|
|
$
|
33.17
|
|
|
|
520,525
|
|
|
April 27, 2006 Equity
|
|
|
10,000
|
|
|
$
|
26.50
|
|
|
|
0
|
|
|
Incentive Award
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Shares authorized for issuance under the
Oppenheimer Employee Share Plan, or the ESP, as at
December 31, 2008 are as follows: All Class A Shares
authorized for issue under the ESP have been approved by our
shareholders.
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Class A
|
|
|
|
|
Weighted average
|
|
|
Shares remaining
|
|
Number of Class A Shares
|
|
exercise price of
|
|
|
available for future
|
|
to be issued upon vesting
|
|
outstanding ESP
|
|
|
issuance under the
|
|
|
of grants under the ESP
|
|
grants
|
|
|
ESP
|
|
|
|
|
508,447
|
|
$
|
34.87
|
|
|
|
414,472
|
|
We issued warrants for the purchase of 1,000,000 Class A
Shares at a price of $48.62 per share exercisable five years
from closing of the CIBC Acquisition to CIBC on connection with
the January 14, 2008 acquisition. See note 18 to our
consolidated financial statements for the year ended
December 31, 2008 included in Item 8 of our Annual
Report on
Form 10-K
for the year ended December 31, 2008 which is incorporated
by reference into this Circular.
Section 16(a)
Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires our directors
and executive officers, and persons who own more than ten
percent of a registered class of our equity securities, to file
by specific dates with the SEC initial reports of ownership and
reports of changes in ownership of our equity securities.
Officers, directors and greater than ten percent shareholders
are required by SEC regulation to furnish us with copies of all
Section 16(a) forms that they file. We are required to
report in this Circular any failure of our directors and
executive officers and greater than ten percent shareholders to
file by the relevant due date any of these reports during the
preceding fiscal year (or, to the extent not previously
disclosed, any prior fiscal year).
To our knowledge, based solely on review of copies of such
reports furnished to us during the fiscal year ended
December 31, 2008 and representations made to us by such
persons, all Section 16(a) filing requirements applicable
to our officers, directors and greater than ten percent
shareholders were complied with.
62
Certain
Relationships and Related Party Transactions
Indebtedness
of Directors and Executive Officers
The following sets out information with respect to the aggregate
indebtedness of our directors and executive officers under
securities purchase and other programs. On December 31,
2008 and since that date, none of our directors and the
executive officers were or have been indebted to us, except as
follows:
Indebtedness
Of Directors And Executive Officers Under (1) Securities
Purchase And (2) Other Programs
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financially
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assisted
|
|
|
|
|
|
|
|
|
|
|
|
|
Largest Amount
|
|
|
Amount
|
|
|
Securities
|
|
|
|
|
|
Amount
|
|
|
|
|
Involvement of
|
|
Outstanding
|
|
|
Outstanding as
|
|
|
Purchases
|
|
|
|
|
|
Forgiven
|
|
|
|
|
Company or
|
|
During
|
|
|
at March 14,
|
|
|
During
|
|
|
Security for
|
|
|
During
|
|
Name and
|
|
Subsidiary
|
|
2008 ($)
|
|
|
2009 ($)
|
|
|
2008 (#)
|
|
|
Indebtedness
|
|
|
2007 ($)
|
|
|
Principal Position(a)
|
|
(b)
|
|
(c)
|
|
|
(d)
|
|
|
(e)
|
|
|
(f)
|
|
|
(g)
|
|
|
|
|
Securities Purchase Programs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Programs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A.G. Lowenthal
(Chairman, CEO, and
Director of the
Corporation)
|
|
Oppenheimer
Margin Account
|
|
$
|
2,811,990
|
|
|
|
Nil
|
|
|
|
—
|
|
|
|
Margined
securities
|
|
|
|
—
|
|
During the year 2008 certain of our directors, executive
officers and senior officers of Oppenheimer & Co. and
Oppenheimer Asset Management, our subsidiaries, maintained
margin accounts with Oppenheimer & Co. in connection
with the purchase of securities (including our securities).
These margin accounts are substantially on the same terms,
including interest rates and collateral, as those prevailing
from time to time for comparable transactions with
non-affiliated persons and do not involve more than the normal
risk of collectibility.
Other
Relationships and Transactions
Robert Lowenthal, the son of A.G. Lowenthal, our Chairman of the
Board and Chief Executive Officer, is the Senior Managing
Director of Oppenheimer & Co.’s Taxable Fixed
Income Trading Department. He received a salary, bonus and
commission income aggregating $558,139 during fiscal 2008.
Andrew Crystal, the brother of R. Crystal, one of our directors,
is an Oppenheimer & Co. financial advisor and is
compensated on the same basis as other Oppenheimer &
Co. financial advisors.
As disclosed under “Security Ownership of Certain
Beneficial Owners and Management”, Olga Roberts, the
mother of E.K. Roberts, one of our directors and President and
Treasurer, owns 324,955 Class A Shares and 44,309
Class B Shares, representing 2.4% of the outstanding
Class A Shares and 44.4% of the outstanding Class B
Shares.
Our Code of Conduct and Business Ethics contains prohibitions
and restrictions on our directors, executive officers and other
employees from entering into or becoming involved in situations
which could give rise to conflicts of interest with us. Our
directors, senior executives and employees and our subsidiaries
are required to avoid investments or other interests and
associations that interfere, might interfere or might be
perceived to interfere, with the independent exercise of
judgment in our best interests.
Our directors, senior executives and employees may not advance
their personal interests at our expense nor may they personally
take or benefit from opportunities arising from their employment
with us.
Normal
Course Issuer Bid
On August 18, 2008, we announced that during the
12-month
period commencing August 19, 2008 we intended to purchase
up to 700,000 of our Class A Shares by way of a Normal
Course Issuer Bid through the facilities of the NYSE,
representing approximately 5% of the outstanding Class A
Shares. We purchased 650,000 Class A Shares in fiscal 2008
at an average price per share of $26.44. All shares purchased by
us pursuant to Normal Course Issuer Bids are cancelled. We may,
at our option, apply to extend the program for an additional
12-month
period. Effective December 22, 2008, our Senior Secured
Credit Note requires a pay down of principal equal to the cost
of any share repurchases made pursuant to the Normal Course
Issuer Bid.
63
PROPOSAL NO. 3 —
APPOINTMENT OF AUDITORS
The Audit Committee has nominated PricewaterhouseCoopers LLP for
reappointment as our auditors for the 2009 fiscal year. The
appointment of auditors and the authorization of the Board of
Directors and Audit Committee to fix the remuneration of the
auditors requires the affirmative vote of a simple majority of
the Class B Shares voted at the Meeting.
OUR BOARD
OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THE
APPOINTMENT OF THE AUDITORS PROPOSAL.
Principal
Accounting Fees and Services
PricewaterhouseCoopers LLP has served as our auditors since
1993. PricewaterhouseCoopers LLP has advised us that neither the
firm nor any of its members or associates has any direct
financial interest or any material indirect financial interest
in us or any of our affiliates other than as our auditor.
The fees billed to us and our subsidiaries by
PricewaterhouseCoopers LLP during the years 2008 and 2007 were
as follows:
| |
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
Audit fees
|
|
$
|
1,095,400
|
|
|
$
|
915,000
|
|
|
Audit-related fees
|
|
|
Nil
|
|
|
|
Nil
|
|
|
Tax fees
|
|
|
8,600
|
|
|
|
8,600
|
|
|
All other fees
|
|
|
23,700
|
|
|
|
Nil
|
|
|
|
|
$
|
1,127,700
|
|
|
$
|
923,600
|
|
The audit fees include the fees for the audit of our annual
consolidated financial statements for the year 2008 and the
review of the quarterly financial statements included in the
Forms 10-Q
filed by us and the interim reports to shareholders sent to
shareholders during the year. During 2007 and 2008, we retained
Ernst & Young LLP to provide tax related services to
us. PricewaterhouseCoopers LLP provides tax compliance services
for us in Canada. Plante Moran, PLLC performs the audit of the
Oppenheimer & Co. Inc. 401(K) Plan. Ernst &
Young LLP has been retained to audit Oppenheimer Israel (OPCO)
Ltd. for fiscal 2008. Margolis & Company P.C. has been
retained to audit Evanston Financial Corporation for fiscal 2008.
The Audit Committee has the sole authority and responsibility to
nominate independent auditors for appointment by shareholders,
and to recommend to shareholders that independent auditors be
removed. The Audit Committee has nominated
PricewaterhouseCoopers LLP for appointment as our auditors by
the shareholders at the Meeting.
The Audit Committee recommends and the Board of Directors
approves all audit engagement fees and terms in addition to all
non-audit engagements and engagement fees submitted by
independent auditors. The process begins prior to the
commencement of the audit. The fees described above were 100%
pre-approved.
INTEREST
OF MANAGEMENT IN THE PROPOSALS TO BE ACTED UPON
No person who has been our director or executive officer since
the beginning of our last fiscal year nor any of their
associates or affiliates has any material interest, direct or
indirect, by way of beneficial ownership of securities or
otherwise, in the domestication other than those interests
arising from their ownership of our capital stock.
LEGAL
MATTERS
Certain legal matters relating to the domestication under United
States law will be passed upon by Bingham McCutchen LLP and
Richards, Layton & Finger, P.A. Certain legal matters
relating to the Canadian tax consequences of the domestication
will be passed upon by Borden Ladner Gervais LLP.
EXPERTS
The financial statements and management’s assessment of the
effectiveness of internal control over financial reporting
(which is included in Management’s Report on Internal
Control over Financial Reporting) incorporated in this Circular
by reference to the Annual Report on
Form 10-K
for the year ended December 31, 2008 have been so
incorporated in reliance on the report of PricewaterhouseCoopers
LLP, an independent registered public accounting firm, given on
the authority of said firm as experts in auditing and accounting.
64
SHAREHOLDER
PROPOSALS
The CBCA, which currently governs our company, provides that
certain registered or beneficial holders of shares entitled to
vote at a meeting of shareholders may, in accordance with the
provisions of the CBCA, submit a notice to us of a proposal that
the holder wishes to be considered by the shareholders entitled
to vote at a meeting of shareholders. If the domestication is
not completed, in order for any shareholder proposal to be
included in the management proxy circular for the next annual
meeting of our shareholders following the Meeting, the proposal
must comply with the provisions of the CBCA and be submitted to
us at our registered office at 20 Eglinton Avenue West,
Suite 1110, Toronto, Ontario M4R 1K8 (Attention:
Secretary) prior to January 3, 2010. If the domestication
is completed, in order for any stockholder proposal to be
included in the proxy statement for the next annual meeting of
stockholders of Oppenheimer Holdings following the Meeting, the
proposal must be submitted to Oppenheimer Holdings at its office
at 20 Eglinton Avenue West, Suite 1110, Toronto, Ontario,
Canada M4R 1K8 (Attention: Secretary) prior to
February 7, 2010.
COMMUNICATIONS
WITH THE BOARD OF DIRECTORS
Holders of Class A and Class B Shares or interested
parties may communicate with the Board of Directors, including
to request copies of our Annual Report on
Form 10-K
for the year ended December 31, 2008, which includes our
financial statements and management discussion and analysis, by
e-mail to
investorrelations@opy.ca (Attention: Board of Directors)
or by mail to:
Oppenheimer Holdings Inc.
Board of Directors
c/o The President
20 Eglinton Avenue West
P.O. Box 2015, Suite 1110
Toronto, Ontario, Canada
M4R 1K8
All such correspondence will be forwarded to the Lead Director
or to any individual director or directors to whom the
communication is or are directed, unless the communication is
unduly hostile, threatening, illegal, does not reasonably relate
to us or our business or is similarly inappropriate. Our
President has the authority to discard or disregard
inappropriate communications or to take other reasonable actions
with respect to any such inappropriate communications.
WHERE YOU
CAN FIND MORE INFORMATION
This Circular constitutes part of a registration statement on
Form S-4
that we filed with the SEC. You may read and copy this Circular
at the SEC’s Public Reference Room at 100 F Street, N.E.,
Washington, D.C. 20549. You may also obtain copies of this
Circular by mail from the Public Reference Section of the SEC at
prescribed rates. To obtain information on the operation of the
Public Reference Room, you can call the SEC at
1-800-SEC-0330.
The SEC also maintains an Internet website that contains
reports, proxy and information statements and other information
regarding issuers, including Oppenheimer Holdings Inc., that
file electronically with the SEC. The address of the SEC’s
Internet website is
http://www.sec.gov.
Additional information relating to us is available on our
website at www.opco.com and on SEDAR at
www.sedar.com.
The SEC allows us to incorporate certain information into this
Circular by reference to other information that has been filed
with the SEC. The information incorporated by reference is
deemed to be part of this Circular, except for any information
that is superseded by information in this Circular. The
documents that are incorporated by reference contain important
information about us and you should read this Circular together
with any other documents incorporated by reference into this
document.
This Circular incorporates by reference the following documents
that we have previously filed with the SEC:
|
|
|
| |
•
|
Annual Report on
Form 10-K
for the year ended December 31, 2008;
|
| |
| |
•
|
Current Report on
Form 8-K
filed with the SEC on March 11, 2009, as amended by
Form 8-K/A; and
|
| |
| |
•
|
Any documents filed by us under Sections 13(a), 13(c) or 14
of the Exchange Act after the date of this Circular and prior to
the date of the Meeting.
|
65
EXHIBIT C —
FORM OF CERTIFICATE OF INCORPORATION
CERTIFICATE OF INCORPORATION
OF
OPPENHEIMER HOLDINGS INC.
I, the undersigned, for the purposes of incorporating and
organizing a corporation under the General Corporation Law of
the State of Delaware (the “DGCL”), do execute this
Certificate of Incorporation and do hereby certify as follows:
Article I
The name of the Corporation is Oppenheimer Holdings Inc. (the
“Corporation”).
Article II
The address of the Corporation’s registered office in the
State of Delaware is 2711 Centerville Road, Suite 400 in
the City of Wilmington, County of New Castle County. The
registered agent in charge thereof is Corporation Service
Company.
Article III
The nature of the business and purposes to be conducted or
promoted by the Corporation is to engage in any lawful act or
activity for which corporations may be organized under the DGCL.
Article IV
The total number of shares of all classes of stock which the
Corporation shall have authority to issue is
100,099,680 shares, consisting solely of:
50,000,000 shares of Preferred Stock, par value $0.001 per
share (the “Preferred Stock”);
50,000,000 shares of Class A Non-Voting Common Stock,
par value $0.001 per share (the “Class A Common
Stock”); and
99,680 shares of Class B Voting Common Stock, par
value $0.001 per share (the “Class B Common
Stock” and together with the Class A Common Stock, the
“Common Stock”).
Upon the effectiveness of the Certificate of Corporate
Domestication of Oppenheimer Holdings Inc., a Canadian
corporation, and this Certificate of Incorporation (the
“Effective Time”), (i) each Class A
non-voting share, no par value, of Oppenheimer Holdings Inc., a
Canadian corporation, issued and outstanding immediately prior
to the Effective Time will for all purposes be deemed to be one
issued and outstanding, fully paid and nonassessable share of
Class A Common Stock, without any action required on the
part of the Corporation or the holders thereof and
(ii) each Class B voting share, no par value, of
Oppenheimer Holdings Inc., a Canadian corporation, issued and
outstanding immediately prior to the Effective Time will for all
purposes be deemed to be one issued and outstanding, fully paid
and nonassessable share of Class B Common Stock, without
any action required on the part of the Corporation or the
holders thereof. Any stock certificate that, immediately prior
to the Effective Time, represented Class A non-voting
shares or Class B voting shares of Oppenheimer Holdings
Inc., a Canadian corporation, will, from and after the Effective
Time, automatically and without the necessity of presenting the
same for exchange, represent the same number of shares of the
Class A Common Stock or Class B Common Stock, as
applicable.
The following is a statement of the powers, designations,
preferences, relative rights, qualifications, limitations, and
restrictions in respect of each class of capital stock of the
Corporation.
|
|
|
| |
A.
|
COMMON STOCK.
|
| |
| |
1.
|
General. The voting, dividend and
liquidation rights of the holders of Common Stock are subject to
and qualified by the rights of the holders of Preferred Stock.
|
69
|
|
|
| |
2.
|
Voting. The holders of Class B
Common Stock are entitled to one vote for each share held as of
the record date for each meeting of stockholders. Except as
expressly provided herein or as required by law, the holders of
Class A Common Stock will have the same powers, rights, and
preferences as, and will rank equally and share proportionately
with, and be identical in all respects as to all matters to, the
Class B Common Stock, including the right to attend
stockholders meetings and receive informational distributions
from the Corporation with respect to such meetings; provided,
however, that the holders of Class A Common Stock will have
no voting rights other than those voting rights required by law.
There shall be no cumulative voting.
|
| |
| |
3.
|
Dividends. Dividends may be declared
and paid on the Common Stock from funds lawfully available
therefor if, as and when determined by the board of directors of
the Corporation (the “Board of Directors”) and subject
to any preferential dividend rights of any then outstanding
shares of Preferred Stock.
|
| |
| |
B.
|
PREFERRED STOCK.
|
Preferred Stock may be issued from time to time in one or more
series. The Board is authorized to fix the number of shares of
any series of Preferred Stock and to determine the designation
of any such series. The Board is also authorized to determine or
alter the powers, rights, preferences, qualifications,
restrictions, and limitations granted to or imposed upon any
wholly unissued series of Preferred Stock and, within the limits
and restrictions stated in any resolution or resolutions of the
Board originally fixing the number of shares constituting any
series, to increase or decrease (but not below the number of
shares of such series then outstanding) the number of shares of
any such series subsequent to the issue of shares of that series.
The number of authorized shares of any class or classes of stock
may be increased or decreased (but not below the number of
shares thereof then outstanding) by the affirmative vote of the
holders of a majority of the outstanding stock of the
Corporation entitled to vote.
Article V
The name and mailing address of the incorporator are as follows:
| |
|
|
|
Name
|
|
Address
|
|
|
|
Dennis McNamara
|
|
Oppenheimer Holdings Inc.
125 Broad Street, 14th Floor
New York, NY 10004
|
Article VI
No director of the Corporation shall be personally liable to the
Corporation or to any of its stockholders for monetary damages
for breach of fiduciary duty as a director, notwithstanding any
provision of law imposing such liability; provided,
however, that to the extent required from time to time by
applicable law, this Article VI shall not eliminate or
limit the liability of a director, to the extent such liability
is provided by applicable law, (i) for any breach of the
director’s duty of loyalty to the corporation or its
stockholders, (ii) for acts or omissions not in good faith
or which involve intentional misconduct or a knowing violation
of law, (iii) under Section 174 of the DGCL, or
(iv) for any transactions from which the director derived
an improper personal benefit. If the DGCL hereafter is amended
to authorize the further elimination or limitation of the
liability of directors, then the liability of a director of the
Corporation, in addition to the limitation on personal liability
provided herein, shall be limited to the fullest extent
permitted by the amended DGCL. No amendment to or repeal of this
Article VI shall apply to or have any effect on the
liability or alleged liability of any director for or with
respect to any acts or omissions of such director occurring
prior to the effective date of such amendment or repeal.
Article VII
Any action required or permitted to be taken by the stockholders
of the Corporation may be taken only at a duly called annual or
special meeting of the stockholders, and no action may be taken
by the written consent of stockholders.
70
Article VIII
In furtherance and not in limitation of the powers conferred by
the laws of the State of Delaware, the Board is expressly
authorized to make, alter and repeal the by-laws of the
Corporation.
Article IX
The powers of the incorporator are to terminate upon the filing
of this Certificate of Incorporation with the Secretary of State
of the State of Delaware. The name and mailing address of the
persons who are to serve as the initial directors of the
Corporation until the annual meeting of stockholders of the
Corporation following the filing of this Certificate of
Incorporation, or until his or her successor is duly elected and
qualified, are: J.L. Bitove, R. Crystal, W. Ehrhardt, M.A.M.
Keehner, A.G. Lowenthal, K.W. McArthur, A.W. Oughtred, E.K.
Roberts, and B. Winberg c/o Oppenheimer Holdings Inc., P.O. Box
2015, Suite 1110, 20 Eglinton Avenue West, Toronto,
Ontario, Canada M4R 1K8.
The effective time of this Certificate of Incorporation shall
be ,
2009.
The undersigned incorporator hereby acknowledges that the
foregoing certificate of incorporation is his act and deed on
this day
of ,
2009.
Name: Dennis McNamara
Title: Incorporator
71
EXHIBIT D —
FORM OF BY-LAWS
OPPENHEIMER
HOLDINGS INC.
BY-LAWS
ARTICLE I
GENERAL
1.1. Offices. The
registered office of Oppenheimer Holdings Inc. (the
”Company”) shall be in the City of Wilmington,
County of New Castle, State of Delaware. The Company may also
have offices at such other places both within and without the
State of Delaware as the Board of Directors may from time to
time determine or the business of the Company may require.
1.2. Seal. The
Company may have one or more different corporate seals, which
the Board of Directors may from time to time adopt or change, on
which the name of the Company shall appear.
1.3. Fiscal Year. The
fiscal year of the Company shall be the period from January 1
through December 31 unless changed by resolution of the Board of
Directors.
ARTICLE II
STOCKHOLDERS
2.1. Place of
Meetings. Each meeting of the
stockholders shall be held upon notice as hereinafter provided,
at such place, either within or without of the State of
Delaware, as the Board of Directors shall have determined and as
shall be stated in the relevant notice of meeting.
2.2. Annual
Meeting. The annual meeting of the
stockholders shall be held each year on such date and at such
time as the Board of Directors may determine. At each annual
meeting the stockholders entitled to vote shall elect such
members of the Board of Directors as are standing for election,
by plurality vote and they may transact such other corporate
business as may properly be brought before the meeting. At the
annual meeting any business may be transacted, irrespective of
whether the notice calling such meeting shall have contained a
reference thereto, except where notice is required by law, the
Company’s Certificate of Incorporation (as amended and in
effect from time to time, the ”Charter”), or
these by-laws.
2.3. Quorum. At all
meetings of the stockholders, the presence, in person or
represented by proxy, of at least two (2) stockholders
holding a majority in voting power of the stock issued and
outstanding and entitled to vote, shall constitute a quorum
requisite for the transaction of business except as otherwise
provided by law, the Charter or these by-laws. Whether or not
there is such a quorum at any meeting, the chairman of the
meeting or the stockholders entitled to vote thereat, present in
person or by proxy, by a majority vote, may adjourn the meeting
from time to time without notice other than announcement at the
meeting. If the adjournment is for more than thirty
(30) days, or if after the adjournment a new record date is
fixed for the adjourned meeting, a notice of the adjourned
meeting shall be given to each stockholder of record entitled to
vote at the meeting. At such adjourned meeting, at which the
requisite amount of voting stock shall be represented, any
business may be transacted that might have been transacted if
the meeting had been held as originally called. The stockholders
present in person or by proxy at a duly called meeting at which
a quorum is present may continue to transact business until
adjournment, notwithstanding the withdrawal of enough
stockholders to leave less than a quorum.
2.4. Right to Vote;
Proxies. Subject to the provisions of the
Charter, each holder of a share or shares of capital stock of
the Company having the right to vote at any meeting shall be
entitled to one vote for each such share of stock held by him.
Any stockholder entitled to vote at any meeting of stockholders
may vote either in person (including by means of remote
communications, if any, by which stockholders may be deemed to
be present in person and vote at such meeting) or by proxy, but
no proxy that is dated more than three years prior to the
meeting at which it is offered shall confer the right to vote
thereat unless the proxy provides that it shall be effective for
a longer period. A proxy may be granted by a writing executed by
the stockholder or his authorized agent or by transmission or
authorization of transmission of a telegram, cablegram, or other
means of electronic transmission to the person who will be the
holder of the proxy or to a proxy
72
solicitation firm, proxy support service organization, or like
agent duly authorized by the person who will be the holder of
the proxy to receive such transmission, subject to the
conditions set forth in Section 212 of the General
Corporation Law of the State of Delaware, as it may be amended
from time to time (the “DGCL”).
2.5. Voting. At all
meetings of stockholders, except as otherwise expressly provided
for by statute, the Charter or these by-laws, (i) in all
matters other than the election of directors, the affirmative
vote of a majority in voting power of shares present in person
or represented by proxy at the meeting and entitled to vote on
such matter shall be the act of the stockholders, and
(ii) members of the Board of Directors, as are standing for
election, shall be elected by a plurality vote.
2.6. Notice of Annual
Meetings. Notice of the annual meeting of
the stockholders shall be given to each stockholder entitled to
vote at such meeting at such address as appears on the stock
books of the Company at least ten (10) days (and not more
than sixty (60) days) prior to the meeting. The Board of
Directors may postpone any annual meeting of the stockholders at
its discretion, even after notice thereof has been mailed. It
shall be the duty of every stockholder to furnish to the
Secretary of the Company or to the transfer agent, if any, of
the class of stock owned by him and his post-office address, and
to notify the Secretary of any change therein. Notice need not
be given to any stockholder who submits a written waiver of
notice given by him before or after the time stated therein.
Attendance of a stockholder at a meeting of stockholders shall
constitute a waiver of notice of such meeting, except when the
stockholder attends the meeting for the express purpose of
objecting, at the beginning of the meeting, to the transaction
of any business because the meeting is not lawfully called or
convened. Neither the business to be transacted at, nor the
purpose of, any regular or special meeting of the stockholders
need be specified in any written waiver of notice.
2.7. Stockholders’
List. A complete list of the stockholders
entitled to vote at any meeting of stockholders, arranged in
alphabetical order and showing the address of each stockholder,
and the number of shares registered in the name of each
stockholder, shall be prepared by the officer who has charge of
the stock ledger and shall be open to examination of any
stockholder, for any purpose germane to the meeting for a period
of at least ten (10) days before such meeting (i) on a
reasonably accessible electronic network, provided that the
information required to gain access to such list is provided
with the notice of the meeting, or (ii) during the ordinary
business hours at the principal office of the Company. Said list
shall be open to examination during the whole time of said
meeting, at the place of said meeting, or, if the meeting held
is by remote communication, on a reasonably accessible
electronic network and the information required to access such
list shall be provided with the notice of the meeting.
2.8. Special
Meetings. Special meetings of the
stockholders for any purpose or purposes, unless otherwise
provided by statute, may be called only by the Chairman of the
Board of Directors, a majority of the Board of Directors, the
Chief Executive Officer or the President. Any such person or
persons may postpone any special meeting of the stockholders at
its or their discretion, even after notice thereof has been
mailed.
2.9. Notice of Special
Meetings. Notice of a special meeting of
stockholders, stating the time and place and object thereof
shall be given not less than ten (10) nor more than sixty
(60) days before such meeting, to each stockholder entitled
to vote at such meeting, at such address as appears on the books
of the Company. No business may be transacted at such meeting
except that referred to in said notice, or in a supplemental
notice given also in compliance with the provisions hereof, or
such other business as may be germane or supplementary to that
stated in said notice or notices. Notice need not be given to
any stockholder who submits a written waiver of notice signed by
him before or after the time stated therein. Attendance of a
stockholder at a meeting of stockholders shall constitute a
waiver of notice of such meeting, except when the stockholder
attends the meeting for the express purpose of objecting, at the
beginning of the meeting, to the transaction of any business
because the meeting is not lawfully called or convened. Neither
the business to be transacted at, nor the purpose of, any
regular or special meeting of the stockholders need be specified
in any written waiver of notice.
2.10. Inspectors.
|
|
|
| |
(a)
|
If required by law, one or more inspectors shall be appointed by
the Board of Directors in advance of any meeting of the
stockholders to act at the meeting and make a written report
thereof. If no inspector or alternate is able to act at a
meeting of the stockholders, the person presiding at the meeting
shall appoint one or more inspectors to act at such meeting.
Before discharging his duties as an inspector, each inspector
shall take and sign an oath to execute his duties with strict
impartiality and to the best of his ability. At the meeting for
which the inspector or inspectors are appointed, he or they
shall ascertain the number of shares outstanding and the voting
power of each, determine the shares represented at the meeting
and the validity of proxies and ballots, count all votes and
ballots, retain for a reasonable period a record of the
disposition of any challenges made to
|
73
|
|
|
| |
|
any determination by the inspectors and certify the
determination of the shares represented and the count of all
votes and ballots.
|
|
|
|
| |
(b)
|
At any time at which the Company has a class of voting stock
that is (i) listed on a national securities exchange, or
(ii) held of record by more than 2,000 stockholders, the
provisions of Section 231 of the DGCL with respect to
inspectors of election and voting procedures shall apply, in
lieu of the provisions of paragraph (a) of this
Section 2.10.
|
2.11. Procedures. Nominations
for the Board of Directors and other business may be brought
before a meeting of stockholders solely by holders of those
classes of stock entitled to voting rights as set forth in the
Charter, and solely in accordance with the provisions of this
Section 2.11. For such nominations for the Board of
Directors or for such other business to be properly brought by a
stockholder before a meeting of stockholders, the stockholder
must first have given timely written notice thereof to the
Secretary of the Company. To be timely, a notice of nominations
or other business to be brought before an annual meeting of
stockholders must be delivered to the Secretary not less than 90
nor more than 120 days prior to the first anniversary of
the date of the Company’s annual meeting of the preceding
year, or if the date of the annual meeting is more than
30 days before or more than 60 days after such
anniversary, such notice must be delivered not earlier than
90 days prior to such annual meeting and not later than the
later of (i) 60 days prior to the annual meeting or
(ii) 10 days following the date on which public
announcement of the date of such annual meeting is first made by
the Company. With respect to special meetings of stockholders,
such notice must be delivered to the Secretary not more than
120 days prior to such meeting and not later than the later
of (i) 90 days prior to such meeting or
(ii) 10 days following the date on which public
announcement of the date of such meeting is first made by the
Company. Such notice must contain the name and address of the
stockholder delivering the notice and a statement with respect
to the amount of the Company’s stock beneficially and/or
legally owned by such stockholder, the nature of any such
beneficial ownership of such stock, the beneficial ownership of
any such stock legally held by such stockholder but beneficially
owned by one or more others, and the length of time for which
all such stock has been beneficially and/or legally owned by
such stockholder, and information about each nominee for
election as a director substantially equivalent to that which
would be required in a proxy statement pursuant to the
Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations promulgated by the
Securities and Exchange Commission thereunder, and/or a
description of the proposed business to be brought before the
meeting, as the case may be.
The foregoing notice requirements of this Section 2.11
shall be deemed satisfied by a stockholder with respect to
business other than a nomination if the stockholder has notified
the Company of his, her or its intention to present a proposal
at an annual meeting in compliance with applicable rules and
regulations promulgated under the Exchange Act and such
stockholder’s proposal has been included in a proxy
statement that has been prepared by the Company to solicit
proxies for such annual meeting.
ARTICLE III
DIRECTORS
3.1. Number of Directors.
|
|
|
| |
(a)
|
Except as otherwise provided by law, the Charter, or these
by-laws, the property and business of the Company shall be
managed by or under the direction of a Board of Directors.
Directors need not be stockholders, residents of Delaware, or
citizens of the United States. The use of the phrase “whole
board” herein refers to the total number of directors which
the Company would have if there were no vacancies.
|
| |
| |
(b)
|
The number of directors constituting the whole Board of
Directors shall be as determined by resolution of the Board of
Directors from time to time, with a minimum of three
(3) and a maximum of eleven (11) directors. Members of
the Board of Directors shall hold office until their respective
successors are elected and qualified or until their earlier
death, incapacity, resignation, or removal.
|
3.2. Terms of Office. The
directors shall be elected by ballot at the annual meeting of
the stockholders and each director shall be elected to serve
until his successor shall be elected and shall qualify or until
his earlier resignation or removal; provided that in the event
of failure to hold such meeting or to hold such election at such
meeting, such election may be held at any special meeting of the
stockholders called for that purpose. If the office of any
director becomes vacant by reason of death, resignation,
disqualification, removal, or otherwise, the remaining
directors, although more or less
74
than a quorum, by a majority vote of such remaining directors
may elect a successor or successors who shall hold office for
the unexpired term.
3.3. Resignation. Any
director of the Company may resign at any time by giving notice
in writing or by electronic transmission to the Chairman of the
Board, the Chief Executive Officer, or the President of the
Company. Such resignation shall take effect at the time
specified therein, at the time of receipt if no time is
specified therein and at the time of acceptance if the
effectiveness of such resignation is conditioned upon its
acceptance. Unless otherwise specified therein, the acceptance
of such resignation shall not be necessary to make it effective.
3.4. Removal. Any director
or the entire Board of Directors may be removed, with or without
cause, by the holders of a majority in voting power of the
shares then entitled to vote at an election of directors.
3.5. Place of Meetings and
Books. The Board of Directors may hold
their meetings and keep the books of the Company outside the
State of Delaware, at such places as they may from time to time
determine.
3.6. General Powers. In
addition to the powers and authority expressly conferred upon
them by these by-laws, the Board of Directors may exercise all
such powers of the Company and do all such lawful acts and
things as are not by statute or by the Charter or by these
by-laws directed or required to be exercised or done by the
stockholders.
3.7. Committees. The Board
of Directors may designate one or more committees, each
committee to consist of one or more of the directors of the
Company. The Board of Directors may designate one or more
directors as alternate members of any committee, who may replace
any absent or disqualified member at any meeting of the
committee. In the absence or disqualification of a member of the
committee, the member or members thereof present at any meeting
and not disqualified from voting, whether or not he, she or they
constitute a quorum, may unanimously appoint another member of
the Board of Directors to act at the meeting in place of any
such absent or disqualified member. Any such committee, to the
extent permitted by law and to the extent provided in the
resolution of the Board of Directors, shall have and may
exercise all the powers and authority of the Board of Directors
in the management of the business and affairs of the Company,
and may authorize the seal of the Company to be affixed to all
papers which may require it.
3.8. Compensation of
Directors. The Board of Directors shall
have the power to fix the compensation of directors and members
of committees of the Board and may delegate this authority to
one or more committees. The directors may be paid their
expenses, if any, of attendance at each meeting of the Board of
Directors and may be paid a fixed sum for attendance at each
meeting of the Board of Directors or a stated salary as
director. No such payment shall preclude any director from
serving the Company in any other capacity and receiving
compensation therefor. Members of special or standing committees
may be allowed like compensation for attending committee
meetings.
3.9. Regular Meetings. No
notice shall be required for regular meetings of the Board of
Directors for which the time and place have been fixed. Written,
oral, or any other mode of notice of the time and place shall be
given for special meetings in sufficient time for the convenient
assembly of the directors thereat. Notice need not be given to
any director who submits a written waiver of notice signed by
him before or after the time stated therein. Attendance of any
such person at a meeting shall constitute a waiver of notice of
such meeting, except when he attends a meeting for the express
purpose of objecting, at the beginning of the meeting, to the
transaction of any business because the meeting is not lawfully
called or convened. Neither the business to be transacted at,
nor the purpose of, any regular or special meeting of the
directors need be specified in any written waiver of notice.
3.10. Special
Meetings. Special meetings of the Board
may be called by the Chairman of the Board, if any, or the Chief
Executive Officer or the President, on two (2) days notice
to each director; special meetings may also be called by the
Secretary in like manner and on like notice, on the written
request of two or more directors.
3.11. Quorum. At all
meetings of the Board of Directors, a majority of the total
number of directors in office (but not less than one-third of
the number of directors established by the Board of Directors
pursuant to Section 3.1 of these by-laws) shall be
necessary and sufficient to constitute a quorum for the
transaction of business, and the act of a majority of the
directors present at any meeting at which there is a quorum
shall be the act of the Board of Directors, except as may be
otherwise specifically permitted or provided by statute, or by
the Charter, or by these by-laws. If at any meeting of the Board
there shall be less than a quorum present, a majority of those
present may adjourn the meeting from time to time until a quorum
is obtained, and no further notice thereof need be given other
than by announcement at said meeting that shall be so adjourned.
3.12. Telephonic Participation in
Meetings. Members of the Board of
Directors or any committee designated by such board may
participate in a meeting of the Board or committee by means of
conference telephone or other
75
communications equipment by means of which all persons
participating in the meeting can hear each other, and
participation in a meeting pursuant to this section shall
constitute presence in person at such meeting.
3.13. Action by Consent. Unless
otherwise restricted by the Charter or these by-laws, any action
required or permitted to be taken at any meeting of the Board of
Directors or of any committee thereof may be taken without a
meeting, if written consents or electronic transmissions thereto
are signed or given by all members of the Board of Directors or
of such committee, as the case may be, and such written consents
or electronic transmissions are filed with the minutes of
proceedings of the Board or committee.
ARTICLE IV
OFFICERS
4.1. Selection; Statutory
Officers. The officers of the Company
shall be chosen by the Board of Directors. There shall be a
Chief Executive Officer, a President, a Secretary, and a
Treasurer, and there may be a Chairman of the Board of
Directors, one or more Vice Chairmen, one or more Vice
Presidents, one or more Assistant Secretaries and one or more
Assistant Treasurers as the Board of Directors may elect. Any
number of offices may be held by the same person, except that
the offices of President and Secretary shall not be held by the
same person simultaneously.
4.2. Time of Election. The
officers above named shall be chosen by the Board of Directors
at its first meeting after each annual meeting of stockholders.
None of said officers need be a director.
4.3. Additional
Officers. The Board may appoint such
other officers and agents as it shall deem necessary, who shall
hold their offices for such terms and shall exercise such powers
and perform such duties as shall be determined from time to time
by the Board of Directors.
4.4. Terms of Office. Each
officer of the Company shall hold office until his successor is
chosen and qualified, or until his earlier resignation or
removal. Any officer elected or appointed by the Board of
Directors may be removed at any time by the Board of Directors.
Any vacancy occurring in any office of the Company by death,
resignation, removal or otherwise shall be filled by the Board
of Directors.
4.5. Compensation of
Officers. The Board of Directors shall
have power to fix the compensation of all officers of the
Company. It may authorize any officer, upon whom the power of
appointing subordinate officers may have been conferred, to fix
the compensation of such subordinate officers.
4.6. Chairman of the
Board. The Chairman of the Board of
Directors shall preside at all meetings of the stockholders and
directors, and shall have such other duties as may be assigned
to him from time to time by the Board of Directors.
4.7. Vice-Chairmen. The
Vice-Chairmen shall perform such of the duties of the Chairman
of the Board on behalf of the Company as may be respectively
assigned to them from time to time by the Board of Directors or
by the Chairman of the Board.
4.8. Chief Executive
Officer. Under the supervision of the
Board of Directors, the Chief Executive Officer shall have the
general control and management of its business and affairs,
subject, however, to the right of the Board of Directors to
confer any specific power, except such as may be by statute
exclusively conferred to the Chief Executive Officer, upon any
other officer or officers of the Company. The Chief Executive
Officer shall perform and do all acts and things incident to the
position of Chief Executive Officer and such other duties as may
be assigned to him from time to time by the Board of Directors.
4.9. President. Unless
there is a Chairman of the Board or a Chief Executive Officer,
the President shall preside at all meetings of directors and
stockholders. Under the supervision of the Board of Directors,
the President shall have the general supervision of the
Company’s business and affairs, subject, however, to the
right of the Board of Directors to confer any specific power,
except such as may be by statute exclusively conferred to the
President, upon any other officer or officers of the Company.
The President shall perform and do all acts and things incident
to the position of President and such other duties as may be
assigned to him from time to time by the Board of Directors or
the Chief Executive Officer.
4.10. Vice-Presidents. The
Vice-Presidents shall perform such of the duties of the
President on behalf of the Company as may be respectively
assigned to them from time to time by the Board of Directors,
the Chief Executive Officer or the President. The Board of
Directors may assign to any Vice President the title of
Executive Vice President, Senior Vice President or any other
title selected by the Board of Directors.
76
4.11. Treasurer. The
Treasurer shall have the care and custody of all the funds and
securities of the Company that may come into his hands as
Treasurer, and the power and authority to endorse checks, drafts
and other instruments for the payment of money for deposit or
collection when necessary or proper and to deposit the same to
the credit of the Company in such bank or banks or depository as
the Board of Directors, or the officers or agents to whom the
Board of Directors may delegate such authority, may designate,
and he may endorse all commercial documents requiring
endorsements for or on behalf of the Company. He may sign all
receipts and vouchers for the payments made to the Company. He
shall render an account of his transactions to the Board of
Directors as often as the Board or any applicable committee
shall require the same. He shall enter regularly in the books to
be kept by him for that purpose full and adequate account of all
moneys received and paid by him on account of the Company. He
shall perform all acts incident to the position of Treasurer,
subject to the control of the Board of Directors. He shall when
requested, pursuant to a vote of the Board of Directors, give a
bond to the Company conditioned for the faithful performance of
his duties, the expense of which bond shall be borne by the
Company.
4.12. Secretary. The
Secretary shall keep the minutes of all meetings of the Board of
Directors and of the stockholders; he shall attend to the giving
and serving of all notices of the Company. Except as otherwise
ordered by the Board of Directors or the Chief Executive
Officer, he shall attest the seal of the Company upon all
contracts and instruments executed under such seal and shall
affix the seal of the Company thereto and to all certificates of
shares of capital stock of the Company. He shall have charge of
the stock certificate book, transfer book and stock ledger, and
such other books and papers as the Board of Directors or the
Chief Executive Officer may direct. He shall, in general,
perform all the duties of Secretary, subject to the control of
the Board of Directors.
4.13. Assistant
Secretary. The Board of Directors or any
two of the officers of the Company acting jointly may appoint or
remove one or more Assistant Secretaries of the Company. Any
Assistant Secretary upon his appointment shall perform such
duties of the Secretary, and also any and all such other duties
as the Board of Directors or the Chief Executive Officer, the
President or the Executive Vice-President or the Treasurer or
the Secretary may designate.
4.14. Assistant
Treasurer. The Board of Directors or any
two of the officers of the Company acting jointly may appoint or
remove one or more Assistant Treasurers of the Company. Any
Assistant Treasurer upon his appointment shall perform such of
the duties of the Treasurer, and also any and all such other
duties as the Board of Directors, the Chief Executive Officer,
or the President or the Executive Vice-President or the
Treasurer or the Secretary may designate.
4.15. Subordinate
Officers. The Board of Directors may
select such subordinate officers as it may deem desirable. Each
such officer shall hold office for such period, have such
authority, and perform such duties as the Board of Directors may
prescribe. The Board of Directors may, from time to time,
authorize any officer to appoint and remove subordinate officers
and to prescribe the powers and duties thereof.
ARTICLE V
STOCK
5.1. Stock. The shares of
the Company’s stock may be certificated or uncertificated
and shall be entered in the books of the Company and registered
as they are issued. Any certificates representing shares of
stock shall be in such form as the Board of Directors shall
prescribe, certifying the number and class and/or series of
shares of the stock of the Company owned by the stockholder. Any
certificate issued to a stockholder of the Company shall be
numbered and shall certify the holder’s name and number and
class and/or series of shares and shall be signed by both of
(i) any one of the Chairman or Vice Chairman, President or
a Vice-President, and (ii) any one of the Treasurer or an
Assistant Treasurer or the Secretary or an Assistant Secretary,
and shall be sealed with the corporate seal of the Company and
any and all signatures on the certificate, including the
corporate seal may be facsimiles. If such certificate is
countersigned (1) by a transfer agent other than the
Company or its employee, or (2) by a registrar other than
the Company or its employee, any or all of the signatures on the
certificate, including the certificate of the transfer agent and
registrar, and the corporate seal may be facsimiles. In case any
officer or officers who shall have signed, or whose facsimile
signature or signatures shall have been used on, any such
certificate or certificates shall cease to be such officer or
officers of the Company, whether because of death, resignation
or otherwise, before such certificate or certificates shall have
been delivered by the Company, such certificate or certificates
may nevertheless be adopted by the Company and be issued and
delivered as though the person or persons who signed such
certificate or whose facsimile signature shall have been used
thereon had not ceased to be such officer or officers of the
Company.
77
5.2. Fractional Share
Interests. The Company may, but shall not
be required to, issue fractions of a share. If the Company does
not issue fractions of a share, it shall (i) arrange for
the disposition of fractional interests by those entitled
thereto, (ii) pay in cash the fair value of fractions of a
share as of the time when those entitled to receive such
fractions are determined, or (iii) issue scrip or warrants
in registered or bearer form that shall entitle the holder to
receive a certificate for a full share upon the surrender of
such scrip or warrants aggregating a full share. A certificate
for a fractional share shall or an uncertificated fractional
share shall, but scrip or warrants shall not unless otherwise
provided therein, entitle the holder to exercise voting rights,
to receive dividends thereon, and to participate in any of the
assets of the Company in the event of liquidation. The Board of
Directors may cause scrip or warrants to be issued subject to
the conditions that they shall become void if not exchanged for
certificates representing full shares or uncertificated full
shares before a specified date, or subject to the conditions
that the shares for which scrip or warrants are exchangeable may
be sold by the Company and the proceeds thereof distributed to
the holders of scrip or warrants, or subject to any other
conditions that the Board of Directors may impose.
5.3. Transfers of
Stock. Subject to any transfer
restrictions then in force, the shares of stock of the Company
shall be transferable only upon its books by the holders thereof
in person or by their duly authorized attorneys or legal
representatives and upon such transfer the old certificates, if
any, shall be surrendered to the Company by the delivery thereof
to the person in charge of the stock and transfer books and
ledgers or to such other person as the directors may designate
by whom they shall be canceled and new certificates, if any,
shall thereupon be issued. The Company shall be entitled to
treat the holder of record of any share or shares of stock as
the holder in fact thereof and accordingly shall not be bound to
recognize any equitable or other claim to or interest in such
share on the part of any other person whether or not it shall
have express or other notice thereof save as expressly provided
by the laws of Delaware.
5.4. Record Date. For the
purpose of determining the stockholders entitled to notice of or
to vote at any meeting of stockholders or any adjournment
thereof, or entitled to receive payment of any dividend or other
distribution or the allotment of any rights, or entitled to
exercise any rights in respect of any change, conversion, or
exchange of stock or for the purpose of any other lawful action,
the Board of Directors may fix, in advance, a record date, which
shall not precede the date upon which the resolution fixing the
record date is adopted by the Board of Directors, that shall not
be more than sixty (60) days nor less than ten
(10) days before the date of such meeting, nor more than
sixty (60) days prior to any other action. If no such
record date is fixed by the Board of Directors, the record date
for determining stockholders entitled to notice of or to vote at
a meeting of stockholders shall be at the close of business on
the day next preceding the day on which notice is given, or, if
notice is waived, at the close of business on the day next
preceding the day on which the meeting is held; and the record
date for determining stockholders for any other purpose shall be
at the close of business on the day on which the Board of
Directors adopts the resolution relating thereto. A
determination of stockholders of record entitled to notice of or
to vote at any meeting of stockholders shall apply to any
adjournment of the meeting; provided, however, that the Board of
Directors may fix a new record date for the adjourned meeting.
5.5. Transfer Agent and
Registrar. The Board of Directors may
appoint one or more transfer agents or transfer clerks and one
or more registrars and may require all certificates of stock to
bear the signature or signatures of any of them.
5.6. Dividends.
|
|
|
| |
(a)
|
Power to Declare. Dividends upon the
capital stock of the Company, subject to the provisions of the
Charter, if any, may be declared by the Board of Directors at
any regular or special meeting, pursuant to law. Dividends may
be paid in cash, in property, or in shares of the capital stock,
subject to the provisions of the Charter and the laws of
Delaware.
|
| |
| |
(b)
|
Reserves. Before payment of any
dividend, there may be set aside out of any funds of the Company
available for dividends such sum or sums as the directors from
time to time, in their absolute discretion, think proper as a
reserve or reserves to meet contingencies, or for equalizing
dividends, or for repairing or maintaining any property of the
Company, or for such other purpose as the directors shall think
conducive to the interest of the Company, and the directors may
modify or abolish any such reserve in the manner in which it was
created.
|
5.7. Lost, Stolen, or Destroyed
Certificates. No certificates for shares
of stock of the Company shall be issued in place of any
certificate alleged to have been lost, stolen, or destroyed,
except upon production of such evidence of the loss, theft, or
destruction and upon indemnification of the Company and its
agents to such extent and in such manner as the Board of
Directors may from time to time prescribe.
78
ARTICLE VI
MISCELLANEOUS
MANAGEMENT PROVISIONS
6.1. Checks, Drafts, and
Notes. All checks, drafts, or orders for
the payment of money, and all notes and acceptances of the
Company shall be signed by such officer or officers, or such
agent or agents, as the Board of Directors may designate.
6.2. Notices.
|
|
|
| |
(a)
|
Notices to directors may, and notices to stockholders shall, be
in writing and (i) delivered personally, (ii) mailed
to the directors or stockholders at their addresses appearing on
the books of the Company or (iii) delivered by a form of
electronic transmission which is consented to by the stockholder
or the director to whom the notice is given. Notice by mail
shall be deemed to be given at the time when the same shall be
mailed. Notice by electronic transmission shall be deemed to be
given (i) if by facsimile telecommunication, when directed
to a number at which the stockholder or the director has
consented to receive notice, (ii) if by electronic mail,
when directed to an electronic mail address at which the
stockholder or the director has consented to receive notice,
(iii) if a posting on an electronic network together with a
separate notice to the stockholder or the director of such
specified posting, upon the later of (A) such posting and
(B) the giving of such separate notice and (iv) if by
any other form of electronic transmission, when directed to the
stockholder or the director. Notice to directors may also be
given by telegram, telecopy, email or orally, by telephone or in
person.
|
| |
| |
(b)
|
Whenever any notice is required to be given under the provisions
of any applicable statute or of the Charter or of these by-laws,
a waiver of notice, given by the person or persons entitled to
said notice, or a waiver of notice by electronic transmission by
the person or persons entitled to said notice, whether before or
after the time stated therein or the meeting or action to which
such notice relates, shall be deemed equivalent to notice.
Attendance of a person at a meeting shall constitute a waiver of
notice of such meeting except when the person attends a meeting
for the express purpose of objecting, at the beginning of the
meeting, to the transaction of any business because the meeting
is not lawfully called or convened.
|
6.3. Conflict of
Interest. No contract or transaction
between the Company and one or more of its directors or
officers, or between the Company and any other corporation,
partnership, association, or other organization in which one or
more of its directors or officers are directors or officers, or
have a financial interest, shall be void or voidable solely for
this reason, or solely because the director or officer is
present at or participates in the meeting of the Board of
Directors or board committee that authorized the contract or
transaction, or solely because his or their votes are counted
for such purpose, if: (i) the material facts as to the
director’s or officer’s relationship or interest and
as to the contract or transaction are disclosed or are known to
the Board of Directors or the committee and the board or
committee in good faith authorizes the contract or transaction
by the affirmative vote of a majority of the disinterested
directors, even though the disinterested directors be less than
a quorum; or (ii) the material facts as to the
director’s or officer’s relationship or interest and
as to the contract or transaction are disclosed or are known to
the stockholders of the Company entitled to vote thereon, and
the contract or transaction is specifically approved in good
faith by vote of such stockholders; or (iii) the contract
or transaction is fair as to the Company as of the time it is
authorized, approved, or ratified, by the Board of Directors, a
committee or the stockholders. Common or interested directors
may be counted in determining the presence of a quorum at a
meeting of the Board of Directors or of a committee that
authorizes the contract or transaction.
6.4. Voting of Securities owned by the
Company. Subject always to the specific
directions of the Board of Directors, (i) any shares or
other securities issued by any other corporation and owned or
controlled by the Company may be voted in person at any meeting
of security holders of such other corporation by the Chief
Executive Officer or the President of the Company if he is
present at such meeting, or in his absence by the Treasurer or
the Secretary of the Company if he is present at such meeting,
and (ii) whenever, in the judgment of the Chief Executive
Officer or President, it is desirable for the Company to execute
a proxy or written consent in respect to any shares or other
securities issued by any other corporation and owned by the
Company, such proxy or consent shall be executed in the name of
the Company by the Chief Executive Officer or President, without
the necessity of any authorization by the Board of Directors,
affixation of corporate seal or countersignature or attestation
by another officer, provided that if the Chief Executive Officer
or President is unable to execute such proxy or consent by
reason of sickness, absence from the United States or other
similar cause, the Treasurer, the Secretary or any other officer
authorized by the Board of Directors may execute such proxy or
79
consent. Any person or persons designated in the manner above
stated as the proxy or proxies of the Company shall have full
right, power and authority to vote the shares or other
securities issued by such other corporation and owned by the
Company the same as such shares or other securities might be
voted by the Company.
ARTICLE VII
INDEMNIFICATION
7.1. Right to
Indemnification. Each person who was or
is made a party or is threatened to be made a party to or is
otherwise involved in any action, suit or proceeding, whether
civil, criminal, administrative or investigative (a
“Proceeding”), by reason of being or having
been a director or officer of the Company or serving or having
served at the request of the Company as a director, trustee,
officer, employee or agent of another corporation or of a
partnership, joint venture, trust or other enterprise, including
service with respect to an employee benefit plan (an
“Indemnitee”), whether the basis of such
proceeding is alleged action or failure to act in an official
capacity as a director, trustee, officer, employee or agent or
in any other capacity while serving as a director, trustee,
officer, employee or agent, shall be indemnified and held
harmless by the Company to the fullest extent authorized by the
DGCL, as the same exists or may hereafter be amended (but, in
the case of any such amendment, only to the extent that such
amendment permits the Company to provide broader indemnification
rights than permitted prior thereto) (as used in this
Article VII, the “Delaware Law”), against
all expense, liability and loss (including attorneys’ fees,
judgments, fines, ERISA excise taxes or penalties and amounts
paid in settlement) reasonably incurred or suffered by such
Indemnitee in connection therewith and such indemnification
shall continue as to an Indemnitee who has ceased to be a
director, trustee, officer, employee, or agent and shall inure
to the benefit of the Indemnitee’s heirs, executors, and
administrators; provided, however, that, except as provided in
Section 7.2 hereof with respect to Proceedings to enforce
rights to indemnification, the Company shall indemnify any such
Indemnitee in connection with a Proceeding (or part thereof)
initiated by such Indemnitee only if such Proceeding (or part
thereof) was authorized by the Board of Directors of the
Company. The right to indemnification conferred in this
Article VII shall be a contract right and shall include the
right to be paid by the Company the expenses (including
attorneys’ fees) incurred in defending any such Proceeding
in advance of its final disposition (an “Advancement of
Expenses”); provided, however, that, if the Delaware
Law so requires, an Advancement of Expenses incurred by an
Indemnitee shall be made only upon delivery to the Company of an
undertaking (an “Undertaking”), by or on behalf
of such Indemnitee, to repay all amounts so advanced if it shall
ultimately be determined by final judicial decision from which
there is no further right to appeal (a “Final
Adjudication”) that such Indemnitee is not entitled to
be indemnified for such expenses under this Article VII or
otherwise.
7.2. Right of Indemnitee to Bring
Suit. If (a) a claim for
indemnification under Section 7.1 hereof (following the
final disposition of such Proceeding) is not paid in full by the
Company within sixty (60) days after a written claim has
been received by the Company, or (b) a claim for an
Advancement of Expenses under Section 7.1 hereof is not
paid in full by the Company within twenty (20) days after
the written claim has been received by the Company, the
Indemnitee may at any time thereafter bring suit against the
Company to recover the unpaid amount of the claim. If successful
in whole or in part in any such suit, or in a suit brought by
the Company to recover an Advancement of Expenses pursuant to
the terms of an Undertaking, the Indemnitee shall be entitled to
be paid also the expense of prosecuting or defending such suit
to the fullest extent permitted by law. In (i) any suit
brought by the Indemnitee to enforce a right to indemnification
hereunder (but not in a suit brought by the Indemnitee to
enforce a right to an Advancement of Expenses) it shall be a
defense that, and (ii) in any suit by the Company to
recover an Advancement of Expenses pursuant to the terms of an
Undertaking the Company shall be entitled to recover such
expenses upon a Final Adjudication that, the Indemnitee has not
met the applicable standard of conduct set forth in the Delaware
Law. Neither the failure of the Company (including its Board of
Directors, independent legal counsel, or its stockholders) to
have made a determination prior to the commencement of such suit
that indemnification of the Indemnitee is proper in the
circumstances because the Indemnitee has met the applicable
standard of conduct set forth in the Delaware Law, nor an actual
determination by the Company (including its Board of Directors,
independent legal counsel, or its stockholders) that the
Indemnitee has not met such applicable standard of conduct,
shall create a presumption that the Indemnitee has not met the
applicable standard of conduct or, in the case of such a suit
brought by the Indemnitee, be a defense to such suit. In any
suit brought by the Indemnitee to enforce a right to
indemnification or to an Advancement of Expenses hereunder, or
by the Company to recover an Advancement of Expenses pursuant to
the terms of an Undertaking, the burden of proving that the
Indemnitee is not entitled to be indemnified, or to such
Advancement of Expenses, under this Article VII or
otherwise shall be on the Company.
80
7.3. Non-Exclusivity of
Rights. The rights to indemnification and
to the Advancement of Expenses conferred in this
Article VII shall not be exclusive of any other right that
any person may have or hereafter acquire under any statute, the
Charter, by-law, agreement, vote of stockholders or
disinterested directors or otherwise.
7.4. Insurance. The Company
may maintain insurance, at its expense, to protect itself and
any director, officer, employee or agent of the Company or
another corporation, partnership, joint venture, trust or other
enterprise against any expense, liability or loss, whether or
not the Company would have the power to indemnify such person
against such expense, liability or loss under this
Article VII or under the Delaware Law.
7.5. Indemnification of Employees and Agents of
the Company. The Company may, to the
extent authorized from time to time by the Board of Directors,
grant rights to indemnification, and to the Advancement of
Expenses, to any employee or agent of the Company or any of its
subsidiaries to the fullest extent of the provisions of this
Article VII with respect to the indemnification and
Advancement of Expenses of directors and officers of the Company.
7.6. Amendment or
Repeal. Any repeal or modification of the
provisions of this Article VII shall not adversely affect
any right or protection hereunder of any Indemnitee in respect
of any proceeding (regardless of when such proceeding is first
threatened, commenced or completed) arising out of, or related
to, any act or omission occurring prior to the time of such
repeal or modification.
ARTICLE VIII
AMENDMENTS
8.1. Amendments. The
by-laws of the Company may be altered, amended or repealed by
the Board of Directors or by the stockholders at any meeting of
the stockholders by the vote of the holders of the majority of
the stock issued and outstanding and entitled to vote at such
meeting, in accordance with the provisions of the Charter and
the laws of Delaware.
81
EXHIBIT E —
SECTION 190 OF THE CANADA BUSINESS CORPORATIONS
ACT
Right to
Dissent
|
|
| (1) |
Subject to sections 191 and 241, a holder of shares of any
class of a corporation may dissent if the corporation is subject
to an order under paragraph 192(4)(d) that affects the
holder or if the corporation resolves to
|
|
|
|
| |
(a)
|
amend its articles under section 173 or 174 to add, change
or remove any provisions restricting or constraining the issue,
transfer or ownership of shares of that class;
|
| |
| |
(b)
|
amend its articles under section 173 to add, change or
remove any restriction on the business or businesses that the
corporation may carry on;
|
| |
| |
(c)
|
amalgamate otherwise than under section 184;
|
| |
| |
(d)
|
be continued under section 188;
|
| |
| |
(e)
|
sell, lease or exchange all or substantially all its property
under subsection 189(3); or
|
| |
| |
(f)
|
carry out a going-private transaction or a squeeze-out
transaction.
|
Further
Right
|
|
| (2) |
A holder of shares of any class or series of shares entitled to
vote under section 176 may dissent if the corporation
resolves to amend its articles in a manner described in that
section.
|
If one
class of shares
|
|
| (2.1) |
The right to dissent described in subsection (2) applies
even if there is only one class of shares.
|
Payment
for Shares
|
|
| (3) |
In addition to any other right the shareholder may have, but
subject to subsection (26), a shareholder who complies with this
section is entitled, when the action approved by the resolution
from which the shareholder dissents or an order made under
subsection 192(4) becomes effective, to be paid by the
corporation the fair value of the shares in respect of which the
shareholder dissents, determined as of the close of business on
the day before the resolution was adopted or the order was made.
|
No
Partial Dissent
|
|
| (4) |
A dissenting shareholder may only claim under this section with
respect to all the shares of a class held on behalf of any one
beneficial owner and registered in the name of the dissenting
shareholder.
|
Objection
|
|
| (5) |
A dissenting shareholder shall send to the corporation, at or
before any meeting of shareholders at which a resolution
referred to in subsection (1) or (2) is to be voted
on, a written objection to the resolution, unless the
corporation did not give notice to the shareholder of the
purpose of the meeting and of their right to dissent.
|
Notice of
Resolution
|
|
| (6) |
The corporation shall, within ten days after the shareholders
adopt the resolution, send to each shareholder who has filed the
objection referred to in subsection (5) notice that the
resolution has been adopted, but such notice is not required to
be sent to any shareholder who voted for the resolution or who
has withdrawn their objection.
|
Demand
for Payment
|
|
| (7) |
A dissenting shareholder shall, within twenty days after
receiving a notice under subsection (6) or, if the
shareholder does not receive such notice, within twenty days
after learning that the resolution has been adopted, send to the
corporation a written notice containing
|
|
|
|
| |
(a)
|
the shareholder’s name and address;
|
| |
| |
(b)
|
the number and class of shares in respect of which the
shareholder dissents; and
|
| |
| |
(c)
|
a demand for payment of the fair value of such shares.
|
82
EXHIBIT F —
PROXY CARDS
OPPENHEIMER
HOLDINGS INC.
Class B
Voting Shares
Proxy, Solicited by Management, for the
Annual and Special Meeting of Shareholders,
May 8, 2009
The undersigned holder of Class B voting shares of
Oppenheimer Holdings Inc. hereby appoints Mr. A.G.
Lowenthal or, failing him, Ms. E.K. Roberts or instead of
either of them
as nominee, with full power of substitution, to attend, vote and
otherwise act for the undersigned at the Annual and Special
Meeting of Shareholders to be held on May 8, 2009 and at
any adjournment thereof to the same extent and with the same
power as if the undersigned were personally present at the said
Meeting or adjournment or adjournments thereof and hereby
revokes any proxy previously given; provided that the
undersigned shareholder specifies and directs the persons above
named that the Class B voting shares registered in the name
of the undersigned shall be:
(or if no specification is made, VOTED FOR) for the change in
jurisdiction of the Corporation to Delaware and the approval of
the Delaware Certificate of Incorporation (Proposal 1 in
the Notice of Meeting)
|
|
| 2. |
VOTED
FOR □ WITHHELD
FROM
VOTING □
|
(or if no specification is made, VOTED FOR) for the election of
directors. (Proposal 2 in the Notice of Meeting).
|
|
| 3. |
VOTED
FOR □ WITHHELD
FROM
VOTING □
|
(or if no specification is made, VOTED FOR) for the appointment
of PricewaterhouseCoopers LLP as auditors and authorizing the
Board of Directors and the Audit Committee to fix the
remuneration of the auditors. (Proposal 3 in the Notice of
Meeting).
DATED ,
2009
| |
|
|
|
|
|
|
|
|
|
Signature of Shareholder
|
|
|
|
|
|
|
|
A Class B Shareholder has the
right to appoint a person, who need not be a Class B
Shareholder, to represent the Class B Shareholder at the Meeting
other than the persons designated herein. To exercise this right
a Class B Shareholder may insert the name of the desired person
in the blank space provided herein or may submit another form of
proxy.
|
|
|
|
|
|
|
|
If any amendments or variations
to Proposal 1 in the Notice of the Meeting are proposed at the
Meeting, this proxy confers discretionary authority to vote on
such amendments or variations according to the best judgment of
the person voting the proxy at the Meeting.
|
|
|
|
|
|
|
|
NOTES:
|
|
|
|
(1) Please date and sign the form of
proxy exactly as your name appears on this form of proxy. If a
shareholder is a corporation the form of proxy must be executed
under its corporate seal or by an officer or attorney thereof
duly authorized.
|
85